Removable embolus blood clot filter

Information

  • Patent Grant
  • 11554006
  • Patent Number
    11,554,006
  • Date Filed
    Monday, June 22, 2020
    3 years ago
  • Date Issued
    Tuesday, January 17, 2023
    a year ago
Abstract
A removable blood clot filter includes a number of locator members and anchor members disposed radially and extending angularly downward from a hub. The locator members include a number of linear portions having distinct axes configured to place a tip portion approximately parallel to the walls of a blood vessel when implanted to apply sufficient force to the vessel walls to position the filter near the vessel centerline. The anchor members each include a hook configured to penetrate the vessel wall to prevent longitudinal movement due to blood flow. The hooks may have a cross section sized to allow for a larger radius of curvature under strain so that the filter can be removed without damaging the vessel wall.
Description
FIELD OF THE INVENTION

This invention relates to a filter device that can be placed in a blood vessel to reduce the risk of embolisms and, if needed, removed from the blood vessel without causing traumatic damage to the blood vessel.


BACKGROUND OF THE INVENTION

In recent years, a number of medical devices have been designed which are adapted for compression into a small size to facilitate introduction into a vascular passageway and which are subsequently expandable into contact with the walls of the passageway. These devices, among others, include blood clot filters which expand and are held in position by engagement with the inner wall of a vein, such as the vena cava. These vena cava filters are designed to remain in place permanently. Such filters include structure to anchor the filter in place within the vena cava, such as elongate diverging anchor members with hooked ends that penetrate the vessel wall and positively prevent migration in either direction longitudinally of the vessel. The hooks on filters of this type are rigid and will not bend, and within two to six weeks after a filter of this type has been implanted, the endothelium layer grows over the diverging anchor members and positively locks the hooks in place. Now any attempt to remove the filter results in a risk of injury to or rupture of the vena cava.


A number of conditions and medical procedures subject the patient to a short term risk of pulmonary embolism which can be alleviated by a filter implant. In such cases, patients are often averse to receiving a permanent implant, for the risk of pulmonary embolism may disappear after a period of several weeks or months. However, most existing filters are not easily or safely removable after they have remained in place for more than several weeks, and consequently longer-term temporary filters that do not result in the likelihood of injury to the vessel wall upon removal are not available.


In an attempt to provide a removable filter, two filter baskets have been formed along a central shaft that are conical in configuration, with each basket being formed by spaced struts radiating outwardly from a central hub for the basket. The central hubs are held apart by a compression unit, and the locator members of the two baskets overlap so that the baskets face one another. Filters of this type require the use of two removal devices inserted at each end of the filter to draw the baskets apart and fracture the compression unit. The end sections of the locator members are formed to lie in substantially parallel relationship to the vessel wall and the tips are inclined inwardly to preclude vessel wall penetration. If a device of this type is withdrawn before the endothelium layer grows over the locator members, vessel wall damage is minimized. However, after growth of the endothelium layer the combined inward and longitudinal movement of the filter sections as they are drawn apart can tear this layer.


SUMMARY OF THE INVENTION

The various embodiments provide for a removable blood filter that allows for filtering of an embolus in a blood vessel by utilizing a plurality of locators and a plurality of anchors. In one aspect, a filter to be placed in a flow of blood through a vessel includes a hub, at least one anchor, and at least one locator. The hub can be disposed along a longitudinal axis. The at least one anchor projects from the hub and includes a hook that penetrates a wall of the blood vessel when the filter is placed in the blood vessel. The hook can be spaced along the longitudinal axis from the hub and spaced a first radial distance from longitudinal axis. The at least one locator has a tip or portion of the locator that engages the wall of the vessel. The tip can be spaced along the longitudinal axis from the hub and spaced a second radial distance from the longitudinal axis. The second radial distance can be less than the first radial distance. The at least one locator has at least four portions and each of the portions can be disposed on respective distinct axes.


In yet another aspect, the various embodiments also provide for a filter to be placed in a flow of blood through a vessel. The filter includes a hub, at least one anchor, and at least one locator. The hub can be disposed along a longitudinal axis. The at least one anchor projects from the hub and includes a hook that penetrates a wall of the blood vessel when the filter is placed in the blood vessel. The hook can be spaced along the longitudinal axis from the hub and spaced a first radial distance from the longitudinal axis. The at least one locator projects from the hub and has a tip or portion of the locator that engages the wall of the vessel. The tip can be spaced along the longitudinal axis from the hub and spaced a second radial distance from the longitudinal axis where the second radial distance can be less than the first radial distance. The locator can be disposed proximate the hub and has at least four portions, and each of the at least four portions can be disposed on respective distinct axes. The at least four portions can include a curved portion being disposed on a radius of curvature that extends along the longitudinal axis.


In yet a further aspect of the various embodiments, a filter is provided to be placed in a flow of blood through a vessel. The filter includes a hub, at least one anchor and at least one locator. The hub can be disposed along a longitudinal axis. The at least one anchor projects from the hub and includes a hook that penetrates a wall of the blood vessel when the filter is placed in the blood vessel, spaced along the longitudinal axis from the hub, and spaced a first radial distance from longitudinal axis. The at least one locator projects from the hub and has a tip or portion of the locator that engages the wall of the vessel. The tip can be spaced along the longitudinal axis from the hub, and spaced a second radial distance from the longitudinal axis, where the second radial distance can be less than the first radial distance. The locator has a first portion distal to the hub and a second portion proximal to the hub. Each of the first and second portions can be generally linear and disposed on distinct axes oblique with respect to the longitudinal axis, where the length of the first portion can be greater than a length of the second portion.


In yet an additional aspect of the various embodiments, a filter is provided to be placed in a flow of blood through a vessel. The filter includes a hub, at least one anchor and at least one locator. The hub can be disposed along a longitudinal axis. The at least one anchor projects from the hub and includes a hook that penetrates a wall of the blood vessel, spaced along the longitudinal axis from the hub, and spaced a first radial distance from the longitudinal axis. The at least one locator projects from the hub and has a tip or portion of the locator that engages the wall of the vessel. The tip can be spaced along the longitudinal axis from the hub, and spaced a second radial distance from the longitudinal axis, where the second radial distance can be less than the first radial distance. The locator has first and second portions oblique to the longitudinal axis. The first portion can be distal to the hub, and a second portion can be proximal to the hub, where a length of the first portion being greater than a length of the second portion.


In yet another aspect of the various embodiments, a filter is provided to be placed in a blood vessel that includes a blood vessel wall. The filter includes a hub, and a first and a second set of members. The hub can be disposed along a longitudinal axis. Each of the first set of members extends from the hub. Each of the first set of members includes a hook spaced along the longitudinal axis from the hub, each hook being spaced radially from the longitudinal axis a first distance. Each of the second set of members extends from the hub and includes a tip being spaced along the longitudinal axis from the hub. Each tip can be spaced radially from the longitudinal axis a second distance less than the first distance.


In yet a further aspect of the various embodiments, a filter to be placed in a blood vessel is provided. The filter includes a hub, a plurality of anchors and a plurality of locators. The hub can be disposed along a longitudinal axis. The plurality of anchors branches from the hub. Each anchor includes a hook that: (i) penetrates a wall of the blood vessel, (ii) can be spaced along the longitudinal axis from the hub, and (iii) can be radially spaced from the longitudinal axis a first distance. The plurality of locators branches from the hub. Each locator includes a base portion proximate the hub, a first portion that extends from the base portion and along a first axis, a second portion that extends from the first portion and along a second axis, which can be distinct from the first axis, and a tip portion that extends from the second portion and along a tip axis, which can be distinct from the first and second axes. The tip portion (i) engages the wall of the blood vessel, (ii) can be spaced along the longitudinal axis from the hub, and (iii) can be radially spaced from the longitudinal axis a second distance, which can be less than the first radial distance.


In yet a further aspect of the various embodiments, a filter to be placed in a blood vessel is provided. The filter includes a hub, a plurality of anchors and a plurality of locators. The hub can be disposed along a longitudinal axis. The plurality of anchors branches from the hub. Each anchor includes a hook that: (i) penetrates a wall of the blood vessel, (ii) can be spaced along the longitudinal axis from the hub, and (iii) can be radially spaced from the longitudinal axis a first distance. The plurality of locators branches from the hub. Each locator includes a base portion proximate the hub, a tip portion that (i) can engage the wall of the blood vessel, (ii) can be spaced along the longitudinal axis from the hub, and (iii) can be radially spaced from the longitudinal axis a second distance, which can be less than the first radial distance, and an intermediate portion coupling the base and tip portion. The intermediate portion can include a first linear segment extending from the base portion a first length along a first axis, which can be oblique with respect to the longitudinal axis and a second linear segment extending between the tip portion and first portions a second length, which can be greater than the first length, and along a second axis, which can be oblique respect to the longitudinal axis and can be distinct from the first axis.


In yet another aspect of the various embodiments, a filter is provided. The filter is to be placed in a flow of blood contained by a wall of a blood vessel. The filter includes a hub that extends along a longitudinal axis and at least one first member having first and second generally linear segments. The filter also includes at least one second member having third and fourth generally linear segments. The first segment defines a portion of a first cone when the first segment is rotated about the longitudinal axis. The second segment defines a cylinder when the second segment is rotated about the longitudinal axis. The third and fourth segments define respective portions of a third and fourth cones when each of the segments is rotated about the longitudinal axis. At least one of the third and fourth segments has a hook portion that penetrates the wall of a blood vessel.


In yet a further aspect of the various embodiments, a blood filter is provided to be placed in a flow of blood contained by a wall of a blood vessel. The filter includes a hub, at least one anchor and a plurality of locators. The hub can be disposed along a longitudinal axis extending generally parallel to the flow of blood. The at least one anchor includes a hook that penetrates the wall of the vessel. The at least one anchor defines a generator of a first conical shape about a longitudinal axis. The first conical shape includes: (i) an apex disposed proximate the hub, each anchor (ii) can be spaced along the longitudinal axis from the hub, and (iii) can be radially spaced from the longitudinal axis at a first distance. The plurality of locators branches from the hub and defines a first frustum having a geometric centroid along the longitudinal axis.


In yet another aspect, a filter is provided. The filter can be placed in a flow of blood contained by a wall of a blood vessel. The filter includes a hub, a plurality of anchors, and a plurality of locators. The hub can be disposed along a longitudinal axis. The plurality of anchors branches from the hub. Each anchor can include a hook that (i) penetrates a wall of the blood vessel, (ii) can be spaced along the longitudinal axis from the hub, and (iii) can be radially spaced from the longitudinal axis a first distance. The plurality of locators branches from the hub. Each locator includes a base portion extending arcuately from the hub. The base portion has a radius of curvature about a transverse axis located at a second distance generally radially from the longitudinal axis. Each of the locators has a tip contiguous to the wall of the vessel. A portion of the tip closest to the hub can be spaced at a third distance along the longitudinal axis from the hub and spaced a fourth radial distance from the longitudinal axis, the fourth radial distance being less than the third distance.


The various embodiments described above may further include a radio-opaque material on or as part of the filter hub. Also, the various embodiments described above may further include a bio-active agent incorporated with or as part of the filter.


The various embodiments further provide a method of centering a blood filtering device within a blood vessel having a plurality of locators extending from a hub to define a first volume and a plurality of anchors extending from the hub to define a second volume. The method can be achieved by enclosing more than 15 percent of the second volume in the first volume, and engaging a hook provided on each locator onto a wall of the blood vessel.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated herein and constitute part of this specification, illustrate presently preferred embodiments of the invention, and, together with the general description given above and the detailed description given below, serve to explain features of the invention.



FIG. 1 is a top down perspective view of a preferred embodiment of the blood filter.



FIG. 2 is a bottom up perspective view of the embodiment of FIG. 1.



FIG. 3 is a plan view of the filter of FIG. 1 on longitudinal axis A.



FIG. 4A is a side view of the filter viewed along view 4A-4A in FIG. 3.



FIG. 4B is a side view of one arm or locator member of the filter of FIG. 1.



FIG. 5A is a side view of the filter viewed along view 5A-5A in FIG. 3.



FIG. 5B is a side view of one locator member of the filter of FIG. 1.



FIG. 5C is a side view of an alternative locator arrangement having a retention member disposed on the locator.



FIG. 5D is a side view of another locator arrangement having a support member to reduce or prevent penetration of a blood vessel wall by the locator.



FIG. 6 is a close up side view of a hook of the anchor member for the filter of FIG. 1.



FIG. 7 is a shaded perspective view of a volume generated by the locator member outside of a hub as it rotates or sweeps around longitudinal axis A.



FIG. 8 is a shaded perspective view of a volume generated by the anchor member outside the hub as the anchor member is rotated or sweeps around the longitudinal axis A.



FIG. 9 illustrate the volume of the anchor member visible outside the volume of the locator member.



FIGS. 10-14 illustrate yet another preferred embodiment having a retrieving hook portion.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

The various embodiments will be described in detail with reference to the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts.


As used herein, the terms “about” or “approximately” for any numerical values or ranges indicates a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein. Also, as used herein, the terms “patient”, “host” and “subject” refer to any human or animal subject and are not intended to limit the systems or methods to human use, although use of the subject invention in a human patient represents a preferred embodiment.



FIGS. 1-14 illustrate the preferred embodiments. Referring to FIG. 1, a filter 100 is illustrated in a perspective view. The filter 100 includes a hub 10, locator member 20, and anchor member 30 that has a hook 40. The filter 100 can be made from a plurality of elongate wires, which are preferably metal, such as, for example, Elgiloy, and more preferably are a super elastic shape memory alloy, such as Nitinol. The wires are held together at the filter trailing end by a hub 10 by a suitable connection technique, such as, for example, welding, laser welding, or plasma welding or being bonded together. Preferably, the wires are plasma welded. As used herein, “wire” refers to any elongated member of narrow cross section, including rods, bars, tubes, wire and narrow sections cut from thin plate, and is not intended to limit the scope of the invention to elongated members of circular cross section, cut from wire stock or manufacture according to a particular method of metal forming.


The locator member 20 has a proximal locator end 20P and a distal locator end 20D. Similarly, the anchor member 30 has a proximal anchor end 30P and a distal anchor end 30D. The distal anchor end 30D can be provided, as shown in FIG. 6, with hook 40.


Referring to FIGS. 4A and 4B, the locator member 30 may be provided with a plurality of locator segments, preferably between 3 and 6 segments and more preferably four locator segments LS1, LS2, LS3, LS4. First locator segment LS1 may be a curved portion extending away from the hub in a first direction along the longitudinal axis A. In an embodiment, the second locator segment LS2 extends generally linearly along a second axis 110; third locator segment LS3 extends generally linearly along a third axis 120; and the fourth locator segment LS4 extends generally linearly along a fourth axis 130. In a preferred embodiment, the various axes A, 110, 120, 130, and 140 are distinct from one another in that each may intersect with one another but none of them are substantially collinear with each other.


The locator segment LS2 may be distinct from locator segment LS3 by virtue of a joint or bend LJ1. The locator segment LS3 may be distinct from locator segment LS4 via a join or bend LJ2. The joint or bend LJ1 or LJ2 can be viewed as a location formed by the intersection of the segments defining a radiused portion connecting any two segments.


The locators 20 may range from 3 to 12 locators. The filter embodiment illustrated in FIG. 4A includes six locators that are generally equiangularly spaced about axis A. In the embodiment illustrated in FIG. 4B, locator segment LS1 extends through an arc with a radius of curvature R1 whose center may be located along an axis orthogonal to axis A over a radially transverse distance d3 and over a longitudinal distance L4 as measured from a terminal surface 12 of the hub 10 along an axis generally parallel to the longitudinal axis A. The locator segment LS2 extends along axis 110 to form a first angle θ1 with respect to the longitudinal axis A whereas the locator segment LS3 extends along axis 120 to form second angle θ2. As shown in FIG. 4B, the first locator joint or bend LJ1 may be located at a longitudinal length L1 generally parallel to axis A from the terminal surface 12. The first locator joint or bend LJ1 may be also located at a distance of about one-half distance “d1” from axis A on a generally orthogonal axis with respect to axis A as shown in FIG. 4A, where the distance d1 is the distance between inside facing surfaces of respective diametrically disposed locators 20. The second locator joint LJ2 may be located over a longitudinal length L2 generally parallel to axis A. The second locator join LJ2 may be located over a distance of about one-half diameter “d2” from axis A. The distance d2 is the distance between the outermost surface of the fourth segment LS4 of respective diametrically disposed locators 20. The thickness of locator member 20 is t1. Where the locator member 20 is a wire of circular cross-section, the thickness t1 of the locator 20 may be the diameter of the wire.


A range of values may be used for the aforementioned dimensional parameters in order to provide locator members that will locate the filter within the vein or vessel in which the filter is to be applied in a manner that positions segment LS4 approximately parallel to the walls of the vein or vessel and provides sufficient lateral force against the vein or vessel wall to center the filter but not so much force as to cause injury to the wall. For example, a filter intended to be placed in a narrow vein or vessel, such as a human infant or canine vena cava, may have smaller dimensions L1, L2, L3, L4, LS1, LS2, LS3, LS4, d1 and d2 so that the positioning members can deploy sufficiently to accomplish the positioning and filtering functions, than a filter intended to be placed in a large vein or vessel, such as an adult human vena cava or other vessel. In an example embodiment suitable for an adult human vena cava filter, when the filter is at the temperature of the subject and unconstrained, the radius of curvature R1 is from about 0.02 inches to about 0.1 inches with the center of the radius R1 being located over a distance d3 from the axis A of about 0.1 inches and length L4 of about 0.2 inches; the length L1 is about 0.3 inches; length L2 is about 0.9 inches; distance d1 (as measured to the inside facing surfaces of diametrically disposed locators 20) is about 0.8 inches; distance d2 is about 1.5 inches, the first angle θ1 is about 58 degrees, the second angle θ2 is about 22 degrees; and the thickness t1 of the locator is about 0.013 inches. It should be noted that the values given herein are approximate, representing a dimension within a range of suitable dimensions for the particular embodiment illustrated in the figures, and that any suitable values can be used as long as the values allow the filter to function as intended in a blood vessel of a subject.


Referring to FIGS. 5A and 5B, the hub 10 can be provided with an internal cylindrical opening with a diameter of about two times the distance d8. Each of the plurality of anchor members 30 can be provided with a first anchor segment LA1, a portion of which is disposed within the hub 10, connected to a second anchor segment LA2 by a first anchor joint or bend AJ1, which can be connected to a third anchor segment LA3 via a second anchor joint or bend AJ2. The third anchor segment LA3 can be connected to the hook 40 via third anchor joint or bend AJ3. The first anchor segment LA1 extends obliquely with respect to axis A. The second anchor segment LA2 extends along axis 130 oblique with respect to the axis A over an angle θ3 with respect to the longitudinal axis A. The third anchor segment LA3 extends along axis 140 oblique with respect to the longitudinal axis A over an angle θ4. The second anchor joint or bend AJ2 can be located at a sixth longitudinal distance L6 as measured on an axis generally parallel to the axis A from the terminal surface 12 of the hub 10 and at about one half the fourth distance d4 as measured between generally diametrical end points of two anchors 30 on an axis generally orthogonal to the axis A. The third anchor joint AJ3 can be located at a seventh longitudinal distance L7 as measured along an axis generally parallel to axis A and at a transverse distance of about one-half distance d7 as measured on an axis orthogonal to the axis A between the inner surfaces of two generally diametric anchors 30. The thickness of anchor member 30 is nominally t2. Where the anchor member 30 is a wire of circular cross-section, the thickness t2 of the anchor 30 may be the diameter of the wire. As shown in FIG. 5B, the hook 40 may be contiguous to a plane located at a longitudinal distance of L10 as measured to the terminal surface 12 of hub 10. The hook 40 can be characterized by a radius of curvature R2, in its expanded configuration at a suitable temperature, e.g., room temperature or the internal temperature of a subject. The center of the hook curvature R2 can be located at a distance L11 as measured along an axis generally parallel to the axis A from the terminal surface 12 of hub 10 and at one-half distance d6 as measured between two generally diametrical hooks 40. The tips 40T of respective diametric hooks 40 may be located at longitudinal distance L12 (which may be approximately the same as longitudinal distance L7 to the third anchor joint AJ3) and at one half of distance d7 between diametric hooks 40.


A range of values may be used for the aforementioned dimensional parameters in order to provide anchor members that will locate and anchor the filter within the vein or vessel in which the filter is to be applied in a manner that positions hooks 40 in contact with the walls of the vein or vessel and provides sufficient lateral force against the vein or vessel wall to ensure the hooks engage the wall but not so much force as to cause injury to the wall. For example, a filter intended to be placed in a narrow vein or vessel, such as a child or dog vena cava, may have smaller dimensions so that the anchor members can deploy sufficiently to accomplish the positioning, anchoring and filtering functions, than a filter intended to be placed in a large vein or vessels, such as an adult vena cava or other vessel. In an example embodiment suitable for an adult human vena cava filter, when the filter is at the temperature of the subject and unconstrained, the longitudinal distance L8 is about 0.02 inches; L9 is about 0.2 inches; L10 is about 1.3 inches; L11 is about 1.2 inches; d6 is about 1.5 inches; d7 is about 1.6 inches; d8 is about 0.01 inches; d9 is between 1.5 and 1.6 inches; L12 is about 1.2 inches; the radius of curvature R2 is about 0.03 inches; and the thickness t2 of the anchor member is about 0.013 inches. Most preferably, a very small radius of curvature R3 can characterize anchor joint or bend AJ2 where R3 can be about 0.01 inches.


In situations where additional retention of the filter may be desired, an anchor member can be coupled to the locator. One arrangement is shown exemplarily in FIG. 5C, where a hook 22 can be coupled to the locator proximate the tip portion. In this arrangement, both the tip portion and hook 22 are configured so that the locator does not penetrate through the blood vessel wall by formation of a stop region 22a defined by both the locator tip and the hook 22. Another arrangement can be by coupling or forming a hook in the same configuration as hook 40 for the anchor members. In yet another arrangement, shown here in FIG. 5D, where it may not be desirable to utilize a hook, one or more stop members 24 can be provided on the locator at any suitable locations. As shown in FIG. 5D, the stop member 24 is in the form of a truncated cone coupled to the locator. However, the stop member 24 can be of any configuration as long as the member 24 reduces or prevents penetration of the locator through the blood vessel wall. And in yet a further arrangement, the hook 22 (or hook 40) can be utilized in combination with the stop member 24 such as for example, a hook 22 coupled to a first locator, a hook 40 coupled to a second locator, a stop member 24 on a third locator, a combination of hook 22 and stop member 24 on a fourth locator, a combination of hook 40 and stop member 24 on a fifth locator.


Referring to FIG. 6, the hook 40 can be provided with a proximal hook portion 40P and a distal hook portion 40D on which a sharpened tip 40T is provided. The hook 40 can be formed to have a thickness t3. Where the hook 40 is formed from a wire having a generally circular cross-section, the thickness t3 may be generally equal to the outside diameter of the wire. In an embodiment, the hook thickness t3 is approximately 0.5 to approximately 0.8 that of the anchor thickness t2. The wire can be configured to follow a radius of curvature R2 whose center is located at longitudinal distance L11 and radial distance d9 when the filter is at the temperature of a subject, as discussed above. The tip 40T can be provided with a generally planar surface 40D whose length can be approximately equal to length h1. The tip 40T may be located over a distance h2 from a plane tangential to the curved portion 40S.


Referring to FIG. 7, the locators 20 are illustrated has being bounded by a first compound surface of revolution SR1 about axis A by rotating one of the locators 20 about axis A for 360 degrees. The first compound surface of revolution SR1 includes a portion of a truncated hyperboloid H, first frustum F1, second frustum F2, and cylindrical surface C1. With reference to FIG. 8, the anchors 30 are illustrated as being bounded by a second compound surface of revolution SR2 about axis A by rotating one of the anchors 30 about axis A for 360 degrees. The second compound surface of revolution SR2 defined by the anchors 30 includes a third, fourth and fifth frustums F3, F4, and F5, respectively.


Several design parameters are believed to allow the preferred embodiments to achieve various advantages over the known filters. The various advantages include, for example, resisting migration of the filter 100 once installed, greater filter volume, and better concentricity with respect to the inner wall of the blood vessel. A number of design parameters may be adjusted to effect performance and fit characteristics of the filter, including, for example, the ratio of the volume V1 defined by the first surface of revolution SR1 to the volume V2 defined by the second surface of revolution SR2, which may be at least 0.92, preferably about 1.0, and most preferably about 0.99. Also, approximately 15% or more of the volume V2 may be surrounded by the volume V1, preferably at least 25% of the volume V2 may be surrounded by the volume V1, and most preferably, about 35% of the volume V2 may be surrounded by volume V1 so that the portion of volume V2 that is not surrounded by volume V1 (i.e., the volume of V1 outside the first volume V1), shown as volume V3 in FIG. 9, is about 0.4 cubic inches. Also, it has been discovered that, in the preferred embodiments, as the cross-sectional area of the hook is increased, the filter 100 tends to resist dislodgement when installed in a simulated blood vessel. Similarly, when the radius of curvature R2 is decreased, while keeping other parameters generally constant, the resistance to dislodgement in a simulated blood vessel is increased.


The material for the filter may be any suitable bio-compatible material such as, for example, polymer, memory polymer, memory metal, thermal memory material, metal, metal alloy, or ceramics. Preferably, the material may be Elgiloy, and most preferably Nitinol which is a thermal shape memory alloy.


The use of a shape memory material, such as Nitinol, for the locator and anchor members facilitates collapsing the filter radially inward from its normally expanded (i.e., unconstrained) configuration toward its longitudinal axis into a collapsed configuration for insertion into a body vessel. The properties of Nitinol allow the filter members to withstand enormous deformations (e.g. 8 times as much as stainless steel) without having any effect of the filter ability to recover to the pre-determined shape. This is due to the crystal phase transitions between rigid austenite and softer martensite. This phenomenon enables the implant to be loaded into a very small diameter sheath for delivery, which significantly reduces the trauma and complications to the insertion site.


Transition between the martensitic and austenitic forms of the material can be achieved by increasing or decreasing the material deformation above and below the transition stress level while the material remains above the transition temperature range, specifically Af. This is particularly important in the case of the hooks, as they may be deformed significantly (hence, becoming martensitic) while the filter is challenged by clots. The super-elastic properties will allow the hooks to re-assume their intended shape as soon as the load is released (e.g. the clot breaks down).


The hooks may be retrieved from the Inferior Vena Cava (“IVC”) wall during the filter removal when longitudinal force is applied to the hub 10 in the direction of the BF (i.e., towards the hub 10 of the filter). Under this concentrated stress, the hooks will straighten and transition to the martensitic state, thereby becoming super-elastic. Thus the hooks 40 are designed to bend toward a substantially straight configuration when a specific hook migration force is applied and spring back to their original shape once the hook migration force is removed.


Alternatively, a reduction in temperature below the Af temperature can be applied to the shape memory material to cause a change in the crystalline phase of the material so as to render the material malleable during loading or retrieval of the filter. Various techniques can be used to cause a change in crystalline phase such as, for example, cold saline, low temperature fluid or thermal conductor.


By virtue of the characteristics of thermal shape memory material, the locator and anchor members can be cooled below the martensitic-to-austenitic transition temperature, and then straightened and held in a collapsed, straight form that can pass through a length of fine plastic tubing with an internal diameter of approximately 2 millimeters (mm), e.g., a #8 French catheter. In its high temperature form (as in a mammalian body), the filter 10 recovers to a preformed filtering shape as illustrated by FIG. 1. Alternatively, the locator and/or anchor members may be made of wires of spring metal which can be straightened and compressed within a catheter or tube and will diverge into the filter shape of FIG. 1 when the tube is removed.


The deployed shapes and configurations of the filter members can be set (imprinted with a memory shape) by annealing the members at high temperature (e.g. approximately 500° C.) while holding them in the desired shape. Thereafter, whenever the filter is in the austenitic form (i.e., at a temperature above the martensitic-to-austenitic transition temperature or Af temperature), the members return to the memory shape. Example methods for setting the high-temperature shape of filters are disclosed in U.S. Pat. No. 4,425,908, the contents of which are hereby incorporated by reference in their entirety.


In the high-temperature form of the shape memory material, the filter has generally coaxial first and second filter baskets or sieves, each filter basket being generally symmetrical about the longitudinal axis of the filter with both filter baskets being concave relative to the filter leading end.


The sieve V2 formed by anchor members 30 is the primary filter and can be up to twelve circumferentially spaced anchor members 30. Six anchor members 30 are shown in the embodiment illustrated in the figures. The anchor members may be of equal length, but may be of different length so that the hooks 40 at the ends of the wires will fit within a catheter without becoming interconnected. The anchor members 30, in their expanded configuration illustrated in FIG. 1 (i.e., unconstrained in the high temperature form), are at a slight angle to the vessel wall, preferably within a range of from ten to forty-five degrees, while the hooks 40 penetrate the vessel wall to anchor the filter against movement. The anchor members 30 are radially offset relative to the locator members 20 and may be positioned radially halfway between the locator members 20 and also may be circumferentially spaced by sixty degrees of arc as shown in FIG. 3. The locator members 20 form sieve V1. Thus, the combined filter sieves V2 and V1 can provide a wire positioned radially about the hub 10, such as at every thirty degrees of arc at the maximum divergence of the filter sections. With reference to the direction of blood flow BF shown by the arrow in FIGS. 2 and 4A, in the illustrated embodiment, the filter section V2 forms a frustum toward the hub 10 of the filter 100 while the filter section V1 forms a generally frustum-like concave sieve with its geometric center proximate the terminal end 12 of the hub 10. In the preferred embodiments, the volume V1 of the surface SR1 may be between about 0.3 and about 1.1 cubic inches, preferably about 0.7 cubic inches and the volume V2 of the surface SR2 may be between about 0.3 and about 1.1 cubic inches, preferably about 0.7 cubic inches.


The structure of the hooks 40 is believed to be important in resisting migration of the filter once installed while allowing for removal from the blood vessel after installation. As in the case of hooks formed on the anchor members of known permanent vena cava filters, these hooks 40 penetrate the vessel wall when the filter 100 is expanded to anchor the filter in place and prevent filter migration longitudinally within the vessel in either direction. However, when the hooks 40 are implanted and subsequently covered by the endothelium layer, they and the filter can be withdrawn without risk of significant injury or rupture to the vena cava. Minor injury to the vessel wall due to hook withdrawal such as damage to the endothelial layer or local vena cava wall puncture is acceptable.


To permit safe removal of the filter, the juncture section 40S may be considerably reduced in cross section relative to the thickness t2 or cross section of the anchor member 30 and the remainder of the hook 40. The juncture section 40S can be sized such that it is of sufficient stiffness when the anchor members 30 are expanded to permit the hook 40 to penetrate the vena cava wall. However, when the hook is to be withdrawn from the vessel wall, withdrawal force in the direction of blood flow BF will cause flexure in the juncture section 40S so that the hook tip 40T moves toward a position parallel with the axis A (i.e., the hook straightens). With the hooks so straightened, the filter can be withdrawn without tearing the vessel wall while leaving only small punctures. In an embodiment, the anchor member 30 has a cross-sectional area of about 0.00013 squared inches, and the hook 40, particularly the curved junction section 40S has a cross-sectional area of about 0.000086 squared inches.


With reference to FIG. 6, it will be noted that the entire hook 40 can be formed with a cross section t3 throughout its length that is less than that of the locator 20 members (which have thickness t1) or anchor members 30 (which have thickness t2). As a result, an axial withdrawal force will tend to straighten the hook 40 over its entire length. This elasticity in the hook structure is believed to prevent the hook from tearing the vessel wall during withdrawal.


As previously indicated, while it is possible that the filter could be made from ductile metal alloys such as stainless steel, titanium, or Elgiloy, it is preferable to make it from Nitinol. Nitinol is a low modulus material that allows the locator and anchor members of the device 100 to be designed to have low contact forces and pressures while still achieving sufficient anchoring strength to resist migration of the device. The force required to cause opening of the hooks 40 can be modulated to the total force required to resist filter migration. This is accomplished by changing the cross sectional area or geometry of the hooks, or by material selection, as discussed above.


In addition to temperature sensitivity, when in the high temperature austenitic state, Nitinol is also subject to stress sensitivity that can cause the material to undergo a phase transformation from the austenitic to the martensitic state while the temperature of the material remains above the transition temperature. By reducing the cross sectional area of a portion or all of the hooks 40 relative to that of the anchor members 30 or locator members 20, stress will be concentrated in the areas of reduced cross section when longitudinal force is applied to the hub 10 in the direction of the BF (i.e., towards the hub 10 of the filter) such as to remove the filter. Under this concentrated stress, the reduced cross section portions of the hooks may transition to the martensitic state, thereby becoming elastic so that they straighten. Thus the hooks 40, whether formed of Nitinol, Elgiloy, spring metal or plastic, are designed to bend toward a substantially straight configuration when a specific hook migration force is applied and spring back to their original shape once the hook migration force is removed.


The force or stress that is required to deform the hooks 40 can be correlated to the force applied to each hook of the device when it is fully occluded and the blood pressure in the vessel is allowed to reach 50 millimeters of mercury (mm Hg) in a test stand. The test stand (not shown) can be configured to have a length of tubing (with various internal diameters) to allow a filter to be suitably attached thereto. The tubing is connected to another tubing having a terminal end exposed to ambient atmosphere and marked with gradations to indicate the amount of pressure differential across the filter, which is related to the force being applied to each anchor of the filter 100. This force is approximately at least 70 grams on each anchor of a six-anchor device for at least 50 millimeters Hg pressure differential in a 28 mm vessel. The desired total migration resistance force for the filter is believed to be approximately 420 grams for the embodiment of a vena cava filter for an adult human subject, and more anchor members 30 with hooks 40 can be added to lower maximum migration force for each hook. The load on the filter would be correspondingly smaller in vessels of smaller diameter. Preferably the hooks 40 perform as an anchoring mechanism at a predetermined filter migration resistance force within a range of about 10 mm Hg up to about 150-200 mm Hg. Having maintained its geometry at a predetermined filter migration resistance force within this range, the hook 40 preferably begins to deform in response to a higher force applied in the direction of the hub, i.e., the filter trailing end TE with respect to blood flow, and release at a force substantially less than that which would cause damage to the vessel tissue. It is the ability of the hook to straighten somewhat that allows for safe removal of the preferred embodiment filters from the vessel wall.


After the filter 100 has remained in place within a blood vessel for a period of time in excess of two weeks, the endothelium layer will grow over the hooks 40. However, since these hooks 40, when subjected to a withdrawal force in the direction of the hub (i.e., toward the trailing end TE) become substantially straight sections of wire oriented at a small angle to the vessel wall, the filter can be removed leaving only six pin point lesions in the surface of the endothelium. To accomplish this, a catheter such as, for example, the unit described and shown in U.S. Pat. No. 6,156,055, which is incorporated by reference herein, or similar retrieval unit is inserted over the hub 10 and into engagement with the locator members 20. While the hub 10 is held stationary, the catheter may be moved downwardly, forcing the locator members 20 to fold towards the axis A, and subsequently engaging the anchor members 30 and forcing them downwardly thereby withdrawing the hooks 40 from the endothelium layer. Then the hub 10 may be drawn into the catheter to collapse the entire filter 100 within the catheter. When the filter is formed from shape memory material, cooling fluid (e.g., chilled saline) may be passed through the catheter during these steps to aid in collapsing the filter.


The primary objective of the hooks 40 is to ensure that the filter does not migrate during normal respiratory function or in the event of a massive pulmonary embolism. Normal inferior vena cava (IVC) pressures are believed to be between about 2 mm Hg and about 8 mm Hg. An occluded IVC can potentially pressurize to 35 mmHg below the occlusion. To ensure filter stability, a 50 mm Hg pressure drop across the filter may therefore be chosen as the design criteria for the filter migration resistance force for the removable filter 100. When a removal pressure is applied to the filter that is greater than at least 50 millimeters Hg, the hooks 40 will deform and release from the vessel wall. The pressure required to deform the hooks can be converted to force by the following calculations.


Since 51.76 mm Hg=1.0 pounds per square inch (psi), 50 mm Hg=0.9668 psi


For a 28 mm vena cava:






A
=



π
4




(
28
)

2







mm
2


=


615.4






mm
2


=


0
.
9


539






inches
2








Migration force is calculated by:






P
=

F
A







F
=

P
×
A





0.9668 psi×0.9539 inches2=0.9223 pounds=418.7 grams


It should be noted that as the vena cava diameter increases so does the force required to resist at least 50 millimeters Hg of pressure.


Depending on the number of filter hooks, the strength of each can be calculated. For a device that has six hooks:











Hook





Strength

=




Filter





Migration





Resistance





Force


Number





of





Hooks








=




4

1


8
.
7


6







=



69.7





grams










In other words, each hook must be capable of resisting approximately at least 70 grams of force for the filter 100 to resist at least 50 millimeters Hg pressure gradient in a 28 mm vessel.


To prevent excessive vessel trauma each individual hook needs to be relatively weak. By balancing the number hooks and the individual hook strength, minimal vessel injury can be achieved while still maintaining the at least 50 millimeters Hg pressure gradient criteria, or some other predetermined pressure gradient criteria within a range of from 10 mmHg to 150 mm Hg.


Referring to FIG. 4A, the anchor members 30 may be angled outwardly from the anchor joint or bend AJ1 adjacent to but spaced from the outer end of each anchor member 30. When the anchor members 30 are released from compression in a catheter or other tube into a body vessel, this bend in each anchor member insures that the hooks 40 are, in effect, spring loaded in the tube and that they will not cross as they are deployed from the tube. Since the anchor members 30 angled outwardly from the shoulders 30, the hooks 40 are rapidly deployed outwardly as the insertion tube is withdrawn.


In another embodiment, bio-active agents can be incorporated with the blood filter, such as by way of a coating on parts of the filter, or dissolvable structures on, within or attached to the filter. Bio-active agent may be included as part of the filter in order to treat or prevent other conditions (such as infection or inflammation) associated with the filter, or to treat other conditions unrelated to the filter itself. More specifically, bio-active agents may include, but are not limited to: pharmaceutical agents, such as, for example, anti-proliferative/antimitotic agents including natural products such as vinca alkaloids (i.e. vinblastine, vincristine, and vinorelbine), paclitaxel, epidipodophyllotoxins (i.e. etoposide, teniposide), antibiotics (dactinomycin (actinomycin D) daunorubicin, doxorubicin and idarubicin), anthracyclines, mitoxantrone, bleomycins, plicamycin (mithramycin) and mitomycin, enzymes (L-asparaginase which systemically metabolizes L-asparagine and deprives cells which do not have the capacity to synthesize their own asparagine); antiplatelet agents such as G(GP) IIb/IIIa inhibitors and vitronectin receptor antagonists; anti-proliferative/antimitotic alkylating agents such as nitrogen mustards (mechlorethamine, cyclophosphamide and analogs, melphalan, chlorambucil), ethylenimines and methylmelamines (hexamethylmelamine and thiotepa), alkyl sulfonates-busulfan, nirtosoureas (carmustine (BCNU) and analogs, streptozocin), and trazenes-dacarbazinine (DTIC); anti-proliferative/antimitotic antimetabolites such as folic acid analogs (methotrexate), pyrimidine analogs (fluorouracil, floxuridine, and cytarabine), purine analogs and related inhibitors (mercaptopurine, thioguanine, pentostatin and 2-chlorodeoxyadenosine {cladribine}); platinum coordination complexes (cisplatin, carboplatin), procarbazine, hydroxyurea, mitotane, aminoglutethimide; hormones (i.e. estrogen); anti-coagulants (heparin, synthetic heparin salts and other inhibitors of thrombin); fibrinolytic agents (such as tissue plasminogen activator, streptokinase and urokinase), aspirin, dipyridamole, ticlopidine, clopidogrel, abciximab; antimigratory agents; antisecretory agents (e.g., breveldin); anti-inflammatory agents, such as adrenocortical steroids (cortisol, cortisone, fludrocortisone, prednisone, prednisolone, 6.alpha.-methylprednisolone, triamcinolone, betamethasone, and dexamethasone), non-steroidal agents (salicylic acid derivatives i.e. aspirin; para-aminophenol derivatives i.e. acetominophen; indole and indene acetic acids (indomethacin, sulindac, and etodalac), heteroaryl acetic acids (tolmetin, diclofenac, and ketorolac), arylpropionic acids (ibuprofen and derivatives), anthranilic acids (mefenamic acid, and meclofenamic acid), enolic acids (piroxicam, tenoxicam, phenylbutazone, and oxyphenthatrazone), nabumetone, gold compounds (auranofin, aurothioglucose, gold sodium thiomalate); immunosuppressives: (cyclosporine, tacrolimus (FK-506), sirolimus (rapamycin), azathioprine, mycophenolate mofetil); angiogenic agents, such as vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF); angiotensin receptor blockers; nitric oxide donors; anti-sense oligionucleotides and combinations thereof; cell cycle inhibitors, such as mTOR inhibitors, and growth factor receptor signal transduction kinase inhibitors; retenoids; cyclin/CDK inhibitors; HMG co-enzyme reductase inhibitors (statins); and protease inhibitors.


A filter delivery unit (not shown) such as, for example, the unit described in U.S. Pat. No. 6,258,026, which is incorporated by reference herein, is adapted to deliver the filter 100 through a catheter or delivery tube to a generally centered position within a blood vessel, as described in further detail in the above mentioned patent. Preferably, the delivery system may be the delivery system shown and described in U.S. Provisional Patent Application No. 60/706,596, entitled “Embolus Blood Clot Filter and Delivery System,” filed on Aug. 9, 2005, or the delivery system shown and described in a patent application that claims priority to the antecedent provisional patent application, PCT Patent Application No. PCT/US2006/017890 entitled “Embolus Blood Clot Filter and Delivery System” filed on May 9, 2006; and both applications are hereby incorporated by reference in their entirety into this application.


In an embodiment, a radio-opaque material can be incorporated in a portion of the filter, preferably the hub 10 of the filter. As used herein, a radio-opaque material is any material that is identifiable to machine or human readable radiographic equipment while the material is inside a mammal body, such as, by way of example but not by way of limitation, gold, tungsten, platinum, barium sulfate, or tantalum. The use of a radio-opaque material in the filter permits the clinician to locate the filter within a blood vessel of the subject using radiographic equipment. Radio-opaque material may be in the form of an additional structure added to the hub, such as a cap, sleeve, shim, wire or braze included around or in the hub assembly. Alternatively, the hub itself may be formed of a radio-opaque alloy.


Instead of a hub 10, as in the above described embodiments, a retrieving hook can be provided as part of filter device 200, as in the embodiment shown in FIG. 10. The filter device 200 includes a hub 210 with a retrieving hook 220. The hook 220 is configured for use by a snaring device to retrieve the filter 200 from a subject. Referring to FIGS. 11 and 12, the retrieving hook 220 can be formed as a monolithic member 230 with the hub 210 or as a separate member joined to the hub 210 by a suitable technique, such as, for example, EDM, laser welding, plasma welding, welding brazing, welding, soldering, or bonding. In a preferred embodiment, the member 230 can be a machined billet member with a blind bore 240 formed through a portion of the hub 210. The hook portion 220 includes ramped surfaces 250 and 260 that are believed to be advantageous in allowing the filter 200 to be retrieved without binding at the catheter opening due to an offset entry position of the filter 200. In other words, there may be circumstances during removal procedures where the axis 300 of the member 230 is not generally parallel or aligned with a longitudinal axis of the catheter retrieving device. In such cases, the greater the retention force, it is believed that the greater the likelihood of the hook being snagged on the catheter inlet opening thereby complicating the filter retrieval process. By virtue of the ramps 250 and 260, it is believed that binding or snagging is substantially reduced. In particular, as shown in FIGS. 13 and 14, the ramp 250 includes a radius of curvature R4 coupled to flat portions 252 and 254. The flat portion 254 can be coupled to a hook portion 256 which has a radiused surface R6. As shown in FIG. 13, the flat portion 252 is coupled to another radiused portion R7. It should be noted that the drawings provided herein are to scale relative to every part illustrated in each drawing.


A range of values may be used for the aforementioned dimensional parameters in order to provide a retrieval hook 230 that is capable of retaining portions of the locator and anchor members 20 and 30 within blind hole 240. For example, a smaller filter may have smaller dimensions so that the retrieval hook 230 does not present undue blockage in the vein, than a filter intended to be placed in a large vein or vessels, such as an adult vena cava or other vessel. Further, the retrieval hook 230 may be made from or include a radio-opaque material to allow a clinician to locate the hook within a subject using radiographic equipment, such as to aid in engaging the hook with a retrieval mechanism.


While the present invention has been disclosed with reference to certain preferred embodiments, numerous modifications, alterations, and changes to the described embodiments are possible without departing from the sphere and scope of the present invention, as defined in the appended claims. Accordingly, it is intended that the present invention not be limited to the described embodiments, but that it have the full scope defined by the language of the following claims, and equivalents thereof.


Referring to FIG. 7, the locators 20 are illustrated has being bounded by a first compound surface of revolution SR1 about axis A by rotating one of the locators 20 about axis A for 360 degrees. The first compound surface of revolution SR1 includes a portion of a truncated hyperboloid H, first frustum F1, second frustum F2, and cylindrical surface C1. With reference to FIG. 8, the anchors 30 are illustrated as being bounded by a second compound surface of revolution SR2 about axis A by rotating one of the anchors 30 about axis A for 360 degrees. The second compound surface of revolution SR2 defined by the anchors 30 includes a third, fourth and fifth frustums F3, F4, and F5, respectively.


Several design parameters are believed to allow the preferred embodiments to achieve various advantages over the known filters. The various advantages include, for example, resisting migration of the filter 100 once installed, greater filter volume, and better concentricity with respect to the inner wall of the blood vessel. A number of design parameters may be adjusted to effect performance and fit characteristics of the filter, including, for example, the ratio of the volume V1 defined by the first surface of revolution SR1 to the volume V2 defined by the second surface of revolution SR2, which may be at least 0.92, preferably about 1.0, and most preferably about 0.99. Also, approximately 15% or more of the volume V2 may be surrounded by the volume V1, preferably at least 25% of the volume V2 may be surrounded by the volume V1, and most preferably, about 35% of the volume V2 may be surrounded by volume V1 so that the portion of volume V2 that is not surrounded by volume V1 (i.e., the volume of V1 outside the first volume V1), shown as volume V3 in FIG. 9, is about 0.4 cubic inches. Also, it has been discovered that, in the preferred embodiments, as the cross-sectional area of the hook is increased, the filter 100 tends to resist dislodgement when installed in a simulated blood vessel. Similarly, when the radius of curvature R2 is decreased, while keeping other parameters generally constant, the resistance to dislodgement in a simulated blood vessel is increased.


Referring to FIG. 7, the locators 20 are illustrated has being bounded by a first compound surface of revolution SR1 about axis A by rotating one of the locators 20 about axis A for 360 degrees. The first compound surface of revolution SR1 includes a portion of a truncated hyperboloid H, first frustum F1, second frustum F2, and cylindrical surface C1. With reference to FIG. 8, the anchors 30 are illustrated as being bounded by a second compound surface of revolution SR2 about axis A by rotating one of the anchors 30 about axis A for 360 degrees. The second compound surface of revolution SR2 defined by the anchors 30 includes a third, fourth and fifth frustums F3, F4, and F5, respectively.


Several design parameters are believed to allow the preferred embodiments to achieve various advantages over the known filters. The various advantages include, for example, resisting migration of the filter 100 once installed, greater filter volume, and better concentricity with respect to the inner wall of the blood vessel. A number of design parameters may be adjusted to effect performance and fit characteristics of the filter, including, for example, the ratio of the volume V1 defined by the first surface of revolution SR1 to the volume V2 defined by the second surface of revolution SR2, which may be at least 0.92, preferably about 1.0, and most preferably about 0.99. Also, approximately 15% or more of the volume V2 may be surrounded by the volume V1, preferably at least 25% of the volume V2 may be surrounded by the volume V1, and most preferably, about 35% of the volume V2 may be surrounded by volume V1 so that the portion of volume V2 that is not surrounded by volume V1 (i.e., the volume of V1 outside the first volume V1), shown as volume V3 in FIG. 9, is about 0.4 cubic inches. Also, it has been discovered that, in the preferred embodiments, as the cross-sectional area of the hook is increased, the filter 100 tends to resist dislodgement when installed in a simulated blood vessel. Similarly, when the radius of curvature R2 is decreased, while keeping other parameters generally constant, the resistance to dislodgement in a simulated blood vessel is increased.

Claims
  • 1. A blood filter comprising: a) a hub;b) an anchor structure connected to the hub, said anchor structure having one or more anchor members diverging from a blood-filter longitudinal axis in an unconstrained state and configured to anchor the filter to a vessel wall;c) a locator structure, connected to the hub, having one or more locator members diverging from the blood-filter longitudinal axis in the unconstrained state and the locator members are configured to center the hub in the vessel; andd) each said locator member having multiple longer segments and a shorter segment that is shorter than any of said longer segments, said shorter segment being the farthest of said segments from the hub.
  • 2. The blood filter of claim 1 wherein the locator member comprises a first segment connected to the hub, a second segment connected to the first segment at an obtuse angle, and a third segment connected to the second segment at an obtuse angle.
  • 3. The blood filter of claim 2 wherein the anchor member comprises a hook configured to penetrate a vessel wall.
  • 4. The blood filter of claim 3 wherein the anchor member is configured to withstand 70 g of force directed parallel to the longitudinal axis.
  • 5. The blood filter of claim 2 wherein the locator member shorter segment is a tip portion connected to the third segment at an obtuse tip angle.
  • 6. The blood filter of claim 5 wherein the tip portion is configured to avoid injury to the vessel wall.
  • 7. The blood filter of claim 6 wherein the anchor member comprises a first anchor-segment connected to the hub and a second anchor-segment connected to the first anchor-segment at an obtuse angle.
  • 8. The blood filter of claim 7 wherein the anchor member comprises a hook configured to penetrate the vessel wall.
  • 9. The blood filter of claim 8 wherein the hook is offset with respect to an anchor member.
  • 10. The blood filter of claim 9 wherein the anchor member is configured to withstand 70 g of force directed parallel to the longitudinal axis.
  • 11. The blood filter of claim 6 wherein the anchor member is configured to withstand 70 g of force directed parallel to the longitudinal axis.
  • 12. The blood filter of claim 1 wherein each said anchor member comprises a first anchor-segment connected to the hub and a second anchor-segment connected to the first anchor-segment at an obtuse angle.
  • 13. The blood filter of claim 12 wherein each said anchor member comprises a hook configured to penetrate a vessel wall.
  • 14. The blood filter of claim 13 wherein the hook is offset with respect to an anchor member.
  • 15. The blood filter of claim 14 wherein the anchor member is configured to withstand 70 g of force directed parallel to the longitudinal axis.
  • 16. The blood filter of claim 1 wherein the anchor member is configured to withstand 70 g of force directed parallel to the longitudinal axis.
  • 17. The blood filter of claim 16 wherein the locator member comprises a first segment connected to the hub, a second segment connected to the first segment at an obtuse hub angle, a third segment connected to the second segment at an obtuse angle and the anchor member comprises a first anchor-segment connected to the hub and a second anchor- segment connected to the first anchor-segment at an obtuse angle.
  • 18. The blood filter of claim 16 wherein each anchor member is independently, cylindrically collapsed in a constrained state and each locator member is independently, cylindrically collapsed in the constrained state.
  • 19. A blood filter comprising: a) a hub;b) an anchor structure, connected to the hub, having one or more anchor members diverging from a blood-filter longitudinal axis in an unconstrained state and configured to anchor the filter to a vessel wall wherein the anchor member comprises a first anchor-segment connected to the hub, a second anchor-segment connected to the first anchor-segment at an obtuse angle, and a hook offset with respect to each said first anchor segment and said second anchor segment, said hook configured to penetrate a vessel wall;c) a locator structure, connected to the hub, having one or more locator members diverging from the blood-filter longitudinal axis in the unconstrained state and the locator members are configured to center the hub in the vessel wherein the locator member comprises multiple segments including a first segment connected to the hub, a second segment connected to the first segment at an obtuse hub angle, a third segment connected to the second segment at an obtuse angle, and a tip section connected to the third segment at an obtuse tip angle and wherein the tip is configured to avoid injury to the vessel wall; andd) wherein each anchor member and each locator member is configured to independently, cylindrically collapsed in a constrained configuration.
  • 20. A blood filter comprising: a) a hub;b) an anchor structure, connected to the hub, having one or more anchor members diverging from a blood-filter longitudinal axis in an unconstrained state and configured to anchor the filter to a vessel wall wherein the anchor member comprises anchor-segment-1 connected to the hub, anchor-segment-2 connected to anchor-segment-1 at an obtuse angle, and a hook offset with respect to an anchor segment, configured to penetrate a vessel wall;c) a locator structure, connected to the hub, having one or more locator members diverging from the blood-filter longitudinal axis in the unconstrained state and the locator members are configured to center the hub in the vessel wherein each said locator member comprises a first segment connected to the hub, a second segment connected to the first segment at an obtuse angle, a third segment connected to the second segment at an obtuse angle, and a tip section connected to the third segment at an obtuse tip angle and wherein the tip section is shorter than others of the said segments and is configured to avoid injury to the vessel wall;d) wherein the said anchor members and locator members are cylindrically collapsed in a constrained state; ande) wherein when the filter is in an unconstrained state the tip section has a length along the longitudinal axis, the first segment extends away from the longitudinal axis and from the hub measured along the longitudinal axis, the second segment extends away from the longitudinal axis and from the hub measured along the longitudinal axis, a portion of the hook on the anchor is spaced from the longitudinal axis and from the hub measured along the longitudinal axis, and the hook has a curved portion with a radius of curvature.
PRIORITY DATA AND INCORPORATION BY REFERENCE

This application is a continuation of U.S. patent application Ser. No. 15/877,159, filed Jan. 22, 2018, now U.S. Pat. No. 10,729,527, which is a continuation of U.S. patent application Ser. No. 15/291,000, filed Oct. 11, 2016, now U.S. Pat. No. 9,872,756, which is a continuation of U.S. patent application Ser. No. 14/070,873, filed Nov. 4, 2013, now U.S. Pat. No. 9,498,318, which is a continuation of U.S. patent application Ser. No. 13/170,054, filed Jun. 27, 2011, now U.S. Pat. No. 8,574,261, which is a continuation of U.S. patent application Ser. No. 11/429,975, filed May 9, 2006, now U.S. Pat. No. 7,967,838, which claims the benefit of priority to U.S. Provisional Patent Application No. 60/680,601, filed May 12, 2005, each of which is incorporated by reference in its entirety into this application.

US Referenced Citations (685)
Number Name Date Kind
893055 Conner Jul 1908 A
2212334 Wallerich Aug 1940 A
2767703 Nieburgs et al. Oct 1956 A
3334629 Cohn et al. Aug 1967 A
3472230 Fogarty et al. Oct 1969 A
3540431 Mobin-Uddin et al. Nov 1970 A
3579798 Henderson et al. May 1971 A
3620212 Fannon et al. Nov 1971 A
3657744 Ersek et al. Apr 1972 A
3875928 Angelchik Apr 1975 A
3885562 Lampkin May 1975 A
3952747 Kimmell, Jr. Apr 1976 A
4000739 Stevens Jan 1977 A
4041931 Elliott et al. Aug 1977 A
4198960 Utsugi Apr 1980 A
4256132 Gunter Mar 1981 A
4282876 Flynn Aug 1981 A
4283447 Flynn Aug 1981 A
4317446 Ambrosio et al. Mar 1982 A
4334536 Pfleger Jun 1982 A
4343048 Ross et al. Aug 1982 A
4411655 Schreck Oct 1983 A
4419095 Nebergall et al. Dec 1983 A
4425908 Simon Jan 1984 A
4494531 Gianturco Jan 1985 A
4562596 Kornberg Jan 1986 A
4572186 Gould et al. Feb 1986 A
4586501 Claracq May 1986 A
4588399 Nebergall et al. May 1986 A
4590938 Segura et al. May 1986 A
4611594 Grayhack et al. Sep 1986 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4643184 Mobin-Uddin Feb 1987 A
4655219 Petruzzi Apr 1987 A
4655771 Wallsten Apr 1987 A
4657024 Coneys Apr 1987 A
4665906 Jervis May 1987 A
4680573 Ciordinik et al. Jul 1987 A
4688553 Metals Aug 1987 A
4710192 Liotta et al. Dec 1987 A
4722344 Cambron et al. Feb 1988 A
4727873 Mobin-Uddin Mar 1988 A
4735616 Eibl et al. Apr 1988 A
4781177 Lebigot Nov 1988 A
4793348 Palmaz Dec 1988 A
4798591 Okada Jan 1989 A
4817600 Herms et al. Apr 1989 A
4832055 Palestrant May 1989 A
4838879 Tanabe et al. Jun 1989 A
4857062 Russell Aug 1989 A
4863442 DeMello et al. Sep 1989 A
4873978 Ginsburg Oct 1989 A
4886506 Lovgren et al. Dec 1989 A
4888506 Umehara et al. Dec 1989 A
4898591 Jang et al. Feb 1990 A
4915695 Koobs Apr 1990 A
4922905 Strecker May 1990 A
4943297 Saveliev et al. Jul 1990 A
4950227 Savin et al. Aug 1990 A
4957501 Lahille et al. Sep 1990 A
4969891 Gewertz Nov 1990 A
4990151 Wallsten Feb 1991 A
4990156 Lefebvre Feb 1991 A
5045072 Castillo et al. Sep 1991 A
5059205 El-Nounou et al. Oct 1991 A
5067957 Jervis Nov 1991 A
5074867 Wilk Dec 1991 A
5098440 Hillstead Mar 1992 A
5108418 Lefebvre Apr 1992 A
5114408 Fleischhaker et al. May 1992 A
5120308 Hess Jun 1992 A
5133733 Rasmussen et al. Jul 1992 A
5147378 Markham Sep 1992 A
5147379 Sabbaghian et al. Sep 1992 A
5152777 Goldberg et al. Oct 1992 A
5171232 Castillo et al. Dec 1992 A
5188616 Nadal Feb 1993 A
5190546 Jervis Mar 1993 A
5203776 Durfee Apr 1993 A
5219358 Bendel et al. Jun 1993 A
5234416 Macaulay et al. Aug 1993 A
5234458 Metais Aug 1993 A
5242462 El-Nounou et al. Sep 1993 A
5292331 Boneau Mar 1994 A
5300086 Gory et al. Apr 1994 A
5304156 Sylvanowicz et al. Apr 1994 A
5324304 Rasmussen Jun 1994 A
5329942 Gunther et al. Jul 1994 A
5344427 Cottenceau et al. Sep 1994 A
5350398 Pavcnik et al. Sep 1994 A
5358493 Schweich, Jr. et al. Oct 1994 A
5370657 Irie Dec 1994 A
5375612 Cottenceau et al. Dec 1994 A
5383887 Nadal Jan 1995 A
5397310 Chu et al. Mar 1995 A
5397355 Marin et al. Mar 1995 A
5413586 Dibie et al. May 1995 A
5421832 Lefebvre Jun 1995 A
5423851 Samuels Jun 1995 A
5443497 Venbrux Aug 1995 A
5464408 Duc Nov 1995 A
5485667 Kleshinski Jan 1996 A
5514154 Lau et al. May 1996 A
5531788 Dibie et al. Jul 1996 A
5545151 O'Connor et al. Aug 1996 A
5545210 Hess et al. Aug 1996 A
5549576 Patterson et al. Aug 1996 A
5549626 Miller et al. Aug 1996 A
5554181 Das Sep 1996 A
5558652 Henke Sep 1996 A
5562698 Parker Oct 1996 A
5562728 Lazarus et al. Oct 1996 A
5591197 Orth et al. Jan 1997 A
5593417 Rhodes Jan 1997 A
5593434 Williams Jan 1997 A
5597378 Jervis Jan 1997 A
5601568 Chevillon et al. Feb 1997 A
5601595 Smith Feb 1997 A
5603721 Lau et al. Feb 1997 A
5624508 Flomenblit et al. Apr 1997 A
5626605 Irie et al. May 1997 A
5630822 Hermann et al. May 1997 A
5634942 Chevillon et al. Jun 1997 A
5641364 Golberg et al. Jun 1997 A
5649906 Gory et al. Jul 1997 A
5669879 Duer Sep 1997 A
5669933 Simon et al. Sep 1997 A
5672153 Lax et al. Sep 1997 A
5672158 Okada et al. Sep 1997 A
5674278 Boneau Oct 1997 A
5681347 Cathcart et al. Oct 1997 A
5683411 Kavteladze et al. Nov 1997 A
5695518 Laerum Dec 1997 A
5695519 Summers et al. Dec 1997 A
5702370 Sylvanowicz et al. Dec 1997 A
5704910 Humes Jan 1998 A
5704926 Sutton Jan 1998 A
5704928 Morita et al. Jan 1998 A
5707376 Kavteladze et al. Jan 1998 A
5709704 Nott et al. Jan 1998 A
5720762 Bass Feb 1998 A
5720764 Naderlinger Feb 1998 A
5720776 Chuter et al. Feb 1998 A
5725550 Nadal Mar 1998 A
5746767 Smith May 1998 A
5755790 Chevillon et al. May 1998 A
5759192 Saunders Jun 1998 A
5769816 Barbut et al. Jun 1998 A
5775790 Ohtake Jul 1998 A
5776162 Kleshinski Jul 1998 A
5776181 Lee et al. Jul 1998 A
5780807 Saunders Jul 1998 A
5800457 Gelbfish Sep 1998 A
5800515 Nadal et al. Sep 1998 A
5800526 Anderson et al. Sep 1998 A
5830222 Makower Nov 1998 A
5836968 Simon et al. Nov 1998 A
5836969 Kim et al. Nov 1998 A
5843164 Frantzen et al. Dec 1998 A
5843167 Dwyer et al. Dec 1998 A
5853420 Chevillon et al. Dec 1998 A
5879382 Boneau Mar 1999 A
5891190 Boneau Apr 1999 A
5893867 Bagaoisan et al. Apr 1999 A
5893869 Barnhart et al. Apr 1999 A
5896869 Maniscalco et al. Apr 1999 A
5897497 Fernandez Apr 1999 A
5911704 Humes Jun 1999 A
5919224 Thompson et al. Jul 1999 A
5928261 Ruiz Jul 1999 A
5935162 Dang Aug 1999 A
5938683 Lefebvre Aug 1999 A
5944728 Bates Aug 1999 A
5951585 Cathcart et al. Sep 1999 A
5954741 Fox Sep 1999 A
5961546 Robinson et al. Oct 1999 A
5968052 Sullivan, III et al. Oct 1999 A
5968071 Chevillon et al. Oct 1999 A
5972019 Engelson et al. Oct 1999 A
5976172 Homsma et al. Nov 1999 A
5984947 Smith Nov 1999 A
5989266 Foster Nov 1999 A
6001118 Daniel et al. Dec 1999 A
6004347 McNamara et al. Dec 1999 A
6007558 Ravenscroft et al. Dec 1999 A
6013093 Nott et al. Jan 2000 A
6036723 Anidjar et al. Mar 2000 A
6051015 Maahs Apr 2000 A
6059814 Ladd May 2000 A
6059825 Hobbs et al. May 2000 A
6066158 Engelson et al. May 2000 A
6068638 Makower May 2000 A
6068645 Tu May 2000 A
6071292 Makower et al. Jun 2000 A
6071307 Rhee et al. Jun 2000 A
6077297 Robinson et al. Jun 2000 A
6077880 Castillo et al. Jun 2000 A
6080178 Meglin Jun 2000 A
6099534 Bates et al. Aug 2000 A
6099549 Bosma et al. Aug 2000 A
6102932 Kurz Aug 2000 A
6113608 Monroe et al. Sep 2000 A
6126645 Thompson Oct 2000 A
6126673 Kim et al. Oct 2000 A
6131266 Saunders Oct 2000 A
6132388 Fleming et al. Oct 2000 A
6146404 Kim et al. Nov 2000 A
6156055 Ravenscroft Dec 2000 A
6159225 Makower Dec 2000 A
6162357 Pakki et al. Dec 2000 A
6165179 Cathcart et al. Dec 2000 A
6165200 Tsugita et al. Dec 2000 A
6171297 Pedersen et al. Jan 2001 B1
6190353 Makower et al. Feb 2001 B1
6193739 Chevillon et al. Feb 2001 B1
6193748 Thompson et al. Feb 2001 B1
6206888 Bicek et al. Mar 2001 B1
6214025 Thistle et al. Apr 2001 B1
6217600 DiMatteo Apr 2001 B1
6228052 Pohndorf May 2001 B1
6231581 Shank et al. May 2001 B1
6231587 Makower May 2001 B1
6231588 Zadno-Azizi May 2001 B1
6231589 Wessman et al. May 2001 B1
6235045 Barbut et al. May 2001 B1
6241738 Dereume Jun 2001 B1
6241746 Bosma et al. Jun 2001 B1
6245012 Kleshinski Jun 2001 B1
6245099 Edwin et al. Jun 2001 B1
6251122 Tsukernik Jun 2001 B1
6254609 Vrba et al. Jul 2001 B1
6254633 Pinchuk et al. Jul 2001 B1
6258026 Ravenscroft et al. Jul 2001 B1
6258101 Blake, III Jul 2001 B1
6264664 Avellanet Jul 2001 B1
6264671 Stack et al. Jul 2001 B1
6267776 O'Connell Jul 2001 B1
6267777 Bosma et al. Jul 2001 B1
6273900 Nott et al. Aug 2001 B1
6273901 Whitcher et al. Aug 2001 B1
6280451 Bates et al. Aug 2001 B1
6280459 Doble Aug 2001 B1
6282222 Wieser et al. Aug 2001 B1
6283983 Makower et al. Sep 2001 B1
6287317 Makower et al. Sep 2001 B1
6287332 Bolz et al. Sep 2001 B1
6287335 Drasler et al. Sep 2001 B1
6290710 Cryer et al. Sep 2001 B1
6302875 Makower et al. Oct 2001 B1
6302891 Nadal Oct 2001 B1
6306163 Fitz Oct 2001 B1
6322541 West et al. Nov 2001 B2
6325790 Trotta Dec 2001 B1
6328755 Marshall Dec 2001 B1
6331183 Suon Dec 2001 B1
6336934 Gilson et al. Jan 2002 B1
6342062 Suon et al. Jan 2002 B1
6342063 DeVries et al. Jan 2002 B1
6344053 Boneau Feb 2002 B1
6355056 Pinheiro Mar 2002 B1
6361546 Khosravi Mar 2002 B1
6383193 Cathcart et al. May 2002 B1
6383195 Richard May 2002 B1
6383206 Gillick et al. May 2002 B1
6391045 Kim et al. May 2002 B1
6402771 Palmer et al. Jun 2002 B1
6416530 DeVries et al. Jul 2002 B2
6425909 Dieck et al. Jul 2002 B1
6428559 Johnson Aug 2002 B1
6432127 Kim et al. Aug 2002 B1
6436120 Meglin Aug 2002 B1
6436121 Blom Aug 2002 B1
6440077 Jung et al. Aug 2002 B1
6442413 Silver Aug 2002 B1
6443971 Boylan et al. Sep 2002 B1
6443972 Bosma et al. Sep 2002 B1
6447530 Ostrovsky et al. Sep 2002 B1
6458145 Ravenscroft et al. Oct 2002 B1
6468290 Weldon et al. Oct 2002 B1
6482222 Bruckheimer et al. Nov 2002 B1
6485500 Kokish et al. Nov 2002 B1
6485501 Green Nov 2002 B1
6485502 Don Michael et al. Nov 2002 B2
6488662 Sirimanne Dec 2002 B2
6497709 Heath Dec 2002 B1
6506205 Goldberg et al. Jan 2003 B2
6511492 Rosenbluth et al. Jan 2003 B1
6511496 Huter et al. Jan 2003 B1
6511503 Burkett et al. Jan 2003 B1
6517559 O'Connell Feb 2003 B1
6517573 Pollock et al. Feb 2003 B1
6527962 Nadal Mar 2003 B1
6537294 Boyle et al. Mar 2003 B1
6537295 Petersen Mar 2003 B2
6537296 Levinson et al. Mar 2003 B2
6540722 Boyle et al. Apr 2003 B1
6540767 Walak et al. Apr 2003 B1
6540768 Diaz et al. Apr 2003 B1
6544280 Daniel et al. Apr 2003 B1
6551303 Van Tassel et al. Apr 2003 B1
6551340 Konya et al. Apr 2003 B1
6551342 Shen et al. Apr 2003 B1
6558404 Tsukernik May 2003 B2
6558405 McInnes May 2003 B1
6558406 Okada May 2003 B2
6563080 Shapovalov et al. May 2003 B2
6569183 Kim et al. May 2003 B1
6569184 Huter May 2003 B2
6572605 Humes Jun 2003 B1
6575997 Palmer et al. Jun 2003 B1
6579314 Lombardi et al. Jun 2003 B1
6582447 Patel et al. Jun 2003 B1
6589266 Whitcher et al. Jul 2003 B2
6592607 Palmer et al. Jul 2003 B1
6592616 Stack et al. Jul 2003 B1
6596011 Johnson et al. Jul 2003 B2
6602226 Smith et al. Aug 2003 B1
6602273 Marshall Aug 2003 B2
6607553 Healy et al. Aug 2003 B1
6610077 Hancock et al. Aug 2003 B1
6616680 Thielen Sep 2003 B1
6616681 Hanson et al. Sep 2003 B2
6620183 DiMatteo Sep 2003 B2
6623450 Dutta Sep 2003 B1
6623506 McGuckin, Jr. et al. Sep 2003 B2
6629993 Voinov Oct 2003 B2
6638293 Makower et al. Oct 2003 B1
6640077 Suzuki et al. Oct 2003 B2
6641590 Palmer et al. Nov 2003 B1
6645152 Jung et al. Nov 2003 B1
6645224 Gilson et al. Nov 2003 B2
6652555 VanTassel et al. Nov 2003 B1
6652556 VanTassel et al. Nov 2003 B1
6652558 Patel et al. Nov 2003 B2
6652692 Pedersen et al. Nov 2003 B2
6656203 Roth et al. Dec 2003 B2
6660021 Palmer et al. Dec 2003 B1
6660031 Tran et al. Dec 2003 B2
6663650 Sepetka et al. Dec 2003 B2
6679902 Boyle et al. Jan 2004 B1
6679903 Kurz Jan 2004 B2
6682540 Sancoff et al. Jan 2004 B1
6685722 Rosenbluth et al. Feb 2004 B1
6685738 Chouinard et al. Feb 2004 B2
6689150 VanTassel et al. Feb 2004 B1
6695813 Boyle et al. Feb 2004 B1
6696667 Flanagan Feb 2004 B1
6702834 Boylan et al. Mar 2004 B1
6702843 Brown et al. Mar 2004 B1
6706054 Wessman et al. Mar 2004 B2
6712834 Yassour et al. Mar 2004 B2
6716208 Humes Apr 2004 B2
6719717 Johnson et al. Apr 2004 B1
6719772 Trask et al. Apr 2004 B2
6726621 Suon et al. Apr 2004 B2
6730108 Van Tassel et al. May 2004 B2
6736842 Healy et al. May 2004 B2
6752819 Brady et al. Jun 2004 B1
6755846 Yadav Jun 2004 B1
6761732 Burkett et al. Jul 2004 B2
6773448 Kusleika et al. Aug 2004 B2
6776770 Trerotola Aug 2004 B1
6776774 Tansey, Jr. et al. Aug 2004 B2
6783538 McGuckin, Jr. et al. Aug 2004 B2
6792979 Konya et al. Sep 2004 B2
6793665 McGuckin, Jr. et al. Sep 2004 B2
6818006 Douk et al. Nov 2004 B2
6837898 Boyle et al. Jan 2005 B2
6840950 Stanford et al. Jan 2005 B2
6843798 Kusleika et al. Jan 2005 B2
6849061 Wagner Feb 2005 B2
6852076 Nikolic et al. Feb 2005 B2
6872217 Walak et al. Mar 2005 B2
6881218 Beyer et al. Apr 2005 B2
6884259 Tran et al. Apr 2005 B2
6887256 Gilson et al. May 2005 B2
6972025 WasDyke Dec 2005 B2
6989021 Bosma et al. Jan 2006 B2
6991641 Diaz et al. Jan 2006 B2
6991642 Petersen Jan 2006 B2
7001424 Patel et al. Feb 2006 B2
7011094 Rapacki et al. Mar 2006 B2
7033376 Tsukernik Apr 2006 B2
7041117 Suon et al. May 2006 B2
7052511 Weldon et al. May 2006 B2
7056286 Ravenscroft et al. Jun 2006 B2
7147649 Thomas Dec 2006 B2
7163550 Boismier Jan 2007 B2
7179275 McGuckin, Jr. et al. Feb 2007 B2
7220257 Lafontaine May 2007 B1
7232462 Schaeffer Jun 2007 B2
7261731 Patel et al. Aug 2007 B2
7279000 Cartier et al. Oct 2007 B2
7303571 Makower et al. Dec 2007 B2
7314477 Ravenscroft et al. Jan 2008 B1
7323003 Lowe Jan 2008 B2
7331992 Randall et al. Feb 2008 B2
7338512 McGuckin, Jr. et al. Mar 2008 B2
7534251 WasDyke May 2009 B2
7544202 Cartier et al. Jun 2009 B2
7572289 Sisken et al. Aug 2009 B2
7582100 Johnson et al. Sep 2009 B2
7625390 Hendriksen et al. Dec 2009 B2
7699867 Hendriksen et al. Apr 2010 B2
7704266 Thinnes, Jr. et al. Apr 2010 B2
7704267 Tessmer Apr 2010 B2
7722635 Beyer et al. May 2010 B2
7722638 Deyette, Jr. et al. May 2010 B2
7736383 Bressler et al. Jun 2010 B2
7736384 Bressler et al. Jun 2010 B2
7749244 Brucheimer et al. Jul 2010 B2
7749246 McGuckin, Jr. et al. Jul 2010 B2
7766932 Melzer et al. Aug 2010 B2
7794472 Eidenschink et al. Sep 2010 B2
7794473 Tessmer Sep 2010 B2
7799049 Ostrovsky et al. Sep 2010 B2
7887580 Randall et al. Feb 2011 B2
7967838 Chanduszko et al. Jun 2011 B2
7972353 Hendriksen et al. Jul 2011 B2
7993362 Lowe et al. Aug 2011 B2
8029529 Chanduszko Oct 2011 B1
8043322 Hendriksen Oct 2011 B2
8062327 Chanduszko et al. Nov 2011 B2
8075606 Dorn Dec 2011 B2
8092484 Kashkarov Jan 2012 B2
8105349 Hendriksen Jan 2012 B2
8133251 Ravenscroft et al. Mar 2012 B2
8167901 Hendriksen May 2012 B2
8241350 Randall et al. Aug 2012 B2
8246648 Tekulve Aug 2012 B2
8246651 Hendriksen Aug 2012 B2
8267954 Decant, Jr. et al. Sep 2012 B2
8317818 Kashkarov Nov 2012 B2
8333785 Chanduszko et al. Dec 2012 B2
8372109 Tessmer Feb 2013 B2
8430903 Chanduszko et al. Apr 2013 B2
8574261 Carr, Jr. et al. Nov 2013 B2
8613754 Chanduszko Dec 2013 B2
8628556 Tessmer Jan 2014 B2
8690906 Ravenscroft Apr 2014 B2
8734479 Kashkarov May 2014 B2
8992562 Tessmer Mar 2015 B2
9017367 Chanduszko Apr 2015 B2
9421081 Kashkarov Aug 2016 B2
9486304 Chanduszko Nov 2016 B2
9498318 Carr, Jr. Nov 2016 B2
9693851 Tessmer Jul 2017 B2
9872756 Carr, Jr. Jan 2018 B2
9895214 Chanduszko Feb 2018 B2
10105206 Simpson Oct 2018 B2
10188498 Kashkarov Jan 2019 B2
10512531 Tessmer Dec 2019 B2
10729527 Carr, Jr. Aug 2020 B2
10813738 Chanduszko Oct 2020 B2
10898311 Kashkarov Jan 2021 B2
20010000799 Wessman et al. May 2001 A1
20010001317 Duerig et al. May 2001 A1
20010016770 Allen et al. Aug 2001 A1
20010020175 Yassour et al. Sep 2001 A1
20010023358 Tsukernik Sep 2001 A1
20010027339 Boatman et al. Oct 2001 A1
20010039431 DeVries et al. Nov 2001 A1
20020002401 McGuckin, Jr. et al. Jan 2002 A1
20020004060 Heublein et al. Jan 2002 A1
20020010350 Tatsumi et al. Jan 2002 A1
20020022853 Swanson et al. Feb 2002 A1
20020032461 Marshall Mar 2002 A1
20020038097 Corvi et al. Mar 2002 A1
20020042626 Hanson et al. Apr 2002 A1
20020045918 Suon et al. Apr 2002 A1
20020052626 Gilson et al. May 2002 A1
20020055767 Forde et al. May 2002 A1
20020072764 Sepetka et al. Jun 2002 A1
20020116024 Goldberg et al. Aug 2002 A1
20020123720 Kusleika et al. Sep 2002 A1
20020138097 Ostrovsky et al. Sep 2002 A1
20020193825 McGuckin, Jr. et al. Dec 2002 A1
20020193826 McGuckin, Jr. et al. Dec 2002 A1
20020193827 McGuckin, Jr. et al. Dec 2002 A1
20020193828 Griffin et al. Dec 2002 A1
20030004540 Linder et al. Jan 2003 A1
20030004541 Linder et al. Jan 2003 A1
20030004946 VanDenAvond et al. Jan 2003 A1
20030028241 Stinson Feb 2003 A1
20030055812 Williams et al. Mar 2003 A1
20030071285 Tsukernik Apr 2003 A1
20030093106 Brady et al. May 2003 A1
20030093110 Vale May 2003 A1
20030097145 Goldberg et al. May 2003 A1
20030109824 Anderson et al. Jun 2003 A1
20030109897 Walak et al. Jun 2003 A1
20030114735 Silver et al. Jun 2003 A1
20030114880 Hansen et al. Jun 2003 A1
20030130680 Russell Jul 2003 A1
20030139765 Patel et al. Jul 2003 A1
20030153945 Patel et al. Aug 2003 A1
20030158595 Randall et al. Aug 2003 A1
20030163159 Patel et al. Aug 2003 A1
20030171771 Anderson et al. Sep 2003 A1
20030176888 O'Connell Sep 2003 A1
20030176912 Chuter et al. Sep 2003 A1
20030191516 Weldon et al. Oct 2003 A1
20030195554 Shen et al. Oct 2003 A1
20030195556 Stack et al. Oct 2003 A1
20030199918 Patel et al. Oct 2003 A1
20030208227 Thomas Nov 2003 A1
20030208229 Kletschka Nov 2003 A1
20030208253 Beyer et al. Nov 2003 A1
20030220683 Minasian et al. Nov 2003 A1
20040006364 Ladd Jan 2004 A1
20040006369 DiMatteo Jan 2004 A1
20040059373 Shapiro et al. Mar 2004 A1
20040068288 Palmer et al. Apr 2004 A1
20040073252 Goldberg et al. Apr 2004 A1
20040082966 WasDyke Apr 2004 A1
20040087999 Bosma et al. May 2004 A1
20040088000 Muller May 2004 A1
20040088001 Bosma et al. May 2004 A1
20040088002 Boyle et al. May 2004 A1
20040093015 Ogle May 2004 A1
20040093064 Bosma May 2004 A1
20040116959 McGuckin, Jr. et al. Jun 2004 A1
20040138693 Eskuri et al. Jul 2004 A1
20040153110 Kurz et al. Aug 2004 A1
20040153118 Clubb et al. Aug 2004 A1
20040153119 Kusleika et al. Aug 2004 A1
20040158267 Sancoff et al. Aug 2004 A1
20040158273 Weaver et al. Aug 2004 A1
20040158274 WasDyke Aug 2004 A1
20040167568 Boyle et al. Aug 2004 A1
20040172042 Suon et al. Sep 2004 A1
20040176672 Silver et al. Sep 2004 A1
20040186510 Weaver Sep 2004 A1
20040186512 Bruckheimer et al. Sep 2004 A1
20040193209 Pavcnik et al. Sep 2004 A1
20040199240 Dorn Oct 2004 A1
20040199270 Wang et al. Oct 2004 A1
20040220610 Kreidler et al. Nov 2004 A1
20040220611 Ogle Nov 2004 A1
20040230220 Osborne Nov 2004 A1
20040243173 Inoue Dec 2004 A1
20050004596 McGuckin et al. Jan 2005 A1
20050015111 McGuckin et al. Jan 2005 A1
20050019370 Humes Jan 2005 A1
20050021075 Bonnette et al. Jan 2005 A1
20050021076 Mazzocchi et al. Jan 2005 A1
20050021152 Ogle et al. Jan 2005 A1
20050027314 WasDyke Feb 2005 A1
20050027345 Horan et al. Feb 2005 A1
20050049609 Gunderson et al. Mar 2005 A1
20050055045 DeVries et al. Mar 2005 A1
20050055046 McGuckin et al. Mar 2005 A1
20050059990 Ayala et al. Mar 2005 A1
20050059993 Ramzipoor et al. Mar 2005 A1
20050065591 Moberg et al. Mar 2005 A1
20050070794 Deal et al. Mar 2005 A1
20050070821 Deal et al. Mar 2005 A1
20050080447 McGuckin, Jr. et al. Apr 2005 A1
20050080449 Mulder Apr 2005 A1
20050085847 Galdonik et al. Apr 2005 A1
20050090858 Pavlovic Apr 2005 A1
20050101982 Ravenscroft et al. May 2005 A1
20050107822 WasDyke May 2005 A1
20050115111 Yamashita et al. Jun 2005 A1
20050131451 Kleshinski et al. Jun 2005 A1
20050131452 Walak et al. Jun 2005 A1
20050159771 Petersen Jul 2005 A1
20050165441 McGuckin, Jr. et al. Jul 2005 A1
20050165442 Thinnes, Jr. et al. Jul 2005 A1
20050171473 Gerdts et al. Aug 2005 A1
20050182439 Lowe Aug 2005 A1
20050222604 Schaeffer Oct 2005 A1
20050234503 Ravenscroft et al. Oct 2005 A1
20050251199 Osborne et al. Nov 2005 A1
20050267512 Osborne et al. Dec 2005 A1
20050267513 Osborne et al. Dec 2005 A1
20050267514 Osborne et al. Dec 2005 A1
20050267515 Oliva et al. Dec 2005 A1
20050288703 Beyer et al. Dec 2005 A1
20050288704 Cartier et al. Dec 2005 A1
20060004402 Voeller et al. Jan 2006 A1
20060015137 WasDyke et al. Jan 2006 A1
20060016299 Chen Jan 2006 A1
20060030875 Tessmer Feb 2006 A1
20060036279 Eidenschink et al. Feb 2006 A1
20060041271 Bosma et al. Feb 2006 A1
20060047300 Eidenschink Mar 2006 A1
20060047341 Trieu Mar 2006 A1
20060069405 Schaeffer et al. Mar 2006 A1
20060069406 Hendriksen et al. Mar 2006 A1
20060079928 Cartier et al. Apr 2006 A1
20060079930 McGuckin et al. Apr 2006 A1
20060095068 WasDyke et al. May 2006 A1
20060100660 Osborne May 2006 A1
20060106417 Tessmer et al. May 2006 A1
20060155320 Bressler et al. Jul 2006 A1
20060157889 Chen Jul 2006 A1
20060178695 Decant Aug 2006 A1
20060203769 Saholt et al. Sep 2006 A1
20060206138 Eidenschink Sep 2006 A1
20060259067 Welch et al. Nov 2006 A1
20060259068 Eidenschink Nov 2006 A1
20070005095 Osborne et al. Jan 2007 A1
20070005104 Kusleika et al. Jan 2007 A1
20070005105 Kusleika et al. Jan 2007 A1
20070039432 Cutler Feb 2007 A1
20070043419 Nikolchev et al. Feb 2007 A1
20070060944 Boldenow et al. Mar 2007 A1
20070088381 McGuckin et al. Apr 2007 A1
20070100372 Schaeffer May 2007 A1
20070112373 Carr et al. May 2007 A1
20070167974 Cully et al. Jul 2007 A1
20070173885 Cartier et al. Jul 2007 A1
20070185524 Diaz et al. Aug 2007 A1
20070191878 Segner et al. Aug 2007 A1
20070191880 Cartier et al. Aug 2007 A1
20070198050 Ravenscroft et al. Aug 2007 A1
20070213685 Bressler et al. Sep 2007 A1
20070219530 Schaeffer Sep 2007 A1
20070250106 Kim Oct 2007 A1
20080014078 Suciu et al. Jan 2008 A1
20080033479 Silver Feb 2008 A1
20080039891 McGuckin et al. Feb 2008 A1
20080091230 Lowe Apr 2008 A1
20080097518 Thinnes et al. Apr 2008 A1
20080103582 Randall et al. May 2008 A1
20080119867 Delaney May 2008 A1
20080183206 Batiste Jul 2008 A1
20080221609 McGuckin et al. Sep 2008 A1
20080221656 Hartley et al. Sep 2008 A1
20080255605 Weidman Oct 2008 A1
20080262506 Griffin et al. Oct 2008 A1
20080275486 Dwyer et al. Nov 2008 A1
20080275488 Fleming Nov 2008 A1
20080294189 Moll et al. Nov 2008 A1
20080300621 Hopkins et al. Dec 2008 A1
20090005803 Batiste Jan 2009 A1
20090043332 Sullivan et al. Feb 2009 A1
20090069840 Hallisey Mar 2009 A1
20090105747 Chanduszko et al. Apr 2009 A1
20090131970 Chanduszko et al. May 2009 A1
20090163926 Sos Jun 2009 A1
20090192543 WasDyke Jul 2009 A1
20090198270 McGuckin, Jr. et al. Aug 2009 A1
20090209996 Kashkarov Aug 2009 A1
20090264915 WasDyke Oct 2009 A1
20090299403 Chanduszko et al. Dec 2009 A1
20090299404 Chanduszko et al. Dec 2009 A1
20090306703 Kashkarov Dec 2009 A1
20090318951 Kashkarov et al. Dec 2009 A1
20100030253 Harris et al. Feb 2010 A1
20100030254 Chanduszko et al. Feb 2010 A1
20100049238 Simpson Feb 2010 A1
20100049239 McGuckin, Jr. et al. Feb 2010 A1
20100063535 Bressler et al. Mar 2010 A1
20100076545 Kleshinski et al. Mar 2010 A1
20100121373 Tekulve May 2010 A1
20100160956 Hendriksen et al. Jun 2010 A1
20100174310 Tessmer Jul 2010 A1
20100222772 Kleshinski et al. Sep 2010 A1
20100256669 Harris et al. Oct 2010 A1
20100312269 McGuckin, Jr. et al. Dec 2010 A1
20100318115 Chanduszko et al. Dec 2010 A1
20110034952 Tessmer Feb 2011 A1
20110118823 Randall et al. May 2011 A1
20110257677 Carr, Jr. et al. Oct 2011 A1
20120065663 Chanduszko et al. Mar 2012 A1
20120184985 Ravenscroft et al. Jul 2012 A1
20130006295 Chanduszko et al. Jan 2013 A1
20130085523 Tessmer Apr 2013 A1
20130096607 Chanduszko et al. Apr 2013 A1
20140058437 Carr, Jr. Feb 2014 A1
20140107695 Chanduszko Apr 2014 A1
20140257364 Kashkarov Sep 2014 A1
20150230908 Tessmer Aug 2015 A1
20150238302 Chanduszko Aug 2015 A1
20170020649 Kashkarov Jan 2017 A1
20170027680 Carr, Jr. Feb 2017 A1
20170027681 Chanduszko Feb 2017 A1
20170360545 Tessmer Dec 2017 A1
20180243072 Carr Aug 2018 A1
20190167405 Kashkarov Jun 2019 A1
20190336263 Chanduszko Nov 2019 A1
20200390536 Carr, Jr. Dec 2020 A1
20210068939 Chanduszko Mar 2021 A1
Foreign Referenced Citations (61)
Number Date Country
2173118 Apr 1995 CA
2648325 Apr 2000 CA
3633527 Jan 1972 DE
0145166 Jun 1965 EP
0188927 Jul 1986 EP
0712614 May 1996 EP
1042996 Oct 2000 EP
1092401 Apr 2001 EP
1336393 Aug 2003 EP
1475110 Nov 2004 EP
2567405 Jan 1986 FR
2718950 Oct 1995 FR
2781143 Jan 2000 FR
2791551 Oct 2000 FR
08257031 Oct 1996 JP
2002525183 Aug 2002 JP
2003521970 Jul 2003 JP
2005503199 Feb 2005 JP
4851522 Jan 2012 JP
5102201 Jan 2012 JP
07A000025 Apr 1997 SV
1995009567 Apr 1995 WO
1995034339 Dec 1995 WO
1996012448 May 1996 WO
1996017634 Jun 1996 WO
1997029794 Aug 1997 WO
1998002203 Jan 1998 WO
1998023322 Jun 1998 WO
1999025252 May 1999 WO
2000012011 Mar 2000 WO
2000018467 Apr 2000 WO
2000056390 Sep 2000 WO
2000076422 Dec 2000 WO
2001017457 Mar 2001 WO
2002004060 Jan 2002 WO
2002055125 Jul 2002 WO
2002102436 Dec 2002 WO
2003003927 Jan 2003 WO
2003004074 Jan 2003 WO
2003073961 Sep 2003 WO
2004012587 Feb 2004 WO
2004049973 Jun 2004 WO
2004098459 Nov 2004 WO
2004098460 Nov 2004 WO
2005009214 Feb 2005 WO
2005072645 Aug 2005 WO
2005102212 Nov 2005 WO
2005102437 Nov 2005 WO
2005102439 Nov 2005 WO
2006036457 Apr 2006 WO
2006055174 May 2006 WO
2006124405 Nov 2006 WO
2007021340 Feb 2007 WO
2007079410 Jul 2007 WO
2007100619 Sep 2007 WO
2007106378 Sep 2007 WO
2007143602 Dec 2007 WO
2008051294 May 2008 WO
2008076970 Jun 2008 WO
2008077067 Jun 2008 WO
2008109131 Sep 2008 WO
Non-Patent Literature Citations (633)
Entry
“Staff Development Special, Get the Edge on Deep Vein Thrombosis”, Nursing Management, Jan. 2004, pp. 21-29.
AbuRahma, A.F. et al., “Endovascular Caval Interruption in Pregnant Patients With Deep Vein Thrombosis of the Lower Extremity”, Journal of Vascular Surgery, 2001, 33:375-378.
AbuRahma, A.F. et al., “Management of Deep Vein Thrombosis of the Lower Extremity in Pregnancy: A Challenging Dilemma”, The American Surgeon, Feb. 1999, vol. 65, No. 2, pp. 164-167A.
AbuRahma, F. et al., “Etiology of Peripheral Arterial Thromboembolism in Young Patients”, The American Journal of Surgery, vol. 176, Aug. 1998, pp. 158-161.
Adams, E. et al., “Retrievable Inferior Vena Cava Filter for Thrombolic Disease in Pregnancy”, British Journal of Obstetrics and Gynaecology, Sep. 1998, vol. 105, pp. 1039-1042.
Adye, B. A., “Case Report: Errant Percutaneous Greenfield Filter Placement Into the Retroperitoneum”, Journal of Vascular Surgery, Jul. 1990, vol. 12, No. 1.
Aheam, G.S. et al., “Massive Pulmonary Embolism During Pregnancy Successfully Treated With Recombinant Tissue Plasminogen Activator”, Archives of Interal Medicine, Jun. 10, 2002, 162(11):1221-1227.
Aklog, L. et al., “Acute Pulmonary Embolectomy”, Circulation, 2002, 105:1416-1419.
Alexander, J. J. et al., “Is the Increasing Use of Prophylactic Percutaneous IVC Filters Justified?”, The American Journal of Surgery, Aug. 1994, vol. 168, pp. 102-106.
Allen, T.L. et al., “Retrievable Vena Cava Filters in Trauma Patients for High-Risk Prophylaxis and Prevention of Pulmonary Embolism”, The American Journal of Surgery, 2005, 189:656-661.
American Gastroenterological Association Clinical Practice Committee, “Technical Review on Obesity,” Sep. 2002 123:883-932.
Anderson, J.T. et al., “Bedside Noninvasive Detection of Acute Pulmonary Embolism in Critically III Surgical Patients”, Archives of Surgery, Aug. 1999, 134(8):869-875.
Andrews, R. T. et al., “Entrapment of J-Tip Guidewires by Venatech and Stainless-Steel Greenfield Vena Cava Filters During Central Venous Catheter Placement: Percutaneous Management in Four Patients”, Cardiovasc Intervent Radiol. Sep.-Oct. 1998;21(5):424-8.
Anthone, G.J. et al., The Duodenal Switch Operation for the Treatment of Morbid Obesity, Annals of Surgery, Oct. 2003, 238(4):618-628.
Arcasoy, S.M. et al., “Thrombolytic Therapy of Pulmonary Embolism”, Chest, 1999, 115:1695-1707.
Arcelus, J.I. et al., “The Management and Outcome of Acute Venous Thromboembolism: A Prospective Registry Including 4011 Patients”, Journal of Vascular Surgery, 2003, 38:916-922.
Arjomand, H. et al., “Right Ventricular Foreign Body: Percutaneous Transvenous Retrieval of a Greenfield Filter From the Right Ventricle”, Angiology, 2003, vol. 54, No. 1, pp. 109-113.
Arnold, D.M. et al., “Missed Opportunities for Prevention of Venous Thromboembolism”, Chest, 2001, 120:1964-1971.
Ascer, E. et al., “Superior Vena Caval Greenfield Filters: Indications, Techniques, and Results”, Journal of Vascular Surgery, Mar. 1996, vol. 23, No. 3.
Asch, M. R., “Initial Experience in Humans With a New Retrievable Inferior Vena Cava Filter”, Radiology, 2002, 225:835-844.
Ascher, E. et al., “Lessons Learned From a 6-Year Clinical Experience With Superior Vena Cava Greenfield Filters”, Journal of Vascular Surgery, Nov. 2000, 32:881-887.
Ashley, D.W. et al., “Accurate Deployment of Vena Cava Filters: Comparison of Intravascular Ultrasound and Contrast Venography”, The Journal of Trauma Injury, Infection, and Critical Care, Jun. 2001, vol. 50, No. 6, pp. 975-981.
Aswad, M. A. et al., “Early Duplex Scan Evaluation of Four Venal Interruption Devices”, Journal of Vascular Surgery, 1996, 24:809-818.
Athanasoulis, C.A. et al., “Inferior Venal Caval Filters: Review of a 26-Year Single-Center Clinical Experience”, Radiology, 2000, 216:54-66.
Authors' Abstract, “Abstracts of Current Literature”, Journal of Vascular and Interventional Radiology, Mar. 2000, vol. 11, No. 3, pp. 401-407.
Authors' Abstract, “Abstracts of Current Literature”, Journal of Vascular and Interventional Radiology, Oct. 2003, vol. 14, No. 10, pp. 1351-1357.
Authors' Abstract, “Abstracts of Current Literature,” Journal of Vascular and Interventional Radiology, Oct. 2002, 13 (10):1062-1068.
Authors' Abstracts, “Abstracts of Current Literature”, Journal of Vascular and Interventional Radiology, Apr. 2002, vol. 13, No. 4, pp. 433-440.
Authors' Abstracts, “Abstracts of Current Literature”, Journal of Vascular and Interventional Radiology, Apr. 2004, pp. 408-415.
Avery, M. et al., “Reverse Engineering of Nitinol Vena Cava Filters”, Material Science 102 Semester Project, Nov. 21, 2000.
Baker, R. J., “Treatment Considerations for Inherited Thrombophilia and Pulmonary Embolus”, Archives of Surgery, Feb. 2001, 136,2:237.
Balshi, J. D. et al., “Original Articles Complications of Caval Interruption by Greenfield Filter in Quadriplegics”, Journal of Vascular Surgery, Apr. 1989, vol. 9, No. 4.
Barraco, R. D. et al., “Dislodgment of Inferior Vena Cava Filters During Central Line Placement: Case Report”, The Journal of Trauma, Injury, Infection and Critical Care, 2000, vol. 48, No. 1, pp. 140-142.
Barreras, J. R. et al., “Recurrent Pulmonary Embolism Despite the Use of a Greenfield Filter”, Clinical Nuclear, Dec. 2001, vol. 26, No. 12, pp. 1040-1041.
Barton, A. L. et al., “Caval Filter Placement for Pulmonary Embolism in a Patient With a Deep Vein Thrombosis and Primary Intracerebral Haemorrhage”, Age and Ageing, Mar. 2002, 31,2:144-146.
Bass, B.L., “What's New in General Surgery: Gastrointestinal Conditions”, The Journal of American College Surgeons, Dec. 2002, vol. 195, No. 6, pp. 835-854.
Becker, D. M. et al., “Inferior Vena Cava Filters”, Archives of Internal Medicine, Oct. 1992, vol. 152, pp. 1985-1994.
Bendick, P.J. et al., Serial Duplex Ultrasound Examination for Deep Vein Thrombosis in Patients With Suspected Pulmonary Embolism, Journal of Fascular Surgery, Nov. 1996, vol. 24, No. 5, pp. 732-737.
Benjamin, M. E. et al., Duplex Ultrasound Insertion of Inferior Vena Cava Filters in Multitrauma Patients:, American Journal of Surgery, Aug. 1999, vol. 178, pp. 92-97.
Bessoud, B. et al., Experience at a Single Institution With Endovascular Treatment of Mechanical Complications Caused by Implanted Central Venous Access Devices in Pediatric and Adult Patients, American Journal of Roentgenology, Feb. 2003, 180:527-532.
Bevoni, L., “Management of Adult Obesity”, Clinician Reviews, May 2003, 13(5):56-62.
Biertho, L. et al., “Laparoscopic Gastric Bypass Versus Laparoscopic Adjustable Gastric Banding: A Comparative Study of 1,200 Cases”, Journal of the American Colloge of Surgeons, Oct. 2003, vol. 197, No. 4, pp. 536-545.
Binkert, C. A. et al., “Inferior Vena Cava Filter Removal After 317-Day Implantation”, Journal of Vascular Radiology, Mar. 2005, 16:393-398.
Bjamason, H. et al., “In Vitro Metal Fatigue Testing of Inferior Vena Cava Filters”, Investigative Radiology, 1994, vol. 29, No. 9, pp. 817-821.
Blachar A. et al., “Gastrointestinal Complications of Laparoscopic Roux-en-Y Gastric Bypass Surgery in Patients Who Are Morbidly Obese: Findings on Radiography and CT”, American Journal of Roentgenology, Dec. 2002, 179:1437-1442.
Blachar, A. et al., “Gastrointestinal Complications of Laparoscopic Roux-en-Y Gastric Bypass Surgery: Clinical and Imaging Findings”, Radiology, 2002, 223:625-632.
Blaszyk, H. et al., “Factor V Leiden and Morbid Obesity in Fatal Postoperative Pulmonary Embolism”, Archives of Surgery, Dec. 2000, 135(12):1410-1413.
Blebea J. et al., “Deep Venous Thrombosis After Percutaneous Insertion of Vena Caval Filters”, Journal of Vascular Surgery, Nov. 1999, 30:821:829.
Bochenek, K. M. et al., “Right Atrial Migration and Percutaneous Retrieval of a Gunther Tulip Inferior Vena Cava Filter”, Journal of Vascular Interventional Radiology, Sep. 2003, 14:1207-1209.
Bochicchio, G. V. et al., “Acute Caval Perforation by an Inferior Vena Cava Filter in a Multitrauma Patient: Hemostatic Control With a New Surgical Hemostat”, The Journal of Trauma Injury, Infection and Critical Care, 2001, 51:991-993.
Capella, J.F. et al., “An Assessment of Vertical Banded Gastroplasty-Roux-en-Y Gastric Bypass for the Treatment of Morbid Obesity,” The American Journal of Surgery 183 (2002) 117-123.
Carabasi Illi, R. A. et al., “Complications Encountered With the Use of the Greenfield Filter”, The American Journal of Surgery, Aug. 1987, Vo. 154, pp. 163-168.
Carlin, A. M. et al., “Prophylactic and Therapeutic Inferior Vena Cava Filters to Prevent Pulmonary Emboli in Trauma Patients”, Archives of Surgery, May 2002, vol. 137, p. 521.
Carman, Teresa L. et al., Outpatient treatment of deep venous thrombosis, Chest; Nov. 1999; 116, 5; Health & Medical Complete, pp. 1492-1493.
Carter, Y. et al., “Deep Venous Thrombosis and ABO Blood Group Are Unrelated in Trauma Patients”, The Journal of Trauma: Injury, Infection, and Critical Care, 2002, 52:112-116.
Castaneda, F. et al., “Catheter-Directed Thrombolysis in Deep Venous Thrombosis With Use of Reteplase: Immediate Results and Complications From a Pilot Study”, Journal of Vascular and Interventional Radiology, 2002, 13:577-580.
Ceelen, W. et al., “Surgical Treatment of Severe Obesity With a Low-Pressure Adjustable Gastric Band, Experimental Data and Clinical Results in 625 Patients”, Annals of Surgery, 2003, 237(1):10-16.
Chanduszko, A., “Determination of Nitinol Transition Temperatures Using a Dynamical Mechanical Analyzer”, The International Conference on Shape Memory and Superelastic Technology, 2000 Conference Proceedings, 2001, pp. 375-381.
Chaturvedi, R. R. et al., “Intraoperative Apical Ventricular Septal Defect Closure Using a Modified Rashkind Double Umbrella”, Heart, Oct. 1996, vol. 76, No. 4, pp. 367-369.
Chengelis, D.L. et al., “Progression of Superficial Venous Thrombosis to Deep Vein Thrombosis”, Journal of Vascular Surgery, 1996, 24:745-749.
Cherian, J. et al., “Recurrent Pulmonary Embolism Despite Inferior Vena Cava Filter Placement in Patients With the Antiphospholipid Syndrome”, Journal of Clinical Rheumatology, Feb. 2005, vol. 11, No. 1, pp. 56-58.
Cho, K. J. et al., “Evaluation of a New Percutaneous Stainless Steel Greenfield Filter”, Journal of Vascular and Interventional Radiology, Mar.-Apr. 1997, 8:181-187.
Choban, P.S. et al., “The Impact of Obesity on Surgical Outcomes: A Review,” Journal of the American College of Surgeons, Dec. 1997, vol. 185, pp. 593-603.
Chung, J.W. et al., “Acute Iliofemoral Deep Vein Thrombosis: Evaluation of Underlying Anatomic Abnormalities by Spiral CT Venography”, Journal of Vascular and Interventional Radiology, 2004, 15:249-256.
Clarke, C.S. et al., “Puerperal Ovarian Vein Thrombosis With Extension Into the Inferior Vena Cava”, The American Surgeon, Feb. 1999, vol. 65, No. 2, pp. 147-150.
Conners III, M. S et al., “Duplex Scan-Directed Placement of Inferior Vena Cava Filters: A Five-year Institutional Experience”, Journal of Vascular Surgery, Feb. 2002, vol. 35, No. 2, pp. 286-291.
Consensus Conference, “Prevention of Venous Thrombosis and Pulmonary Embolism”, JAMA, Aug. 8, 1986, vol. 256, No. 6, pp. 744-749.
Cook “Bird's Nest” Vena Cava Filter, Cook Incorporated, a Cook Group Company, Nov. 1982.
Cook, “Gunther Tulip Vena Cava Mreye.TM. Filter” Sales Brochure (2001).
Cooper, S.G. et al., “Distal Retraction and Inversion of the Simon Nitinol Filter During Surgical Venous Procedures: Report of Two Cases”, Journal of Vascular and Interventional Radiology, 1997, 8:433-435.
Cottam, D.R. et al., “Laparoscopic Era of Operations for Morbid Obesity”, Archives of Surgery, Apr. 2003, 138 (4):367-375.
Couch, G. G. et al., “An In Vitro Comparison of the Hemodynamics of Two Inferior Vena Cava Filters”, Journal of Vascular Surgery, Mar. 2000, 31:539-549.
Couch, G.G. et al., “In Vitro Assessment of the Hemodynamic Effects of a Partial Occlusion in a Vena Cava Filter”, Journal of Vascular Surgery, Apr. 1997, vol. 25, No. 4, pp. 663-672.
Cragg et al., “Nonsurgical Placement of Arterial Endoprostheses: A New Technique Using Nitinol Wire” Radiology 147:261-263 (Apr. 1983).
Cragg, A. et al., “A New Percutaneous Vena Cava Filter”, American Journal of Roentgenology, Sep. 1983, 141:601-604.
Criado, Enrique, Letters to the Editor, Journal of the American College of Surgeons, Mar. 1996, vol. 182, pp. 279-280.
Critical Care Medicine, vol. 32, No. 12 (Suppl.), pp. A181-A188, 2004.
Crochet, D. et al., “Evaluation of the LGM Vena-Tech Intrarenal Vena Cava Filter in an Ovine Venous Thromboembolism Model”, Journal of Vascular Interventional Radiology, Jun. 2001, 12:739-745.
Crochet, D. P. et al., “Long-Term Follow-Up of Vena Tech-LGM Filter: Predictors and Frequency of Caval Occlusion, Journal of Vascular Interventional Radiology”, Feb. 1999, 10:137-142.
Crochet, D. P. et al., “Vena Tech-LGM Filter: Long-Term Results of a Prospective Study”, Radiology, 1993, 188:857-860.
Cvoro,V. et al., “Inferior Vena Caval Filters or Anticoagulation for Patients With Haemorrhagic Stroke Complicated by Venouse Thromboembolism?”, Age and Ageing, Mar. 2002, vol. 32, No. 2, Research Library, pp. 85-86.
Cynamon et al., “Percutaneous Removal of a Titanium Greenfield Filter” AJR 159:777-778 (Oct. 1992).
Hammond, F.M. et al., “Venous Thromboembolism in the Patient With Acute Traumatic Brain Injury: Screening, Diagnosis, Prophylaxis, and Treatment Issues”, Journal of Head Trauma Rehabilitation, Feb. 1998, vol. 13, No. 1, pp. 36-48.
Hansen, James, “Metals that Remember”, Science 81, vol. 2, No. 5, pp. 44-47, Jun. 1981.
Hardhammar, P.A. et al., “Reduction in Thrombotic Events With Heparin-Coated Palmaz-Schatz Stents in Normal Porcine Coronary Arteries”, Circulation, Feb. 1, 1996, vol. 93, No. 3, pp. 423-430.
Harold, K.L. et al., “Laparoscopic Approach to Open Gastric Bypass”, The American Journal of Surgery, 2002, 184:61-62.
Harries, S.R., “Long-Term Follow-Up of the Antheor Inferior Vena Cava Filter”, Clinical Radiology, 1998, 53:350-352.
Harris, E.J. Jr. et al., “Phlegmasia Complicating Prophylactic Percutaneous Inferior Vena Caval Interruption: A Word of Caution”, Journal of Vascular Surgery, 1995, vol. 22, No. 5, pp. 606-611.
Hastings, G.S. et al., “Repositioning the 12-F Over-the-Wire Greenfield Filter”, Journal of Vascular and Interventional Radiology, 2000, 11:1207-1210.
Hawkins, S.P. et al., “The Simon Nitinol Inferior Vena Cava Filter: Preliminary Experience in the UK”, Clinical Radiology, 1992, 46:378-380.
Headrick, J.R. et al., “The Role of Ultrasonography and Inferior Vena Cava Filter Placement in High-Risk Trauma Patients”, American Surgeon, Jan. 1997, vol. 63, Issue 1.
Helfet, D., Magnetic Resonance Venography to Evaluate Deep Venous Thrombosis in Patients With Pelvic and Acetabular Trauma, The Journal of Trauma: Injury, Infection, and Critical Care, Jul. 2001, p. 178.
Heng, J.T. et al., “Occlusion of Persistent Left Superior Vena Cava to Unroofed Coronary Sinus Using Vena Cava Filterand Coils”, Hears, Jun. 1997, vol. 77, No. 6, pp. 579-580.
Henkle, G. et al., “Patterns of Referral for Inferior Vena Caval Filtration: Delays and Their Impact”, American Journal of Roentgenology, Oct. 2004, 183:1021-1024.
Hicks, M.E. et al., “Prospective Anatomic Study of the Inferior Vena Cava and Renal Veins: Comparison of Selective Renal Venography With Cavography and Relevance in Filter Placement”, Journal of Vascular and Interventional Radiology, 1995, 6:721-729.
Higa, K.D. et al., “Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity”, Archives of Surgery, Sep. 2000, vol. 135, No. 9, pp. 1029-1034.
Hill, S.L. et al., “Deep Venous Thrombosis in the Trauma Patient”, The American Surgeon, Jun. 1994, vol. 60, pp. 405-408.
Hingorani, A. et al., “Upper Extremity Deep Venous Thrombosis and Its Impact on Morbidity and Mortality Rates in a Hospital-Based Population”, Journal of Vascular Surgery, Nov. 1997, 26:853-860.
Hirsch, D. R. et al., “Prevalence of Deep Venous Thrombosis Among Patients in Medical Intensive Care”, JAMA, Jul. 26, 1995, 274(4):335337.
Hirsch, S. B. et al., Case Reports: Accidental Placement of the Greenfield Filter in the Heart: Report of Two Cases et al., Journal of Vascular Surgery, Dec. 1987, vol. 6, No. 6.
Goodman, L.R. et al., “Subsequent Pulmonary Embolism: Risk After a Negative Helical CT Pulmonary Angiogram—Prospective Comparison With Scintigraphy”, Radiology, 2000, 215:535-542.
Gosin, J. S., “Efficacy of Prophylactic Vena Cava Filters in High-Risk Trauma Patients”, Annals of Vascular Surgery, 1997, 11:100-105.
Gottlieb, R.H., “Randomized Prospective Study Comparing Routine Versus Selective Use of Sonography of the Complete Calf in Patients With Suspected Deep Venous Thrombosis”, American Journal of Roentgenology, Jan. 2003, 180:241-245.
Grandas, O.H. et al., “Deep Venous Thrombosis in the Pediatric Trauma Population: An Unusual Event: Report of Three Cases”, The American Surgeon, Mar. 2000, vol. 66, pp. 273-276.
Grassi, C.L. et al., “Quality Improvement Guidelines for Percutaneous Permanent Inferior Vena Cava Filter Placement for the Prevention of Pulmonary Embolism”, Journal of Vascular and Interventional Radiology, Sep. 2003, 14:S271-S275.
Grassi, C.L. et al., “Vena Caval Occlusion After Simon Nitinol Filter Placement: Identification With MR Imaging in Patients With Malignancy”, Journal of Vascular and Interventional Radiology, 1992, 3(3):535-539.
Greene, F.L. et al., Letters to the Editor, The Journal of Trauma: Injury, Infection, and Critical Care, May 2005, vol. 5 8, No. 5, pp. 1091-1092.
Greenfield, L. J. et al., “Clinical Experience With the Kim-Ray Greenfield-Vena Caval Filter”, Ann Surg, Jun. 1977, vol. 185, No. 6, pp. 692-698.
Greenfield, L. J. et al., “Experimental Embolic Capture by Asymmetric Greenfield Filters”, Journal of Vascular Surgery, Sep. 1992, vol. 16, No. 3, pp. 436-444.
Greenfield, L.J. et al., “Filter Complications and Their Management”, Seminars in Vascular Surgery, vol. 13, No. 3, Sep. 2000, pp. 213-216.
Greenfield, L.J. et al., “Free-Floating Thrombus and Pulmonary Embolism/Reply”, Archives of Internal Medicine, Dec. 8-Dec. 22, 1997, pp. 2661-2662.
Greenfield, L.J. et al., “Limb Asymmetry in Titanium Greenfield Filters: Clinically Significant?”, Journal of Vascular Surgery, 1997, 26:770-775.
Greenfield, L.J. et al., “Prophylactic Vena Caval Filters in Trauma: The Rest of the Story”, Journal of Vascular Surgery, 2000, 32:490-497.
Greenfield, L.J. et al., “Recommended Reporting Standards for Vena Caval Filter Placement and Patient Follow-Up”, Journal of Vascular and Interventional Radiology, 1999, 10:1013-1019.
Greenfield, L.J. et al., “Results of a Multicenter Study of the Modified Hook-Titanium Greenfield Filter” Journal of Vascular Surgery 14:253-257 (Sep. 1991).
Greenfield, L.J. et al., “The Percutaneous Greenfield Filter: Outcomes and Practice Patterns”, Journal of Vascular Surgery, 2000, 32:888-893.
Greenfield, L.J. et al., “Twenty-Year Clinical Experience With the Greenfield Filter”, Cardiovascular Surgery, Apr. 1995, vol. 3, No. 2, pp. 199-205.
Greenfield, L.J., “Cost vs Value in Vena Caval Filters”, Chest, Jul. 1998, vol. 114, No. 1, pp. 9-10.
Greenfield, L.J., “Current Indications for and Results of Greenfield Filter Placement”, Journal Vascular Surgery, May 1984, vol. 1, No. 3, pp. 502-504.
Greenfield, L.J., “Does Cervical Spinal Cord Injury Induce Higher Incidence of Complications After Prophylactic Greenfield Filter Usage?”, Journal of Vascular and Interventional Radiology, Jul.-Aug. 1997, pp. 719-720.
Greenfield, L.J., “Recurrent Thromboembolism in Patients With Vena Cava Filters”, Journal of Vascular Surgery, 2001, 33:510-514.
Greenfield, L.J., “Staging of Fixation and Retrievability of Greenfield Filters”, Journal of Vascular Surgery, Nov. 1994, vol. 20, No. 5, pp. 744-750.
Greenfield, Lazar J. et al., “A New Intracaval Filter Permitting Continued Flow and Resolution of Emboli”, Surgery, Apr. 1973, vol. 73, No. 4, pp. 599-606.
Greenfield, Lazar J. et al., “Suprarenal Filter Placement, Journal of Vascular Surgery”, Sep. 1998, 28:432-438.
Greenfield, Lazar J. et al., “Vena Caval Filter Use in Patients With Sepsis”, Archives of Surgery, Nov. 2003, vol. 138, No. 11, Health & Medical Complete, pp. 1245-1248.
Greenfield, Lazar J. et al., “Extended Evaluation of the Titanium Greenfield Vena Caval Filter”, Journal of Vascular Surgery, Nov. 1994, vol. 20, No. 3, pp. 458-465.
Gunther, Rolf W. et al., “Vena Caval Filter to Prevent Pulmonary Embolism: Experimental Study”, Radiology, Aug. 1985,156:315-320.
Haage, Patrick et al., “Prototype Percutaneous Thrombolytic Device: Preclinical Testing in Subacute Inferior Vena Caval Thrombosis in a Pig Model”, Radiology, Jul. 2001,220:135-141.
Hagspiel, K.D. et al., “Inferior Vena Cava Filters: An Update”, Applied Radiology, Nov. 1998, pp. 20-34.
Hagspiel, K.L. et al., “Difficult Retrieval of a Recovery IVC Filter”, Journal of Vascular and Interventional Radiology (Letters to the Editor), Jun. 2004, vol. 15, No. 6, pp. 645-650.
Hainaux, B. et al., “Intragastric Band Erosion After Laparoscopic Adjustable Gastric Banding for Morbid Obesity: Imaging Characteristics of an Underreported Complication”, American Journal of Roentgenology, Jan. 2005, 184:109-112.
Hak, D.J., “Prevention of Venous Thromboembolism in Trauma and Long Bone Fractures”, Current Opinion in Pulmonary Medicine, 2001, 7:338-343.
Hammer, Frank D. et al., “In Vitro Evaluation of Vena Cava Filters”, Journal of Vascular and Interventionai Radiology, Nov.-Dec. 1994, 5:869-876.
Kazmers, A. et al., “Pulmonary Embolism in Veterans Affairs Medical Centers: Is Vena Cava Interruption Underutilized?”, The American Surgeon, Dec. 1999, vol. 65, No. 12, pp. 1171-1175.
Kearon, C. et al., “Management of Anticoagulation Before and After Elective Surgery”, The New England Journal of Medicine, May 22, 1997, vol. 336, No. 21, pp. 1506-1511.
Kellum, J. M., “Gastric Banding” Annals of Surgery, Jan. 2003, vol. 237, No. 1, pp. 17-18.
Kelly, J. et al., “Anticoagulation or Inferior Vena Cava Filter Placement for Patients With Primary Intracerebral Hemorrhage Developing Venous Thromboembolism?”, Stroke, 2003, 34:2999-3005.
Kercher, K. et al., “Overview of Current Inferior Vena Cava Filters”, The American Surgeon, Aug. 2003, vol. 69, pp. 643-648.
Kerlan, R.K., Jr. et al., “Residual Thrombus Within a Retrievable IVC Filter”, Journal of Vascular and Interventional Radiology, 2005, 16:555-557.
Kerr, A. et al., “Bidirectional Vena Cava Filter Placement”, Journal of Vascular Surgery, Oct. 1995, vol. 22, No. 4.
Khansarinia, S. et al., Prophylactic Greenfield Filter Placement in Selected High-Risk Trauma Patients, Journal of Vascular Surgery, 1995, 22:231-236.
Kim et al., “Insertion of the Simon Nitinol Caval Filter: Value of the Antecubital Vein Approach” AJR 157:521-522 (Sep. 1991).
Kim et al., “Perforation of the Inferior Vena Cava with Aortic and Vetebral Penetration by a Suprarenal Greenfield Filter” Radiology 172:721-723 (1989).
Kim et al., “The Simon Nitinol Filter: Evaluation by MR and Ultrasound” Angiology 43:541-548 (Jul. 1992).
Kim et al., “Vena Cava Filter Placement via the External Jugular Vein” AJR 155:898-899 (Oct. 1990).
Kim, D. et al., “Insertion of the Simon Nitinol Caval Filter: Value of the Antecubital Vein Approach”, American Journal of Roentgenology, Sep. 1991, 157:521-522.
Kim, J. et al., “Preliminary Report on the Safety of Heparin for Deep Venous Thrombosis Prophylaxis After Severe Head Injury”, The Journal of Trauma: Injury, Infection, and Critical Care, Jul. 2002, vol. 53, No. 1, pp. 38-43.
Kim, V. et al., “Epidemiology of Venous Thromboembolic Disease”, Emergency Medicine Clinics of North America, Nov. 2001, vol. 19, No. 4, pp. 839-859.
Kimmerly, W. S. et al., “Graduate Surgical Trainee Attitudes Toward Postoperative Thromboprophylaxis”, Southern Medical Journal, Aug. 1999, vol. 92, No. 9, pp. 790-794.
King, J.N. et al., “Vena Cava Filters”, The Western Journal of Medicine, Mar. 1992, vol. 156, No. 3, pp. 295-296.
Linsenmaier U. et al., “Indications, Management, and Complications of Temporary Inferior Vena Cava Filters”, Cardiovascular and Interventional Radiology, 1998, 21:464-469.
Lipman, J.C., “Removal of Vena Caval Filter at 224 Days”, Southern Medical Journal, May 2005, vol. 98, No. 5, pp. 556-558.
Loehr, S.P. et al., “Retrieval of Entrapped Guide Wire in an IVC Filter Facilitated With Use of a Myocardial Biopsy Forceps and Snare Device”, Journal of Vascular and Interventional Radiology (Letter to Editor), Sep. 2001, vol. 12, No. 9, pp. 1116-1118.
Lopez-Beret, P. et al., “Systematic Study of Occult Pulmonary Thromboembolism in Patients With Deep Venous Thrombosis”, Journal of Vascular Surgery, 2001, 33:515-521.
Lorch, H. et al., “Current Practice of Temporary Vena Cava Filter Insertion: A Multicenter Registry”, Journal of Vascular and Interventional Radiology, 2001, 11:83-88.
Lorch, H. et al., “In Vitro Studies of Temporary Vena Cava Filters”, Cardiovascular and Interventional Radiology, 1998, 21:146-150.
Lorch, H. et al., “Temporary Vena Cava Filters and Ultrahigh Streptokinase Thrombolysis Therapy: A Clinical Study”, Cardiovascular Interventional Radiology, 2000, 23:273-278.
Lujan, J. A. et al., “Laparoscopic Versus Open Gastric Bypass in the Treatment of Morbid Obesity”, Annals of Surgery, Apr. 2004, vol. 239, No. 4, pp. 433-437.
Lund, G. et al., “A New Vena Caval Filter for Percutaneous Placement and Retrieval Experimental Study”, Radiology, 1984, 152:369-372.
Lund, G. et al., “Retrievable Vena Caval Filter Percutaneously Introduced”, Radiology, 1985, vol. 155, p. 831.
Luo, X. Y. et al., “Non-Newtonian Flow Patterns Associated With an Arterial Stenosis”, Journal of Biomechanical Engineering, Nov. 1992, 114:512-514.
MacDonald, K. G. Jr., “Overview of the Epidemiology of Obesity and the Early History of Procedures to Remedy Morbid Obesity”, Archives of Surgery, Apr. 2003, 138(4):357-360.
Machado, L.G. et al., “Medical Applications of Shape Memory Alloys”, Brazilian Journal of Medical and Biological Research, 2003, 36:683-691.
Magnant, J.G. et al., “Current Use of Inferior Vena Cava Filters”, Journal of Vascular Surgery, Nov. 1992, vol. 16, No. 5, pp. 701-706.
Malden et al., “Transvenous Retreival of Misplaced Stainless Steel Greenfield Filters” JVIR 3:703-708 (1992).
Manke, C. et al., “MR Imaging-Guided Stent Placement in Iliac Arterial Stenoses: A Feasibility Study”, Radioilogy, 2001, 219:527-534.
Marston, W.A. et al., “Re: Comparison of the AngioJet Rheolytic Catheter to Surgical Thrombectomy for the Treatment of Thrombosed Hemodialysis Grafts”, Journal of Vascular and Interventional Radiology (Letters to the Editor), Sep. 2000, vol. 11, No. 8, pp. 1095-1099.
Matteson, B. et al., “Role of Venous Duplex Scanning in Patients With Suspected Pulmonary Embolism”, The Journal of Vascular Surgery, 1996, 24:768-773.
Matthews, B. D. et al., “Inferior Vena Cava Filter Placement: Preinsertion Inferior Vena Cava Imaging”, The American Surgeon, Aug. 2003, vol. 69, No. 8, pp. 649-653.
Mattos, M.A. et al., “Prevalence and Distribution of Calf Vein Thrombosis in Patients With Symptomatic Deep Venous Thrombosis: A Color-Flow Duplex Study”, Journal of Vascular Surgery, 1996, 24:738-744.
Maxwell, R.A. et al., “Routine Prophylactic Vena Cava Filtration is Not Indicated After Acute Spinal Cord Injury”, The Journal of Trauma: Injury, Infection, and Critical Care, 2002, 52:902-906.
McCowan, T.C. et al., “Complications of the Nitinol Vena Caval Filter”, Journal of Vascular and Interventional Radiology, 1992, 3:401-408.
McMurtry, A.I. et al., “Increased Use of Prophylactic Vena Cava Filters in Trauma Patients Failed to Decrease Overall Incidence of Pulmonary Embolism”, Journal of the American College of Surgeons, 1999, 189:314-320.
Meissner, M.H. et al., Venous Thromoembolism in Trauma: A Local Manifestation of Systemic Hypercoagulability?, The Journal of Trauma: Injury, Infection, and Critical Care, Feb. 2003, vol. 54, No. 2, pp. 224-231.
Melinek, J. et al., “Autopsy Findings Following Gastric Bypass Surgery for Morbid Obesity”, Arch Path Lab Med, 2002 126:1091-1095.
Mihara, H. et al., “Use of Temporary Vena Cava Filters After Catheter-Directed Fragmentation and Thrombolysis in Patients With Acute Pulmonary Thromboembolism”, Japanese Circulartion Journal, Jun. 1998, vol. 62, pp. 462-464.
Miller, A. C., “British Thoracic Society Guidelines for the Management of Suspected Acute Pulmonary Embolism”, Thorax, Jun. 2003, 58(6): 470-483.
Miller, Karl E., “Indications for Vena Cava Filters for Recurrent DVT”, American Family Physician, Feb. 1, 2003, vol. 67, No. 3, p. 593.
Millward, S., “Re: Temporary IVC Filtration Before Patent Foramen Ovale Closure in a Patient With Paradoxic Embolism”, Letter to the Editor, J Vasc Intery Radiol. Jul. 2003;14(7):937.
Millward, S.F. et a l., “Preliminary Clinical Experience with the Gunther Temporary Inferior Vena Cava Filter”, Journal of Vascular and Interventional Radiology, 1994, 5:863-868.
Millward, S.F. et al., “Gunther Tulip Filter Preliminary Clinical Experience With Retrieval”, Journal of Vascular and Interventional Radiology, 2000, 11:75-82.
Millward, S.F. et al., “Gunther Tulip Retrievable Vena Cava Filter: Results From the Registry of the Canadian Interventional Radiology Association”, Journal of Vascular and Interventional Radiology, 2001, 12:1053-1058.
Millward, S.F. et al., “LGM (Vena Tech), Vena Caval Filter: Clinical Experience in 64 Patients”, Journal of Vascular and Interventional Radiology, Nov. 1991, 2:429-433.
Millward, S.F. et al., “LGM (Vena Tech), Vena Caval Filter: Experience at a Single Institution”, Journal of Vascular and Interventional Radiology, Mar.-Apr. 1994, 5:351-356.
Millward, S.F. et al., “Reporting Standards for Inferior Venal Caval Filter Placement and Patient Follow-Up: Supplement for Temporary and Retrievable/Optional Filters”, Journal of Vascular and Interventional Radiology, Apr. 2005, 16:441-443.
Millward, S.F., “Gunther Tulip Retrievable Filter Why, When and How?”, JACR, Jun. 2001, vol. 52, No. 3, pp. 188-192.
Millward, S.F., “Temporary and Retrievable Inferior Vena Cava Filters Current Status”, Journal of Vascular and Interventional Radiology, May-Jun. 1998, vol. 9, No. 3, pp. 381-387.
Mobin-Uddin, K. et al., “Evolution of a New Device for the Prevention of Pulmonary Embolism, The American Journal of Surgery”, vol. 168, Oct. 1994, pp. 330-334.
Mohan, C.R. et al., “Comparative Efficacy and Complications of Vena Caval Filters”, Journal of Vascular Surgery, 1995, 21:235-236.
Montessuit, M. et al., “Screening for Patent Foramen Ovale and Prevention of Paradoxical Embolus”, Ann Fasc Surg, 1997, 11:168-172.
Montgomery, K.D et al., The Detection and Management of Proximal Deep Venous Thrombosis in Patients With Acute Acetabular Fractures: A Follow-up Report:, Journal of Orthopedic Trauma, Jul. 1997, 1(5):330-336.
Mortele, K. J. et al., “The Swedish Laparoscopic Adjustable Gastric Banding for Morbid Obesity: Radiologic Findings in 218 Patients”, American Journal of Roentgenology, 2001, 177:77-84.
Munir, M.A. et al., “An In Situ Technique to Retrieve an Entrapped J-Tip Guidewire From an Inferior Vena Cava Filter”, Anesth Analo, 2002, 95:308-309.
Murakami, M. et al., “Deep Venous Thrombosis Prophylaxis in Trauma: Improved Compliance With a Novel Miniaturized Pneumatic Compression Device”, Journal of Vascular Surgery, 2003, 38:923-927.
Nakagawa, N. et al., “A Retrievable Nitinol Vena Cava Filter: Experimental and Initial Clinical Results”, Journal of Vascular and Interventional Radiology, 1994, 5:507-512.
Nakajima, Osamu et al., “Massive Deep Vein Thrombosis After Cesarean Section Treated With a Temporary Inferior Vena Cava Filter: A Case Report”, J Cardioi 2000; 36(5): pp. 337-342.
Napolitano, L. M. et al., “Asymptomatic Deep Venous Thrombosis in the Trauma Patient: Is an Aggressive Screening Protocol Justified?”, The Journal of Trauma: Injury, Infection, and Critical Care, 1997, vol. 39, No. 4, pp. 651-659.
Nazario, R. et al., “Treatment of Venous Thromboembolism”, Cardiology in Review, 2002, 10(4):249-259.
Neeman, Z. et al., “Metastatic Involvement of a Retrieved Inferior Vena Cava Filter”, J Vase Interv Radiol. Dec. 2003; 14(12): 1585.
Neill, A. M. et al., “Retrievable Inferior Vena Caval Filter for Thromboembolic Disease in Pregnancy”, British Journal of Obstetrics and Gynaecology, Dec. 1997, vol. 104, pp. 1416-1418.
U.S. Appl. No. 11/966,203, filed Dec. 28, 2007 Non-Final Office Action dated Aug. 17, 2009.
U.S. Appl. No. 11/997,832, filed Aug. 20, 2008 Non-Final Office Action dated Aug. 16, 2010.
U.S. Appl. No. 11/997,832, filed Aug. 20, 2008 Non-Final Office Action dated Feb. 23, 2011.
U.S. Appl. No. 12/093,814, filed Jun. 8, 2009 Non-Final Office Action dated Jul. 10, 2012.
U.S. Appl. No. 12/095,700, filed Jun. 17, 2010 Final Office Action dated Sep. 28, 2012.
U.S. Appl. No. 12/095,700, filed Jun. 17, 2010 Non-Final Office Action dated Jun. 11, 2012.
U.S. Appl. No. 12/095,700, filed Jun. 17, 2010 Non-Final Office Action dated Oct. 9, 2013.
U.S. Appl. No. 12/095,991, filed Jul. 31, 2008 Advisory Action dated Sep. 20, 2012.
U.S. Appl. No. 12/095,991, filed Jul. 31, 2008 Final Office Action dated May 4, 2012.
U.S. Appl. No. 12/095,991, filed Jul. 31, 2008 Non-Final Office Action dated Nov. 14, 2011.
U.S. Appl. No. 12/095,991, filed Jul. 31, 2008 Notice of Abandonment dated Nov. 23, 2012.
U.S. Appl. No. 12/096,783, filed Aug. 20, 2009 Non-Final Office Action dated Apr. 25, 2013.
U.S. Appl. No. 12/299,300, filed Feb. 24, 2009 Non-Final Office Action dated Apr. 30, 2012.
U.S. Appl. No. 12/299,300, filed Feb. 24, 2009 Notice of Allowance dated Aug. 17, 2012.
U.S. Appl. No. 12/299,304, filed Jun. 16, 2009 Non-Final Office Action dated Aug. 21, 2013.
U.S. Appl. No. 12/299,304, filed Jun. 16, 2009 Non-Final Office Action dated Jun. 21, 2012.
U.S. Appl. No. 12/303,545, filed Jun. 29, 2009 Advisory Action dated Jul. 24, 2013.
U.S. Appl. No. 12/303,545, filed Jun. 29, 2009 Non-Final Office Action dated Jun. 8, 2012.
U.S. Appl. No. 12/336,454, filed Dec. 12, 2008 Non-Final Office Action dated Jan. 24, 2011.
U.S. Appl. No. 12/727,116, filed Mar. 18, 2010 Non-Final Office Action dated Jul. 18, 2012.
U.S. Appl. No. 12/846,680, filed Jul. 29, 2010 Advisory Action dated Feb. 8, 2013.
U.S. Appl. No. 12/846,680, filed Jul. 29, 2010 Final Office Action dated Nov. 30, 2012.
U.S. Appl. No. 12/846,680, filed Jul. 29, 2010 Non-Final Office Action dated May 7, 2012.
U.S. Appl. No. 12/846,680, filed Jul. 29, 2010 Notice of Allowance dated Aug. 28, 2013.
U.S. Appl. No. 13/009,727, filed Jan. 19, 2011 Notice of Allowance dated Apr. 27, 2012.
U.S. Appl. No. 13/170,054, filed Jun. 27, 2011 Final Office Action dated Apr. 3, 2013.
U.S. Appl. No. 13/170,054, filed Jun. 27, 2011 Non-Final Office Action dated Jul. 2, 2012.
U.S. Appl. No. 13/170,054, filed Jun. 27, 2011 Notice of Allowance dated Jul. 15, 2013.
U.S. Appl. No. 13/300,469, filed Nov. 18, 2011 Non-Final Office Action dated Sep. 20, 2012.
U.S. Appl. No. 13/300,469, filed Nov. 18, 2011 Notice of Allowance dated Jan. 10, 2013.
U.S. Appl. No. 13/414,605, filed Mar. 7, 2012 Non-Final Office Action dated Aug. 12, 2013.
U.S. Appl. No. 13/688,031, filed Nov. 28, 2012 Final Office Action dated Jul. 9, 2013.
U.S. Appl. No. 13/688,031, filed Nov. 28, 2012 Non-Final Office Action dated Mar. 14, 2013.
Valji, K., “Evolving Strategies for Thrombolytic Therapy of Peripheral Vascular Occlusion”, Journal of Vascular and Interventional Radiology, 2000, 11:411-420.
Van Ha, Thuong G. et al., “Removal of Gunther Tulip Vena Cava Filter Through Femoral Vein Approach”, Journal of Vascularand Interventional Radiology, 2005, 16:391-394.
Van Natta, Timothy L. et al., “Elective Bedside Surgery in Critically Injured Patients is Safe and Cost-Effective”, American Surgery, May 1998, 227(5):618-626.
Vedantham, S. et al., “Endovascular Recanalization of the Thrombosed Filter-Bearing Inferior Vena Cava”, Journal of Vascularand Interventional Radiology, 2003, 14:893-903.
Vedantham, S. et al., “Lower Extremity Venous Thrombolysis With Adjunctive Mechanical Thrombectomy”, Journal of Vascularand Interventional Radiology, 2002, 13:1001-1008.
Vedantham, S. et al., “Pharmacomechanical Thrombolysis and Early Stent Placement for Iliofemoral Deep Vein Thrombosis”, Journal of Vascular and Interventional Radiology, 2004, 15:565-574.
Velmahos, G. C. et al., “Inability of an Aggressive Policy of Thromboprophylaxis to Prevent Deep Venous Thrombosis (DVT) in Critically Injured Patients: Are Current Methods of DVT Prophylaxis Insufficient”, Journal of the American College of Surgeons, 1998, 187:529-533.
Velmahos, G. C. et al., “Prevention of Venous Thromboembolism After Injury: An Evidence-Based Report—Part 1: Analysis of Risk Factors and Evaluation of the Role of Vena Caval Filters”, The Journal of Trauma: Injury, Infection, and Critical Care, Jul. 2000, 49:132-139.
Velmahos, G. C. et al., “Prevention of Venous Thromboembolism After Injury: An Evidence-Based Report—Part II: Analysis of Risk Factors and Evaluation of the Role of Vena Caval Filters”, The Journal of Trauma: Injury, Infection, and Critical Care, Jul. 2000, 49:140-144.
Velmahos, G. C. et al., “Spiral Computed Tomography for the Diagnosis of Pulmonary Embolism in Critically III Surgical Patients”, Archives of Surgery, May 2001, 136(5):505-511.
Venbrux, Anthony C., “Protection Against Pulmonary Embolism: Permanent and Temporary Caval Filters” Presentation, Department of Radiology—CVDL, The Johns Hopkins Medical Institutions, Baltimore MD, 7 pages, 2007.
Vesely, T. M. et al., “Preliminary Investigation of the Irie Inferior Vena Caval Filter”, Journal of Vascular and Interventional Radiology, 1996, 7:529-535.
Vorwerk, D. et al., “Use of a Temporary Caval Filter to Assist Percutaneous lliocaval Thrombectomy: Experimental Results, Journal of Vascular and Interventional Radiology”, Sep.-Oct. 1995, 6(5):737-740.
Vos, Louwerens D. et al., “The Gunther Temporary Inferior Vena Cava Filter for Short-Term Protection Against Pulmonary Embolism”, Cardiovascular and Interventional Radiology, 1997, 20:91-97.
Vrachliotis, T. G. et al., “Percutaneous Management of Extensive Clot Trapped in a Temporary Vena Cava Filter”, Journal of Endovascular Therapy, 2003, 10:1001-1005.
Wakefield, T. W., Treatment Options for Venous Thrombosis, Journal of Vascular Surgery, Mar. 2000, 31(3):613-620.
Wallace, M. J. et al., “Inferior Vena Caval Stent Filter”, AJR, Dec. 1986, 147:1247-1250.
Hoff, W. S. et al., “Early Experience With Retrievable Inferior Vena Cava Filters in High-Risk Trauma Patients”, Journal of the American College of Surgeons, Dec. 2004, vol. 199, No. 6, pp. 869-874.
Holtzman, R.B. et al., “Comparison of Carbon Dioxide and Iodinated Contrast for Cavography Prior to Inferior Vena Cava Filter Placement”, The American Journal of Surgery, 2003, 185:364-368.
Hosaka, J. et al., “Placement of a Spring Filter During Interventional Treatment of Deep Venous Thrombosis to Reduce the Risk of Pulmonary Embolism”, Acta Radiologica, 1999, 40:545-551.
Hughes, G.C. et al., “The Use of a Temporary Vena Caval Interruption Device in High-Risk Trauma Patients Unable to Receive Standard Venous Thromboembolism Prophylaxis”, Investigative Radiology, Feb. 1999, vol. 46, No. 2, pp. 246-249.
Hunter, D.W. et al., “Retrieving the Amplatz Retrievable Vena Cava Filter”, Cardiovascular and Interventional Radiology, 1987, 10:32-36.
Hyers, T. M. et al., “Antithrombotic Therapy for Venous Thromboembolic Disease”, Chest, Jan. 2001, 119 (1):176S-193S.
Ihnat, D. M. et al., “Treatment of Patients With Venous Thromboembolism and Malignant Disease: Should Vena Cava Filter Placement Be Routine?”, Journal of Vascular Surgery, Nov. 1998, vol. 28, No. 8, pp. 800-807.
Inge, T. H. et al., “Bariatric Surgery for Severely Overweight Adolescents: Concerns and Recommendations”, Pediatrics, Jul. 2004, vol. 114, No. 1, pp. 217-223.
Izutani, H. et al., “Migration of an Inferior Vena Cava Filter to the Right Ventricle and Literature Review”, Can J Cardiol, Feb. 2004, vol. 20, No. 2, pp. 233-235.
Jackson Slappy, A.L. et al., “Delayed Transcaval Renal Penetration of a Greenfield Filter Presenting as Symptomatic Hydronephrosis”, The Journal of Urology, Apr. 2002, vol. 167, pp. 1778-1779.
Jacobs, D. G. et al., “The Role of Vena Caval Filters in the Management of Venous Thromboembolism” The American Surgeon, Aug. 2003, vol. 69, No. 8, pp. 635-642.
Jacobs, D. G. et al., Letters to the Editor, The Journal of Trauma, Dec. 1997, vol. 43, No. 6, pp. 988-989.
Jaeger, H.J. et al., “A Physiologic In Vitro Model of the Inferior Vena Cava With a Computer-Controlled Flow System for Testing of Inferior Vena Cava Filters”, Investigative Radiology, Sep. 1997, vol. 32, No. 9, pp. 511-522.
Jain, V. et al., “Preoperative Vena Caval Interruption for Venous Thrombosis Associated With Ovarian Malignancy”, Acta Obstet Gynecol Scand 2002: 81: 270-271.
James Kevin V. et al., “Tricuspid Insufficiency After Intracardiac Migration of a Greenfield Filter: Case Report and Review of the Literature”, Journal of Vascular Surgery, Sep. 1996, vol. 24, No. 3, pp. 494-498.
Jarrett B.P. et al., Inferior Vena Cava Filters in Malignant Disease, Journal of Vascular Surgery, 2002, 36:704-707.
Joels, C. S. et al., “Complications of Inferior Vena Cava Filters”, The American Surgeon, Aug. 2003, vol. 69, No. 8, pp. 654-659.
Johnson, M.S., “Current Strategies for the Diagnosis of Pulmonary Embolus”, Journal of Vascular and Interventional Radiology, 2002, 13:13-23.
Johnson, S.P. et al., “Single Institution Prospective Evaluation of the Over-The-Wire Greenfield Vena Caval Filter”, Journal of Vascular and Interventional Radiology, 1998, 9:766-773.
Jones, A.L. et al., “Case Report: Use of an IVC Filter in the Management of IVC Thrombosis Occurring as a Complication of Acute Pancreatitis”, Clinical Radiology, 1998, 53:462-464.
Joshi, A. et al., “Filter-Related, Thrombotic Occlusion of the Inferior Vena Cava Treated With a Gianturco Stent”, Journal of Vascular and Interventional Radiology, 2003, 14:381-385.
JP 2008-543433 filed May 30, 2008 Office Action dated Jan. 11, 2012.
Kaplan, S. et al., “Surgical Management of Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus, The American Journal of Surgery”, 2002, 183:292-299.
Karmy-Jones, R. et al., “Surgical Management of Cardiac Arrest Caused by Massive Pulmonary Embolism in Trauma Patients”, The Journal of Trauma: Injury, Infection, and Critical Care, 2000, vol. 48, No. 3, pp. 519-520.
Kasirajan, K. et al., “Percutaneous AngioJet Thrombectomy in the Management of Extensive Deep Venous Thrombosis”, Journal of Vascular and Interventional Radiology, 2001, 12:179-185.
Katsamouris, A.A. et al., “Inferior Vena Cava Filters: In Vitro Comparison of Clot Trapping and Flow Dynamics”, Radiology, 1988, 166:361-366.
Reddy, K. et al., “Insertion of an Inferior Venocaval Filter in a Pregnant Woman at Risk for Pulmonary Embolism—A Challenging Management”, Departments of Obstetrics and Gynaecology and Radiology, Wexham Park Hospital, Slough, UK, 2003, p. 198.
Kaufman, J.A. et al., “Guide-Wire Entrapment by Inferior Vena Caval Filters: In Vitro Evaluation”, Radiology, 1996, 198:71-76.
Kaufman, J.A. et al., “Operator Errors During Percutaneous Placement of Vena Cava Filters”, American Journal of Roentgenology, Nov. 1995, 165:1281-1287.
Kaufman, John A., “Re: Metastatic Involvement of a Retrieved Inferior Vena Cava Filter”, Journal of Vascular and Interventional Radiology, Jul. 2004, vol. 15, No. 7, pp. 775-776.
Kaw, L.L., Jr. et al., “Use of Vena Cava Filters”, Techniques in Orthopaedics, 2004, 19(4):327-336.
Kazmers, A. et al., “Duplex Examination of the Inferior Vena Cava”, The American Surgeon, Oct. 2000, vol. 66, pp. 986-989.
Kazmers, A. et al., “Intraoperative Insertion of Greenfield Filters: Lessons Learned in a Personal Series of 152 Cases”, The American Surgeon, Oct. 2002, vol. 68, pp. 877-882.
Gamblin, T.C. et al., “A Prospective Evaluation of a Bedside Technique for Placement of Inferior Vena Cava Filters: Accuracy and Limitations of Intravascular Ultrasound”, The American Surgeon, May 2003, vol. 69, pp. 382-386.
Garcia, N.D., “Is Bilateral Ultrasound Scanning of the Legs Necessary for Patients With Unilateral Symptoms of Deep Vein Thrombosis”, Journal of Vascular Surgery, 2001, 34:792-797.
Gayer, G. et al., “Congenital Anomalies of the Inferior Vena Cava Revealed on CT in Patients With Deep Vein Thrombosis”, American Journal of Roentgenology, Mar. 2003, vol. 180, pp. 729-732.
Geerts, W.H., “A Prospective Study of Venous Thromboembolism After Major Trauma”, Dec. 15, 1994, vol. 331, No. 24, pp. 1601-1606.
Gelbfish, G. A. et al., “Intracardiac and Intrapulmonary Greenfield Filters: A Long-Term Follow-Up”, Journal of Vascular Surgery, Nov. 1991, Vo. 14, No. 5, pp. 614-617.
Gelfand, E.V. et al., “Venous Thromboembolism Guidebook, Fourth Edition”, Critical Pathways in Cardiology, Dec. 2003, vol. 2, No. 4, pp. 247-265.
Georgopoulos, S.E. et al., “Paradoxical Embolism”, Journal of Cardiovascular Surgery, 2001, 42:675-677.
Ginsberg, M.S. et al., “Clinical Usefulness of Imaging Performed After CT Angiography That Was Negative for Pulmonary Embolus in a High-Risk Oncologic Population”, American Journal of Roentgenology, Nov. 2002, 179:1205-1208.
Girard, R. et al., Medical Literature and Vena Cava Filters, Chest, 2002, 122:963-967.
Girard, T. D. et al., “Prophylactic Vena Cava Filters for Trauma Patients: A Systematic Review of the Literature”, Thrombosis Research, 2003, 112:261-267.
Goldberg, M.E., “Entrapment of an Exchange Wire by an Inferior Vena Caval Filter: A Technique for Removal”, Anesth Analg., Apr. 2003, 96:4, 1235-1236.
Goldhaber, S.Z. et al., “Acute Pulmonary Embolism: Part II Risk Stratification, Treatment, and Prevention”, Circulation, 2003, 108:2834-2838.
Goldhaber, S.Z., “A Free-Floating Approach to Filters”, Archives of Internal Medicine, Feb. 10, 1997, vol. 157, No. 3, pp. 264-265.
Goldhaber, S.Z., “Venous Thromboembolism in the Intensive Care Unit: The Last Frontier for Pro . . . ”, Chest, Jan. 1998, 113(1):5-7.
Goldman, H.B. et al., “Ureteral Injury Secondary to an Inferior Vena Caval Filter”, The Journal of Urology, Nov. 1996, vol. 156, No. 5, p. 1763.
Golueke, P.J. et al., “Interruption of the Vena Cava by Means of the Greenfield Filter: Expanding the Indications”, Surgery, Jan. 1988, vol. 103, No. 1, pp. 111-117.
Gonze, M.D. et al., “Orally Administered Heparin for Preventing Deep Venous Thrombosis”, American Journal of Surgery, Aug. 1998, vol. 176, pp. 176-178.
Peck, K. E. et al., “Postlaparoscopic Traumatic Inferior Vena Caval Thrombosis”, Heart & Lung, Jul./Aug. 1998, vol. 27, No. 4, pp. 279-281.
Pelage, J. et al., “Re: Leiomyoma Recurrence After Uterine Artery Embolization, Journal of Vascular and Interventional Radiology,” Jul. 2004, vol. 15, No. 7, pp. 773-776.
Peskin, Gerald R. (ed.), Papers of the Western Surgical Association, “Directed Parathyroidectomy-Feasibility and Performance in 100 Consecutive Patients With Primary Hyperparathyroidism”, Archives of Surgery, Jun. 2003, vol. 138, p. 581.
Peterson, D. A. et al., “Computed Tomographic Venography is Specific But Not Sensitive for Diagnosis of Acute Lower-Extremity Deep Venous Thrombosis in Patients With Suspected Pulmonary Embolus”, Journal of Vascular Surgery, 2001, 34:798-804.
Podnos, Y. D. et al., “Complications After Laparoscopic Gastric Bypass”, Archives of Surgery, Sep. 2003, 138:957-961.
Poletti, P.A. et al., “Long-Term Results of the Simon Nitinol Inferior Vena Cava Filter”, Eur. Radiol., 1998, vol. 8, pp. 289-294.
Ponchon, M. et al., “Temporary Vena Caval Filtration Preliminary Clinical Experience With Removable Vena Caval Filters”, Acta Clinica Belgica, 1999, vol. 54, pp. 223-228.
Porcellini, Massimo et al., “Intracardiac Migration of Nitinol TrapEase.TM. Vena Cava Filter and Paradoxical Embolism”, European Journal of Cardio-Thoracic Surgery, vol. 22, 2002, pp. 460-461.
Porter, J. M. et al., “Reporting Standards in Venous Disease: An Update”, Journal of Vascular Surgery, 1995, 21:635-645.
Poster: Clinical Science: Pulmonary Disease or Dysfunctional/Mechanical Ventilation/Weaning (Adult), Critical Care Medicine, vol. 32, No. 12 (Suppl.), pp. A111-A120, 2004.
Prince et al., Local Intravascular Effects of the Nitinol Wire Blood Clot Filter Investigative Radiology 23:294-390 (Apr. 1988).
Prince, M. R. et al., “The Diameter of the Inferior Vena Cava and Its Implications for the Use of Vena Caval Filters”, Radiology, 1983, 149:687-689.
Proctor, M. C. et al., “Assessment of Apparent Vena Caval Penetration by the Greenfield Filter”, Journal of Endovascualr Surgery, 1998, 5:251-258.
Proctor, M. C., “Indications for Filter Placement”, Seminars in Vascular Surgery, Sep. 2000, vol. 13, No. 3, pp. 194-198.
Putnam et al., “Placement of Bilateral Simon Nitinol Filters for an Inferior Vena Cava Duplication through a Single Groin Access” JVIR 10:431-433 (1999).
Putterman, Daniel et al., “Aortic Pseudoaneurysm After Penetration by a Simon Nitinol Inferior Vena Cava Filter”, J Vasc Interv Radiol, 2005, 16:535-538.
Qanadli, S. D. et al., “Pulmonary Embolism Detection: Prospective Evaluation of Dual-Section Helical CT Versus Selective Pulmonary Arteriography in 157 Patients”, Radiology, 2000, 217:447-455.
Qian et al., “In Vitro and In Vivo Experimental Evaluation of a New Vena Caval Filter” JVIR 5:513-518 (1994).
Quality Improvement Guidelines for Percutaneous Inferior Vena Cava Filter Placement for the Prevention of Pulmonary Embolism (European Standards adopted and Modified by CIRSE in Cooperation With SCVIR Standards of Practice Committee), http:www.cirse.org/vena_cava_filter_crise.htm, retrieved May 17, 2002, 11 pages.
Questions and Answers: Vena Caval filters and anticoagulants, JAMA; Oct. 20, 1993; 270, 15; pp. 1867-1868.
Quirke, T. E. et al., “Inferior Vena Caval Filter Use in U.S. Trauma Centers a Practitioner Survey”, The Journal of Trauma: Injury, Infection, and Critical Care, 1997, vol. 43, No. 2, pp. 333-337.
Rabkin, D. J. et al., “Nitinol Properties Affecting Uses in Interventional Radiology”, Journal of Vascular and Interventional Radiology, 2000, 11:343-350.
Radke, R W. et al., “Thrombosis in Behcet's Disease: Report of a Case Followed by a Systematic Review Using the Methodology of Evidence-Based Medicine”, Journal of Thrombosis and Thrombolysis, Apr. 2001, 11 (2):137-141.
Rajan, Dheeraj K. et al., “Retrieval of the Bard Recovery Filter from the Superior Vena Cava,” JVIR, Letters to the Editor, vol. 15, No. 10, Oct. 2004, pp. 1169-1171.
Raju, N. L. et al., “Case 37: Juxtacaval Fat Collection-Mimic of Lipoma in the Subdiaphragmatic Inferior Vena Cava”, Radiology, 2001, 220:471-474.
Rascona, D. A. et al., “Pulmonary Embolism-Treatment vs Nontreatment”, Chest, Jun. 1999, vol. 115, No. 6, p. 1755.
Ray Jr., C. E. et al., “Complications of Inferior Vena Cava Filters”, Abdominal Imaging, 1996, 21:368-374.
Razavi, M. K. et al., “Chronically Occluded Inferior Venae Cavae: Endovascular Treatment”, Radiology, 2000, 214:133-138.
RD Heparin Arthroplasty Group, “RD Heparin Compared With Warfarin for Prevention of Venous Thromboembolic Disease Following Total Hip or Knee Arthroplasty”, The Journal of Bone and Joint Surgery, Incorporation, Aug. 1994, vol. 76-A, No. 8, pp. 1174-1185.
Reed, Ricahrd A., “The Use of Inferior Vena Cava Filters in Pediatric Patients for Pulmonary Embolus Prophylaxis”, Cardiovascular and Interventional Radiology, 1996,19:401-405.
Reekers, J. A. et al., “Evaluation of the Retrievability of the OptEase IVC Filter in an Animal Model”, Journal of Vascular and Interventional Radiology, 2004, 15:261-267.
Reekers, Jim A., “Re Current Practice of Temporary Vena Cava Filter Insertion: A Multicenter Registry”, Journal of Vascular Interventional Radiology, Nov.-Dec. 2000, pp. 1363-1364.
Ricco, Jean Baptiste et al., “Percutaneous Transvenous Caval Interruption with the LGM Filter”, Ann Vase Surg, 1988,3:242-247.
Ricotta, J. J., “Regarding Recurrent Thromboembolism in Patients With Vena Caval Filters”, Journal of Vascular Surgery, 2001, vol. 33, p. 657.
Riedel, M., “Acute Pulmonary Embolism 2: Treatment”, Heart, Mar. 2001, 85(3):351-360.
Robinson, Jeffrey D. et al., “In Vitro Evaluation of Caval Filters”, Cardiovascular and Interventionalradiology, 1988, 11 :346-351.
Robrer, M. J. et al., “Extended Indications for Placement of an Inferior Vena Cava Filter”, Journal of Vascular Surgery, Jul. 1990, vol. 12, No. 1.
Rodrigues, H. L. et al., “Update of the Management of Venous Thromboembolism [16]”, Rev Port Cardiol, 2002, 21(2):183-199.
Rodriguez, J. L. et al., “Eady Placement of Prophylactic Vena Caval Filters in Injured Patients at High Risk for Pulmonary Embolism”, The Journal of Trauma, Injury, Infection, and Critical Care, 1996, vol. 40, No. 5, pp. 797-804.
Roehm Jr., John O. F. et al., “The Bird's Nest Inferior Vena Cava Filter: Progress Report”, Radiology, Sep. 1988,168:745-749.
Roehm Jr., John O. F., “The Bird's Nest Filter: A New Percutaneous Transcatheter Inferior Vena Cava Filter”, Journal of Vascular Surgery, Oct. 1984, vol. 1, No. 3.
Rogers, F. B. et al., “Five-Year Follow-Up of Prophylactic Vena Cava Filters in High-Risk Trauma Patients”, Archives of Surgery, Apr. 1998, 133:406-411.
Rogers, F. B. et al., “Immediate Pulmonary Embolism After Trauma: Case Report, Journal of Trauma: Injury, Infection, and Critical Care”, vol. 48, No. 1, pp. 146-148, Jan. 2000.
Rogers, F. B. et al., “Practice Management Guidelines for the Prevention of Venous Thromboembolism in Trauma Patients: The East Practice Management Guidelines Work Group”, The Journal of Trauma: Injury, Infection, and Critical Care, Jul. 2002, 53:142-164.
Rogers, F. B. et al., “Prophylactic Vena Cava Filter Insertion in Selected High-Risk Orthopaedic Trauma Patients”, Journal of Orthopaedic Trauma, 1997, 11(4):267-272.
Rogers, F. B. et al., “Prophylactic Vena Cava Filter Insertion in Severely Injured Trauma Patients: Indications and Preliminary Results”, The Journal of Trauma, Oct. 1993, 35(4):637-642.
Rogers, F. B. et al., “Routine Prophylactic Vena Cava Filter Insertion in Severely Injured Trauma Patients Decreases the Incidence of Pulmonary Embolism”, Journal of the American College of Surgeons, Jun. 1995 180 (6):641-647.
Rogers, F. B., “Venous Thromboembolism in Trauma Patients: A Review”, Surgery, Jul. 2001, vol. 130, No. 1, pp. 1-12.
Rohrer, M. J. et al., “Extended Indications for Placement of an Inferior Vena Cava Filter”, Journal of Vascular Surgery, Jul. 1989, vol. 10. No. 1, pp. 44-50.
Rose, S. C. et al., “Placement of Inferior Vena Caval Filters in the Intensive Care Unit”, Journal of Vascular and Interventional Radiology, 1997, 8:61-64.
Dabbagh, A. et al., “Late Complication of a Greenfield Filter Associating Caudal Migration and Perforation of the Abdominal Aorta by a Ruptured Strut”, Journal of Vascular Surgery, Aug. 1995, vol. 22, No. 2, pp. 182-187.
Dake, M.D. et al., “Thrombolytic Therapy in Venous Occlusive Disease”, Journal of Vascular and Interventional Radiology, 1995, 6:73S-77S.
Dalman, R. et al., “Cerebrovascular Accident After Greenfield Filter Placement for Paradoxical Embolism”, Journal of Vascular Surgery, Mar. 1989, vol. 9, No. 3, pp. 452-454.
Danetz, J. S. et al., “Selective Venography Versus Nonselective Venography Before Vena Cava Filter Placement Evidence for More, Not Less”, Journal of Vascular Surgery, Nov. 2003, Vo. 38, No. 5, pp. 928-934.
Danikas, Dimitrios et al., “Use of a Fogarty Catheter to Open an Incompletely Expanded Vena Tech-LGM Vena Cava Filter”, Angiology, Apr. 2001, vol. 52, No. 4, pp. 283-286.
Darcy, M.D. et al., “Short-Term Prophylaxis of Pulmonary Embolism by Using a Retrievable Vena Cava Filter”, American Journal of Roentgenology, 1986, 147:836-838.
Dardik, Alan et al., “Vena Cava Filter Ensnarement and Delayed Migration: An Unusual Series of Cases”, Journal of Vascular Surgery, Nov. 1997, vol. 26, No. 5.
David, W. et al., “Pulmonary Embolus After Vena Cava Filter Placement”, The American Surgeon, Apr. 1999, vol. 65, pp. 341-346.
Davidson, B.L., “DVT Treatment in 2000: State of the Art”, Orthopedics, Jun. 2000, 23(6):pp. S651-s654.
Davison, Brian D. et al., “TrapEase Inferior Vena Cava Filter Placed via the Basilic Arm Vein: A New Antecubital Access”, J Vase Interv Radiol, Jan. 2002, 13:107-109.
De Godoy, Jose Maria Pereira et al., “In-Vitro Evaluation of a New Inferior Vena Cava Filter—The Stent-Filter”, Vascular and Endovascular Surgery, Nov. 3, 2004, vol. 38, pp. 225-228.
De Gregorio, M.A. “Inferior Vena Cava Filter Update”, Arch Bronconeumol, 2004, vol. 40, No. 5, pp. 193-195.
De Gregorio, M.A. et al., “Animal Experience in the Gunther Tulip Retrievable Inferior Vena Cava Filter”, Cardiovascular and Interventional Radiology, Nov. 2001, 24:413-417.
De Gregorio, M.A. et al., “Mechanical and Enzymatic Thrombolysis for Massive Pulmonary Embolism, Journal of Vascular and Interventional Radiology”, 2002, 13:163-169.
De Gregorio, Miguel Angel et al., “The Gunther Tulip Retrievable Filter: Prolonged Temporary Filtration by Repositioning Within the Inferior Vena Cava”, J Vase Interv Radiol, Oct. 2003, 14:1259-1265.
De Gregorio, Miguel Angel et al., “Retrievability of Uncoated Versus Paclitaxel-Coated Gunther-Tulip IVC Filters in an Animal Model”, J Vase Interv Radiol, Jul. 2004, 15:719-726.
Debing, E. et al., “Popliteal Venous Aneurysm With Pulmonary Embolism”, Journal of Cardiovascular Surgery, Oct. 1998, vol. 39, No. 5, pp. 569-572.
Decousus, H. et al., “A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients With Proximal Deep-Vein Thrombosis”, The New England Journal of Medicine, Feb. 12, 1998, vol. 338, No. 7, pp. 409-415.
DeMaria, E.J. et al., “Results of 281 Consecutive Total Laparoscopic Roux-en-Y Gastric Bypasses to Treat Morbid Obesity”, Annals of Surgery, 2002, vol. 235, No. 5 pp. 640-647.
Dennis, J.W. et al., “Efficacy of Deep Venous Thrombosis Prophylaxis in Trauma Patients and Identification of High-Risk Groups”, The Journal of Trauma, 1993, vol. 35, No. 1, pp. 132-137.
Denny, D.F. Jr., “Errant Percutaneous Greenfield Filter Placement Into the Retroperitoneum Journal of Vascular Surgery” Jun. 1991, vol. 13, No. 6.
Dewald, C.L. et al., Vena Cavography With CO2 Versus With Iodinated Contrast Material for Inferior Vena Cava Filter Placement: A Prospective Evaluation, Radiology, 2000, 216:752-757.
Dibie, A. et al., “In Vivo Evaluation of a Retrievable Vena Cava Filter—The Dibie-Musset Filter: Experimental Results”, Cardiovascular and Interventional Radiology, 1998, 21:151-157.
Dick, A. et al., “Declotting of Embolized Temporary Vena Cava Filter by Ultrasound and the Angiojet: Comparative Experimental In Vitro Studies, Investigative Radiology”, Feb. 1998, vol. 33(2), pp. 91-97.
Doherty, C., “Special Problems of Massive Obesity”, Primary Care Physician's Resource Center, file://D:\Special%20Problems%20of%20Massive%20Obesity.htm, retrieved Jul. 26, 2005.
Dotter et al., “Transluminal Expandable Nitinol Coil Stent Grafting: Preliminary Report” Radiology 147:259-260 (Apr. 1983).
Duperier, T. et al., “Acute Complications Associated With Greenfield Filter Insertion i High-Risk Trauma Patients”, The Journal of Trauma: Injury, Infection, and Critical Care, Mar. 2003, vol. 54, No. 3, pp. 545-549.
Ebaugh, James L. et al., “Bedside Vena Cava Filter Placement Guided With Intravascular Ultrasound”, Journal of Vascular Surgery, Jul. 2001,34:21-26.
Edlow, J.A., “Emergency Department Management of Pulmonary Embolism”, Emergency Medicine Clinics of North America, Nov. 2001, vol. 19, No. 4, pp. 995-1011.
Egermayer, P., “Follow-Up for Death or Recurrence Is Not a Reliable Way of Assessing the Accuracy of Diagnostic Tests for Thromboembolic Disease”, Chest 1997, 111:1410-1413.
Ekim, N. et al., “Pulmonary Thromboembolism With Massive Vaginal Bleeding Due to Thrombolytic Therapy”, Respirology, 2003, 8:246-248.
Engmann, E. et al., “Clinical Experience With the Antecubital Simon Nitinol IVC Filter”, Journal of Vascular and Interventional Radiology, 1998, 9:774-778.
EP 99951426 European Search Report dated Mar. 18, 2003.
Epstein et al., “Experience with the Amplatz Retrievable Vena Cava Filter” Radiology 175:105-110 (1989).
Fava, M. et al., “Massive Pulmonary Embolism: Percutaneous Mechanical Thrombectomy During Cardiopulmonary Resuscitation”, Journal of Vascular and Intervention Radiology, 2005, 16:119-123.
Fava, M. et al., “Massive Pulmonary Embolism: Treatment With the Hydrolyser Thrombectomy Catheter”, Journal of Vascular and Intervention Radiology, 2000, 11:1159-1164.
Feezor, R.J. et al., “Duodenal Perforation With an Inferior Vena Cava Filter: An Unusual Cause of Abdominal Pain”, Journal of Vascular Surgery, 2002, pp. 1-3.
Fernandez, A.Z. Jr. et al., “Multivariate Analysis of Risk Factors for Death Following Gastric Bypass for Treatment of Morbid Obesity”, Annals of Surgery, May 2004, vol. 239, No. 5, pp. 698-703.
Ferral, H., “Regarding “Lessons Learned From a 6-Year Clinical Experience With Superior Vena Cava Greenfield Filters””, Journal of Vascular Surgery, Apr. 2001, vol. 33, No. 4.
Ferraro, F. et al., “Thromboembolism in Pregnancy: A New Temporary Caval Filter”, Miverva Anestesiologica, 2001, vol. 67, No. 5, pp. 381-385.
Ferris, E.J. et al., “Percutaneous Inferior Vena Caval Filters: Follow-Up of Seven Designs in 320 Patients”, Radiology 1993, 188:851-856.
Fink, S. et al., “Pulmonary Embolism and Malpractice Claims”, Southern Medical Journal, Dec. 1998, vol. 91, No. 12, pp. 1149-1152.
Fobbe, Franz et al., “Gunther Vena Caval Filter: Results of Long-Term Follow-Up”, AJR, Nov. 1988, 151:1031-1034.
Foley, M. et al., “Pulmonary Embolism After Hip or Knee Replacement: Postoperative Changes on Pulmonary Scintigrams in Asymptomatic Patients”, Radiology, 1989, 172:481-485.
Fraser, J.D. et al., “Deep Venous Thrombosis: Recent Advances and Optimal Investigation With US”, Radiology, 1999, 211:9-24.
Frezza, E.E. et al., “Entrapment of a Swan Ganz Catheter in an IVC Filter Requiring Caval Exploration”, Journal of Cardiovascular Surgery, 1999, 40:905-908.
Friedell, M.L. et al., “Case Report: Migration of a Greenfield Filter to the Pulmonary Artery: Case Report”, Journal of Vascular Surgery, Jun. 1986, vol. 3, No. 6, pp. 929-931.
Friedland, M. et al., “Vena Cava Duplex Imaging Before Caval Interruption”, Journal of Vascular Surgery, Oct. 1995, vol. 24, No. 4, pp. 608-613.
Gabelmann, A. et al., “Percutaneous Retrieval of Lost of Misplaced Intravascular Objects”, American Journal of Radiology, Jun. 2001, 176:1509-1513.
Galus, Maria et al., “Indications for inferior vena cava filters,” Internal Medicine, Aug. 11, 1997; 157, 15; Health and Medical Complete, pp. 1770-1771.
Wallace, M. J., “Transatrial Stent Placement for Treatment of Inferior Vena Cava Obstruction Secondary to Extension of Intracardiac Tumor Thrombus From Hepatocellular Carcinoma”, Journal of Vascular Interventional Radiology, 2003, 14:1339-1343.
Wang, W. Y. et al., “Use of a Nitinol Gooseneck Snare to Open an Incompletely Expanded Over-the-Wire Stainless Steel Greenfield Filter”, American Journal of Roentgenology, Feb. 1999, 172:499-500.
Watanabe, N. et al., “Images in Cardiology: Large Thrombus Entrapped in a Patent Foramen Ovale of the Atrial Septum, Which Apparently “Disappeared” Without Embolic Events”, Heart, Nov. 2002, 88(5):474.
Watanabe, S. et al., “Superior Vena Caval Placement of a Temporary Filter: A Case Report”, Vascular Surgery, Jan./Feb. 2001, vol. 35, Issue 1.
Watanabe, Shun-ichi et al., “Clinical Experience With Temporary Vena Cava Filters”, Vascular Surgery, vol. 35, No. 4, 2001, pp. 285-291.
Weeks, S. M. et al., “Primary Gianturco Stent Placement for Inferior Vena Cava Abnormalities Following Liver Transplantation”, Journal of Vascular and Interventional Radiology, Feb. 2000, 11:177-187.
Welch, H. J. et al., “Duplex Assessment of Venous Reflux and Chronic Venous Insufficiency: The Significance of Deep Venous Reflux”, Journal of Vascular Surgery, 1996, 24:755-762.
Wellons, E. D. et al., “Bedside Intravascular Ultrasound-Guided Vena Cava Filter Placement”, Journal of Vascular Surgery, 2003, 38:455-458.
Wells, J. L. et al., “Diagnosing Pulmonary Embolism: A Medical Masquerader”, Clinician Reviews, 2001, 11 (2):66-79.
Westling, A. et al., “Incidence of Deep Venous Thrombosis in Patients Undergoing Obesity Surgery”, World Journal of Surgery, 2002, 26:470-473.
White, R. H. et al., “A Population-Based Study of the Effectiveness of Inferior Vena Cava Filter Use Among Patients With Venous Thromboembolism”, Archives of Internal Medicine, Jul. 10, 2000, 160(13):2033-2041.
Whitehill, T. A., “Current Vena Cava Filter Devices and Results”, Seminars in Vascular Surgery, Sep. 2000, 13 (3):204-212.
Wholey, M. et al., “Technique for Retrieval of a Guidewire Lodged in a Vena Cava Filter”, Vascular and Endovascular Surgery, 2002, 36(5):385-387.
Wiles, C. E., Letters to Editor, Journal of Trauma, Aug. 1999, 47(2):438.
Wilson, J. T. et al., “Prophylactic Vena Cava Filter Insertion in Patients With Traumatic Spinal Cord Injury: Preliminary Results”, Neurosurgery, 1994, 35:234-239.
Winchell, R. J. et al., “Risk Factors Associated With Pulmonary Embolism Despite Routine Prophylaxis: Implications for Improved Protection”, The Journal of Trauma, 1994, 37(4):600-606.
Wittenberg, G. et al., “Long-Term Results of Vena Cava Filters: Experiences With the LGM and the Titanium Greenfield Devices”, Cardiovascular and Interventional Radiology, 1998, 21:225-229.
Wittich, G. R. et al., “Anchoring a Migrating Inferior Vena Cava Stent With Use of a T-Fastener”, Journal of Vascular and Interventional Radiology, 2001, 12:994-996.
Wojcik, R. et al., “Long-Term Follow-Up of Trauma Patients With a Vena Caval Filter, The Journal of Trauma: Injury, Infection, and Critical Care”, Nov. 2000, 49(5):839-843.
Wojtowycz, M. M. et al., “The Bird's Nest Inferior Vena Caval Filter: Review of a Single-Center Experience”, Journal of Vascular and Interventional Radiology, 1997, 8:171-179.
Woodward, E. B. et al., “Delayed Retroperitoneal Arterial Hemorrhage After Inferior Vena Cava (IVC) Filter Insertion Case Report and Literature Review of Caval Perforations by IVC Filters”, Annals of Vascular Surgery, 2002, 16:193-196.
Xian, Z. Y. et al., “Multiple Emboli and Filter Function: An In Vitro Comparison of Three Vena Cava Filters”, Journal of Vascular and Interventional Radiology, 1995, 6:887-893.
Xu, X. Y. et al., “Flow Studies in Canine Artery Bifurcations Using a Numerical Simulation Method”, Journal of Biochemical Engineering, Nov. 1992, 114:504-511.
Yagi, A. et al., “Pulmonary Thromboembolism Evaluating the Indication and Effect of a Vena Caval Filter With Indium-111-Platelet Scintigraphy”, Circulation Journal, Jun. 2004, 68:599-601.
Yavuz, Kivilcim et al., “Retrievable of a Malpositioned Vena Cava Filter With Embolic Protection With Use of a Second Filter, Journal of Vascular Interventional Radiology”, 2005, 16:531-534.
Yonezawa, K. et al., “Effectiveness of an Inferior Vena Cava Filter as a Preventive Measure Against Pulmonary Thromboembolism After Abdominal Surgery”, Surgery Today, 1999, 29:821-824.
Yucel, E. Kent, “Pulmonary MR Angiography: Is It Ready Now?”, Radiology, 1999, 210:301-303.
Zamora, C. A. et al., “Prophylactic Stenting of the Inferior Vena Cava Before Transcatheter Embolization of Renal Cell Carcinomas: An Alternative to Filter Placement”, Journal of Endovascular Therapy, 2004, 11:84-88.
Zanchetta, M. et al., “A New Permanent and Retrievable Vena Cava Filter: Its Removal After Five Months”, Italian Heart Journal, Sep. 2001, 2(9):715-716.
Zeni, P. T. et al., “Use of Rheolytic Thrombectomy in Treatment of Acute Massive Pulmonary Embolism”, Journal of Vascular and Interventional Radiology, 2003, 14:1511-1515.
Zinzindohoue, F. et al., “Laparoscopic Gastric Banding: A Minimally Invasive Surgical Treatment for Morbid Obesity—Prospective Study of 500 Consecutive Patients”, Annals of Surgery, 2003, 237(1):1-9.
Zwaan et al., “Clinical Experience with Temporary Vena Cava Filters” JVIR 9:594-601 (1998).
Neri, E. et al., “Protected Iliofemoral Venous Thrombectomy in a Pregnant Woman With Pulmonary Embolism and Ischemic Venous Thrombosis”, Texas Heart Institute Journal, 2002, vol. 29, No. 2, pp. 130-132.
Neuerburg et al., “New Retrievable Percutaneous Vena Cava Filter: Experimental In Vitro and In Vivo Evaluation” Cardiovasc Intervent Radiol. 16:224-229 (1993).
Neuerburg, J.M. et al., “Percutaneous Retrieval of the Tulip Vena Cava Filter: Feasibility, Short- and long-Term Changes—An Experimental Study in Dogs”, Cardiovascular and Interventional Radiology, 2001, 24:418-423.
Neuerburg, Jorg et al., “Developments in Inferior Vena Cava Filters: A European Viewpoint”, Seminars in Interventiona Radiology, vol. 11, No. 4, Dec. 1994, pp. 349-357.
Nguyen, N. T. et al., “A Comparison Study of Laparoscopic Versus Open Gastric Bypass for Morbid Obesity”, Journal of the American College of Surgeons, Aug. 2000, vol. 191, No. 2, pp. 149-155.
Nguyen, N. T. et al., “Comparison of Pulmonary Function and Postoperative Pain After Laparoscopic Versus Open Gastric Bypass: A Randomized Trial”, Journal of American College of Surgeons, 2001, 192:469-477.
Nitnol Medical Technologies, Inc., Simon Nitinol Filter Instructions for Use, 1995.
Norwood, S. H. et al., “A Potentially Expanded Role for Enoxaparin in Preventing Venous Thromboembolism in High Risk BluntTrauma Patients”, Journal of the American College of Surgeons, 2001, 192:161-167.
Nunn, C. R. et al., “Cost-Effective Method for Bedside Insertion of Vena Caval Filters in Trauma Patients,” The Journal of Trauma, Nov. 1997, vol. 43, No. 5, pp. 752-758.
Nutting, Charles et al., “Use of a TrapEase Device as a Temporary Caval Filter”, Journal of Vascular Interventional Radiology, Aug. 2001, 12:991-993.
O'Brien, P. E. et al., “Laparoscopic Adjustable Gastric Banding in the Treatment of Morbid Obesity”, Archives of Surgery, Apr. 2003, 138(4):376-382.
O'Malley, K. F. et al., “Prevention of Pulmonary Embolism After Pelvic Fracture: Rational Use of Inferior Vena Caval Filters”, (Cooper Hospital/University Medical Center), Jan. 1996, vol. 40.
O'Sullivan, G. J. et al., “Endovascular Management of Iliac Vein Compression (May-Thurner) Syndrome”, Journal of Vascular and Interventional Radiology, 2000, 11:823-836.
Offner, P. J. et al., “The Role of Temporary Inferior Vena Cava Filters in Critically III Surgical Patients”, Archives of Surgery, Jun. 2003, vol. 138, pp. 591-595.
Olearchyk, A. S., “Insertion of the Inferior Vena Cava Filter Followed by Iliofemoral Venous Thrombectomy for Ischemic Venous Thrombosis”, Journal of Vascular Surgery, Apr. 1987, vol. 5, No. 4, pp. 645-647.
Olin, J. W., “Pulmonary Embolism”, Reviews in Cardiovascular Medicine, 2002, 3(2):S68-S75.
Oppat, W. F. et al., “Intravascular Ultrasound-Guided Vena Cava Filter Placement”, Journal of Endovascular Surgery, 1999, 6:285-287.
Omstein, D. L. et al., “Cancer, Thrombosis, and Anticoagulants”, Current Opinion in Pulmonary Medicine, 2000, 6:301-308.
Rose, S. C. et al., “Regarding “Bedside Vena Cava Filter Placement Guided With Intravascular Ultrasound””, Journal of Vascular Surgery, Apr. 2002, vol. 35, No. 4.
Rossi, G. et al., “Open to Critique: An Unusual Complication of Vena Cava Filter Placement”, Journal of Vascular Surgery, Nov. 1996, vol. 24, No. 5.
Rousseau, Herve et al., “The 6-F Nitinol TrapEase Inferior Vena Cava Filter: Results of a Prospective Multicenter Trial”, J Vase Interv Radiol, 2001,12:299-304.
Rubin, B. G. et al., “Care of Patients With Deep Venous Thrombosis in an Academic Medical Center: Limitations and Lessons”, Journal of Vascular Surgery, 1994, 20:698-704.
Ruiz, A. J. et al., “Heparin, Deep Venous Thrombosis, and Trauma Patients”, The American Journal of Surgery, Aug. 1991, 162:159-162.
Ryskamp, R. P. et al., “Utilization of Venous Thromboembolism Prophylaxis in a Medical-Surgical ICU”, Chest, Jan. 1998, 113(1):162-164.
S. Raghavan et al., “Migration of Inferior Vena Cava Filter Into Renal Hilum”, Nephron, Jun. 2002; 91, 2; Health & Medical Complete; pp. 333-335.
Salamipour et al., “Percutaneous Transfemoral Retrieval of a Partially Deployed Simon-Nitinol Filter Misplaced into the Ascending Lumbar Vein” JVIR 7:917-919 (1996).
Salamipour, H. et al., “Percutaneous Transfemoral Retrieval of a Partially Deployed Simon-Nitinol Filter Misplaced Into the Ascending Lumbar Vein”, Journal of Vascular and Interventional Radiology, 1996, 7:917-919.
Sapala, J. A. et al., “Fatal Pulmonary Embolism After Bariatric Operations for Morbid Obesity: A 24-Year Retrospective Analysis”, Obesity Surgery, 2003, 13:819-825.
Sarasin, F. P. et al., “Management and Prevention of Thromboemboli in Patients With Cancer-Related Hypercoagulable”, Journal of General Internal Medicine, Sep. 1993, 8:476-485.
Savader, Scott J., Venous Interventional Radiology with Clinical Perspectives, Chapter 28: Inferior Vena Cava Filters, pp. 367-399, Apr. 2000.
Savin, M. A. et al., “Greenfield Filter Fixation in Large Vena Cavae”, Journal of Vascular and Interventional Radiology, 1998, 9:75-80.
Savin, Michael A. et al., “Placement of Vena Cava Filters: Factors Affecting Technical Success and Immediate Complications”, AJR, Sep. 2002, Vo. 179, pp. 597-602.
Schanzer, H. et al., “Guidewire Entrapment During Deployment of the Over-the-Guidewire Stainless Steel Greenfield Filter: A Device Design-Related Complication”, Journal of Vascular Surgery, 2000, 31:607-610.
Schleich, J.-M. et al., “Long-Term Follow-up of Percutaneous Vena Cava Filters: A Prospective Study in 100 Consecutive Patients”, Eur J Vase Endovasc Surg, 2001, vol. 21, pp. 450-457.
Schultz, D. J. et al., “Incidence of Asymptomatic Pulmonary Embolism in Moderately to Severely Injured Trauma Patients”, Journal of Trauma: Injury, Infection, and Critical Care, 2004, 56:727-733.
Sequeira et al., “A Safe Technique for Introduction of the Kimray-Greenfield Filter” Radiology 133:799-800 (Dec. 1979).
Shackford, S. R. et al., “Venous Thromboembolism in Patients With Major Trauma”, The American Journal of Surgery, Apr. 1990, vol. 1 59, pp. 365-369.
Shaer, J. et al., “An Unusual Cause of Low Back Pain?: A Case Report”, Spine, Jun. 15, 1998, 23(12):1349-1350.
Shahmanesh, Maryam et al., “Inferior Vena Cava Filters for HIV Infected Patients With Pulmonary Embolism and Contraindications to Anticoagulation”, Sex Transm Inf, 2000, 76:395-397.
Sharafuddin, M. J. et al., “Endovascular Management of Venous Thrombotic and Occlusive Diseases of the Lower Extremities”, Journal of Vascular and Interventional Radiology, Apr. 2003, 14:405-423.
Sharpe, R. P. et al., “Incidence and Natural History of Below-Knee Deep Venous Thrombosis in High-Risk Trauma Patients”, The Journal of Trauma: Injury, Infection, and Critical Care, Dec. 2002, 53:1048-1052.
Sheikh, M. A. et al., “Images in Vascular Medicine”, Vascular Medicine 2001, 6:63-64.
Sheikh, M. A. et al., “Isolated Internal Jugular Vein Thrombosis: Risk Factors and Natural History”, Vascular Medicine, 2002, 7:177-179.
Shellock, F. G. et al., “MR Procedures: Biologic Effects, Safety, and Patient Care”, Radiology, 2004, 232:635-652.
Siddique, R. M. et al., “Thirty-Day Case-Fatality Rates for Pulmonary Embolism in the Elderly”, Archives of Internal Medicine, Nov. 11, 1996, 156:2343-2347.
Siegel and Robertson, “Percutaneous Tranfemoral Retrieval of a Free-Floating Titanium Greenfield Filter with an Amplatz Goose Neck Snare” JVIR 4:565-568 (1993).
Simon et al., “Transvenous Devices for the Management of Pulmonary Embolism”, Cardiovascular and Interventional Radiology, 3:308-313, 1980, pp. 112-120.
Simon Nitinol Filter Brochure, Nitinol Medical Technologies, Inc., 1995, p. 290.
Simon Nitinol Filter SNF/SL Filter Sets, C. R. Bard, Inc. PK5014851 Rev. 01, 2002 (2002).
Simon, M. et al., “Comparative Evaluation of Clinically Available Inferior Vena Cava Filters With an In Vitro Physiologic Simulation of the Vena Cava”, Radiology, 1993, 189:769-774.
Simon, M. et al., “Paddle-Wheel CT Display of Pulmonary Arteries and Other Lung Structures: A New Imaging Approach”, American Journal of Roentgenology, Jul. 2001, pp. 195-198.
Simon, M., “Vena Cava Filters: Prevalent Misconceptions”, Journal of Vascular and Interventional Radiology, 1999, 10:1021-1024.
Simon, Morris et al., “Simon Nitinol Inferior Vena Cava Filter: Initial Clinical Experience”, Radiology, vol. 172, No. 1, DO 99-103, Jul. 1989.
Simon,M. et al., “A Vena Cava Filter Using Thermal Shape Memory Alloy”, Radiology, Oct. 1977, 125:89-94.
Sing, R. F. et al., “Bedside Carbon Dioxide (CO2) Preinsertion Cavagram for Inferior Vena Cava Filter Placement Case Report”, Journal of Trauma, Dec. 1999, 47(6):1140-1142.
Sing, R. F. et al., “Bedside Carbon Dioxide Cavagrams for Inferior Vena Cava Filters: Preliminary Results”, Journal of Vascular Surgery, 2000, 32:144-147.
Sing, R. F. et al., “Bedside Insertion of Inferior Vena Cava Filters in the Intensive Care Unit”, Journal of American College of Surgeons, May 2001, 192(5):570-575.
Sing, R. F. et al., “Bedside Insertion of Inferior Vena Cava Filters in the Intensive Care Unit”, Journal of Trauma, Dec. 1999, 47(6):1104-1109.
Sing, R. F. et al., “Bedside Insertion of the Inferior Vena Cava Filter in the Intensive Care Unit”, The American Surgeon, Aug. 2003, 69:660-662.
Sing, R. F. et al., “Guidewire Incidents With Inferior Vena Cava Filters”, JAOA, Apr. 2001, 101(4):231-233.
Sing, R. F. et al., “Preliminary Results of Bedside Inferior Vena Cava Filter Placement”, Chest, Jul. 1998, 114(1):315.
Sing, R. F. et al., “Regarding Bedside Vena Cava Filter Placement Guided With Intravascular Ultrasound”, Journal of Vascular Surgery, May 2002, vol. 25, No. 5.
Sing, Ronald F., “Safety and Accuracy of Bedside Carbon Dioxide Cavography for Insertion of Inferior Vena Cava Filters in the Intensive Care Unit”, American College of Surgeons, Feb. 2, 2001, vol. 192, pp. 168-171.
Smith, T. P. et al., “Acute Pulmonary Thromboembolism-Comparison of the Diagnostic Capabilities of Convention Film-Screen and Digital Angiography”, Chest, 2002, 122:968-972.
Smith, T. P., “Pulmonary embolism: What's Wrong With This Diagnosis”, American Journal of Roentgenology, Jun. 2000, 174:1489-1498.
Spain, D. A. et al., “Venous Thromboembolism in the High-Risk Trauma Patient: Do Risks Justify Aggressive Screening and Prophylaxis?”, The Journal of Trauma: Injury, Infection, and Critical Care, 1997, vol. 42, No. 3, pp. 163-169.
Spence, Liam D. et al., “Acute Upper Extremity Deep Venous Thrombosis, Safety and Effectiveness of Superior Vena Caval Filters”, Radiology, Jan. 1999, vol. 210, DO 53-58.
Stavropoulos, S. W. et al., “In Vitro Study of Guide Wire Entrapment in Currently Available Inferior Vena Cava Filters”, Journal of Vascular and Interventional Radiology, 2003, 14:905-910.
Stecker, M. S. et al., “Evaluation of a Spiral Nitinol Temporary Inferior Vena Caval Filter”, Academic Radiology, 2001, 8:484-493.
Stein, P. D. et al., “Deep Venous Thrombosis in a General Hospital”, Chest, 2002, 122:960-962.
Stein, P. D., “Opinions Regarding the Diagnosis and Management of Venous Thromboembolic Disease”, Chest, Feb. 1998, vol. 113, No. 2, pp. 499-504.
Still, J. et al., “Experience With the Insertion of Vena Caval Filters in Acutely Burned Patients”, The American Surgeon, Mar. 2000, vol. 66, No. 3, pp. 277-279.
Stoneham G. W. et al., “Temporary Inferior Vena Cava Filters: In Vitro Comparison With Permanent IVC Filters”, Journal of Vascular and Interventional Radiology, Sep.-Oct. 1995, vol. 6, pp. 731-736.
Stosslein, F. et al., “A Rare Complication With an Antheor Vena Cava Filter”, Cardiovascular and Interventional Radiology, 1998, 21:165-167.
Stover, M. D. et al., “Prospective Comparison of Contrast-Enhanced Computed Tomography Versus Magnetic Resonance Venography in the Detection of Occult Deep Pelvic Vein Thrombosis in Patients With Pelvic and Acetabular Fractures”, Journal of Orthopaedic Trauma, 2002, 16(9):613-621.
Streib, E. W. et al., “Complications of Vascular Access Procedures in Patients With Vena Cava Filters”, The Journal of Trauma: Injury Infection, and Critical Care, Sep. 2000, vol. 49, No. 3, pp. 553-558.
Streiff, Michael B. “Vena Caval Filters: A Comprehensive Review”, Blood, Jun. 15, 2000, vol. 95, No. 12, pp. 3669-3677.
Sue, L. P. et al., “Iliofemoral Venous Injuries: An Indication for Prophylactic Caval Filter Placement”, The Journal of Trauma: Injury, Infection, and Critical Care, 1995, vol. 39, No. 4, pp. 693-695.
Sugerman, H. J. et al., “Risks and Benefits of Gastric Bypass in Morbidity Obese Patients With Severe Venous Stasis Disease”, Annals of Surgery, 2001, vol. 234, No. 1, pp. 41-46.
Sultan, S. et al., “Operative and Endovascular Management of Extracranial Vertebral Artery Aneurysm in Ehlers-Danlos Syndrome: A Clinical Dilemma”, Vascular and Endovascular Surgery, 2002, 36(5):389-392.
Taheri, S. A. et al., “Case Report: A Complication of the Greenfield Filter: Fracture and Distal Migration of Two Struts—A Case Report”, Journal of Vascular Surgery, Jul. 1992, vol. 16, No. 1, pp. 96-99.
Tai, N. R. M. et al., “Modem Management of Pulmonary Embolism”, British Journal of Surgery, 1999, 86:853-868.
Tardy, B. et al., “Older People Included in a Venous Thrombo-Embolism Clinical Trial: A Patients' Viewpoint”, Age and Ageing, 2003, 32:149-153.
Tay, Kiang-Hiong et ai, “Repeated Gunther Tulip Inferior Vena Cava Filter Repositioning to Prolong Implantation Time”, J Vase Interv Radiol, May 2002, 13:509-512.
Taylor, Frank C. et al., “Vena Tech Vena Cava Filter: Experience and Early Follow-up”, Journal of Vascular Interventional Radiology, Nov. 1991, 2:435-440.
Teitelbaum, G. P. et al., Low-Artifact Intravascular Devices: MR Imaging Evaluation, Radiology, Sep. 1988, 168:713-719.
Terhaar, Olaf Alfons et al., “Extended Interval for Retrieval of Gunther Tulip Filters”, J Vascinterv Radioi, Nov. 2004,15:1257-1262.
Thery, C. et al., “Use of a New Removable Vena Cava Filter in Order to Prevent Pulmonary Embolism in Patients Submitted to Thrombolysis”, European Heart Journal, 1990, vol. 11,334-341.
Thomas, J. H. et al., “Vena Caval Occlusion After Bird's Nest Filter Placement”, American Journal of Surgery, Dec. 1998, vol. 176, pp. 598-600.
Thomas, L. A. et al., “Use of Greenfield Filters in Pregnant Women at Risk for Pulmonary Embolism”, Southern Medical Journal, Feb. 1997, vol. 90, Issue 2.
Tillie-Leblond, I. et al., “Risk of Pulmonary Embolism After a Negative Spiral CT Angiogram in Patients With Pulmonary Disease: 1—Year Clinical Follow-Up Study”, Radiology, 2002, 223:461-467.
Tola, J. C. et al., “Bedside Placement of Inferior Vena Cava Filters in the Intensive Care Unit”, The American Surgeon, Sep. 1999, vol. 65, No. 9, pp. 833-838.
Tovey, C. et al., “Diagnosis, Investigation, and Management of Deep Vein Thrombosis”, British Medical Journal, May 31, 2003, vol. 326, i7400, p. 1180(5), 9 pages.
Trerotola, S. O. et al., “Mechanical Thrombolysis of Venous Thrombosis in an Animal Model With Use of Temporary Caval Filtration”, Journal of Vascular and Interventional Radiology, Sep. 2001, 12:1075-1085.
Trerotola, S. O. et al., “Preclinical in Vivo Testing of the Arrow-Trerotola Percutaneous Thrombolytic Device for Venous Thrombosis”, Journal of Vascular and Interventional Radiology, 2001, 12:95-103.
Trujillo-Santos,J. et al., “Bed Rest or Ambulation in the Initial Treatment of Patients With Acute Deep Vein Thrombosis or Pulmonary Embolism”, Chest, 2005, 127:1631-1636.
Tuna, I. C. et al., “Massive Pulmonary Embolus”, Texas Heart Institute Journal, 2002, vol. 29, No. 2, pp. 144-145.
Uflacker, R., “Interventional Therapy for Pulmonary Embolism”, Journal of Vascular Interventional Radiology, Feb. 2001, 12:147-164.
Urena, R. et al., “Bird's Nest Filter Migration to the Right Atrium”, American Journal of Roentgenology, Oct. 2004, 183:1037-1039.
U.S. Appl. No. 09/640,865, filed Aug. 18, 2000 Advisory Action dated Apr. 19, 2007.
U.S. Appl. No. 09/640,865, filed Aug. 18, 2000 Advisory Action dated Mar. 23, 2006.
U.S. Appl. No. 09/640,865, filed Aug. 18, 2000 Final Office Action dated Jan. 16, 2007.
U.S. Appl. No. 09/640,865, filed Aug. 18, 2000 Final Office Action dated Nov. 30, 2005.
U.S. Appl. No. 09/640,865, filed Aug. 18, 2000 Non-Final Office Action dated Apr. 7, 2005.
U.S. Appl. No. 09/640,865, filed Aug. 18, 2000 Non-Final Office Action dated Aug. 8, 2006.
U.S. Appl. No. 09/640,865, filed Aug. 18, 2000 Non-Final Office Action dated Jun. 5, 2003.
U.S. Appl. No. 10/079,155, filed Feb. 20, 2002 Final Office Action dated Jan. 20, 2006.
U.S. Appl. No. 10/079,155, filed Feb. 20, 2002 Non-Final Office Action dated Jul. 13, 2004.
U.S. Appl. No. 10/079,155, filed Feb. 20, 2002 Non-Final Office Action dated Mar. 7, 2007.
U.S. Appl. No. 10/079,155, filed Feb. 20, 2002 Non-Final Office Action dated Nov. 20, 2006.
U.S. Appl. No. 10/079,155, filed Feb. 20, 2002 Non-Final Office Action dated Sep. 11, 2006.
U.S. Appl. No. 11/150,661, filed Jun. 10, 2005 Final Office Action dated May 27, 2010.
U.S. Appl. No. 11/150,661, filed Jun. 10, 2005 Non-Final Office Action dated Jul. 22, 2011.
U.S. Appl. No. 11/150,661, filed Jun. 10, 2005 Non-Final Office Action dated Nov. 5, 2009.
U.S. Appl. No. 11/334,829, filed Jan. 19, 2006 Non-Final Office Action dated Aug. 18, 2008.
U.S. Appl. No. 11/429,975, filed May 9, 2006 Non-Final Office Action dated Oct. 7, 2010.
U.S. Appl. No. 11/429,975, filed May 9, 2006 Notice of Allowance dated Feb. 18, 2011.
U.S. Appl. No. 11/966,203, filed Dec. 28, 2007 Final Office Action dated Dec. 4, 2009.
Kinney, T. B. et al., “Regarding “Limb Asymmetry in Titanium Greenfield Filters: Clinically Significant?””, Journal of Vascular Surgery, Jun. 1998, vol. 27, No. 6.
Kinney, T.B. et al., “Does Cervical Spinal Cord Injury Induce a Higher Incidence of Complications After Prophylactic Greenfield Inferior Vena Cava Filter Usage?”, Journal of Vascular and Interventional Radiology, 1996, 7:907-915.
Kinney, T.B. et al., “Fatal Paradoxic Embolism Occurring During IVC Filter Insertion in a Patient With Chronic Pulmonary Thromboembolic Disease, Journal of Vascular and Interventional Radiology”, 2001, 12:770-772.
Kinney, T.B., “Translumbar High Inferior Vena Cava Access Placement in Patients With Thrombosed Inferior Vena Cava Filters”, Journal of Vascular and Interventional Radiology, 2003, 14:1563-1567.
Kinney, T.B., “Update on Inferior Vena Cava Filters”, Journal of Vascular and Interventional Radiology, 2003, 14:425-440.
Kistner, R. L., Definitive Diagnosis and Definitive Treatment in Chronic Venous Disease: A Concept Whose Time Has Come:, Journal of Vascular Surgery, Nov. 1996, vol. 24, No. 5, pp. 703-710.
Knudson, M. M. et al., “Prevention of Venous Thromboembolism in Trauma Patients”, The Journal of Trauma, Sep. 1994, vol. 37, No. 3, pp. 480-487.
Knudson, M. M. et al., “Thromboembolism After Trauma—An Analysis of 1602 Episodes From the American College of Surgeons National Trauma Data Bank” Annals of Surgery, Sep. 2004, vol. 240, No. 3, pp. 490-498.
Knudson, M. M. et al., Thromboembolism Following Multiple Trauma, The Journal of Trauma, Jan. 1992, vol. 32, No. 1, pp. 2-11.
Knudson, M. M. et al., “Venous Thromboembolism After Trauma”, Current Opinion in Critical Care, 2004, 10:539-548.
Koga, F. et al., “Deep Vein Thrombosis During Chemotherapy in a Patient With Advanced Testicular Cancer Successful Percutaneous Thrombectomy Under Temporary Placement of Retrievable Inferior Vena Cava Filter”, International Journal of Uroloty, 2001, 8:90-93.
Konya, A. et al., “New Embolization Coil Containing a Nitinol Wire Core: Preliminary in Vitro and in Vivo Experiences”, Journal of Vascular and Interventional Radiology, 2001, 12:869-877.
Kozak, T.K.W. et al., “Massive Pulmonary Thromboembolism After Manipulation of an Unstable Pelvic Fracture: A Case Report and Review of the Literature”, The Journal of Trauma: Injury, Infection, and Critical Care, 1995, vol. 38, pp. 366-367.
Kraimps, J. et al., “Optical Central Trapping (OPCETRA) Vena Caval Filter: Results of Experimental Studies”, Journal of Vascular and Interventional Radiolory, 1992, 3:697-701.
Kreutzer J. et al., “Healing Response to the Clamshell Device for Closure of Intracardiac Defects in Humans”, Catheterization and Cardiovascular Interventions, 2001, vol. 54.
Kronemyer, B., “Temporary Filter Traps Pulmonary Emboli,” Orthopedics Today, p. 34, 2005.
Kudsk, K. A. et al., “Silent Deep Vein Thrombosis in Immobilized Multiple Trauma Patients”, The American Journal of Surgery, Dec. 1989, vol. 158, pp. 515-519.
Kupferschmid, J.P. et al., “Case Report: Small-Bowel Obstruction From an Extruded Greenfield Filter Strut: An Unusual Late Complication”, Journal of Vascular Surgery, Jul. 1992, vol. 16, No. 1, pp. 113-115.
Kurgan, A. et al., “Case Reports: Penetration of the Wall of an Abdominal Aortic Aneurysm by a Greenfield Filter Prong: A Late Complication”, Journal of Vascular Surgery, Aug. 1993, vol. 18, No. 2, pp. 303-306.
Kuszyk, B. et al., “Subcutaneously Tethered Temporary Filter: Pathologic Effects in Swine”, Journal of Vascular and Interventional Radiology, Nov.-Dec. 1995, Vo. 6, No. 6, pp. 895-902.
Kyrle, P. A. et al., Deep Vein Thrombosis, The Lancet, Mar. 26-Apr. 1, 2005, 365(9465):1163-1174.
Langan III, E. M. et al., “Prophylactic Inferior Vena Cava Filters in Trauma Patients at High Risk: Follow-Up Examination and Risk/Benefit Assessment”, Journal of Vascular Surgery, 1999, 30:484-490.
Leach, T. A. et al., “Surgical Prophylaxis for Pulmonary Embolism”, The American Surgeon, Apr. 1994, vol. 60, No. 4, pp. 292-295.
Leask, R.L. et al., “Hemodynamic Effects of Clot Entrapment in the TrapEase Inferior Vena Cava Filter, Journal of Vascular and Interventional Radiology”, 2004, 15:485-490.
Leask, R.L. et al., “In Vitro Hemodynamic Evaluation of a Simon Nitinol Vena Cava Filter: Possible Explanation of IVC Occlusion”, Journal of Vascular and Interventional Radiology, 2001, 12:613-618.
Lemmon, G.W. et al., “Incomplete Caval Protection Following Suprarenal Caval Filter Placement”, Angiology the Journal of Vascular Diseases, Feb. 2000, vol. 51, No. 2, pp. 155-159.
Leoni, C. J. et al., “Classifying Complications of Interventional Procedures: A Survey of Practicing Radiologists”, Journal of Vascular and Interventional Radiology, 2001, 12:55-59.
Letai, A., “Cancer, Coagulation, and Anticoagulation”, The Oncologist, 1999, 4:443-449.
Lewis-Carey, M. B. et al., “Temporary IVC Filtration Before Patent Foramen Ovale Closure in a Patient With Paradoxic Embolism, Journal of Vascular and Interventional Radiology”, 2002, 13:1275-1278.
Lidagoster, M. I. et al., Superior Vena Cava Occlusion After Filter Insertion, Journal of Vascular Surgery, Jul. 1994, vol. 20, No. 1.
Lin, J. et al., “Factors Associated With Recurrent Venous Thromboembolism in Patients With Malignant Disease”, Journal of Vascular Surgery, 2003, 37:976-983.
Lin, M. et al., “Successful Retrieval of Infected Gunther Tulip IVC Filter”, Journal of Vascular and Interventional Radiology, 2000, 11:1341-1343.
Lin, P. H. et al., “The Regained Referral Ground and Clinical Practice of Vena Cava Filter Placement in Vascular Surgery”, The American Surgeon, Oct. 2002, vol. 68, No. 10, pp. 865-870.
Ortega, M. et al., “Efficacy of Anticoagulation Post-Inferior Vena Caval Filter Placement”, American Surgeon, May 1998, vol. 64, Issue 5, pp. 419-423.
Ortiz-Saracho, J. et al., “An Unusual Cause of Pulmonary Artery Thrombosis”, Chest, 1998, 114:309-310.
Owings, J. T. et al., “Timing of the Occurrence of Pulmonary Embolism in Trauma Patients”, Archives of Surgery, Aug. 1997, 132(8):862-867.
Padberg, F. T. et al., “Hemodynamic and Clinical Improvement After Superficial Vein Ablation in Primary Combined Venous Insufficiency With Ulceration”, Journal of Vascular Surgery, 1996, 24:711-718.
Pais, S. O. et al., “Percutaneous Insertion of the Greenfield Inferior Vena Cava Filter: Experience With Ninety-Six Patients”, Journal of Vascular Surgery, Oct. 1988, vol. 8. No 4.
Palastrant et al., “Comparative In Vitro Evaluation of the Nitinol Inferior Vena Cava Filter” Radiology 145:351-355 (Nov. 1982).
Palestrant, Aubrey M. et al., “Comparative In Vitro Evaluation of the Nitinollnferior Vena Cava Filter”, Radiology, Nov. 1982,145:351-355.
Participants in the Vena Caval Filter Consensus Conference, “Recommended Reporting Standards for Vena Caval Filter Placement and Patient Follow-Up”, Journal of Vascular and Interventional Radiology, 2003, 14:S427-S432.
Participants in the Vena Caval Filter Consensus Conference, “Recommended Reporting Standards for Vena Caval Filter Placement and Patient Follow-Up”, Journal of Vascular Surgery, 1999, 30:573-579.
Partsch, H. et al., “Frequency of Pulmonary Embolism in Patients Who Have Iliofemoral Deep Vein Thrombosis and Are Treated With Once- or Twice-Daily Low-Molecular Weight Heparin”, Journal of Vascular Surgery, 1996, 24:774-782.
Passman, M. A. et al., “Pulmonary Embolism is Associated With the Combination of Isolated Calf Vein Thrombosis anti Respiratory Symptoms”, Journal of Vascular Surgery, 1997, 25:39-45.
Patterson, R. B. et al., “Case Reports: Repositioning of Partially Dislodged Greenfield Filters From the Right Atrium by Use of a Tip Deflection Wire, Journal of Vascular Surgery”, Jul. 1990, vol. 12, No. 1, pp. 70-72.
Patton, J. H. Jr., et al., “Prophylactic Greenfield Filters: Acute Complications and Long-Temn Follow-Up”, The Journal of Trauma: Injury, Infection, and Critical Care, 1996, vol. 41, No. 2, pp. 231-237.
Pavcnik, Dusan et al., “Retrievable IVC Square Stent Filter: Experimental Study”, Cardiovascular Interventional Radiology, 1999,22:239-245.
PCT/US03/05385 filed Feb. 20, 2003 International Search Report dated Jun. 17, 2003.
PCT/US07/09215 filed Apr. 16, 2007 International Preliminary Report on Patentability dated Sep. 23, 2008.
PCT/US07/09215 filed Apr. 16, 2007 International Search Report dated Sep. 23, 2008.
PCT/US1999/020883 filed Sep. 23, 1999 Search Report dated Jan. 20, 2000.
PCT/US2006/017889 filed May 9, 2006 International Preliminary Report on Patentability dated Jul. 14, 2009.
PCT/US2006/017889 filed May 9, 2006 International Search Report dated Jul. 1, 2009.
PCT/US2006/017889 filed May 9, 2006 Written Opinion dated Jul. 1, 2009.
PCT/US2006/017890 filed May 9, 2006 Preliminary Report on Patentability dated Feb. 12, 2008.
PCT/US2006/017890 filed May 9, 2006 Search Report dated Nov. 2, 2006.
PCT/US2006/017890 filed May 9, 2006 Written Opinion dated Nov. 2, 2006.
PCT/US2006/044826 filed Nov. 17, 2006 International Preliminary Report on Patentability and Written Opinion dated Apr. 10, 2008.
PCT/US2006/044826 filed Nov. 17, 2006 International Search Report dated Apr. 10, 2008.
PCT/US2006/045738 filed Nov. 11, 2006 Search Report dated Oct. 9, 2007.
PCT/US2006/045738 filed Nov. 11, 2006 Written Opinion dated Oct. 9, 2007.
DCT/US2007/009186 filed Apr. 16, 2007 International Preliminary Report on Patentability and Written Opinion dated Nov. 4, 2008 and Sep. 29, 2008.
PCT/US2007/009186 filed Apr. 16, 2007 International Search Report dated Sep. 29, 2008.
PCT/US2010/043787 filed Jul. 29, 2010 Search Report dated Dec. 3, 2010.
PCT/US2010/043787 filed Jul. 29, 2010 Written Opinion dated Dec. 3, 2010.
Bovyn, G. et al., “The Tempofilter.RTM.: A Multicenter Study of a New Temporary Caval Filter Implantable for up to Six Weeks”, Annals of Vascular Surgery, 1997, 11:520-528.
Bracale, G. et al., “Spontaneous Rupture of the Iliac Vein”, The Journal of Cardiovascular Surgery, 1999, 40:871-875.
Brasel, K.J. et al., “Cost-Effective Prevention of Pulmonary Embolus in High-Risk Trauma Patients”, The Journal of Trauma: Injury, Infection, and Critical Care, Mar. 1997, vol. 42, No. 3, pp. 456-462.
Bravo, S. M. et al., “Percutaneous Venous Interventions”, Vascular Medicine, 1998, 3:61-66.
Bridges, G.G. et al., “Expedited Discharge in Trauma Patients Requiring Anticoagulation for Deep Venous Thrombosis Prophylaxis: The LEAP Program”, The Journal of Trauma: Injury, Infection and Critical Care, Feb. 2003, vol. 54, No. 2, pp. 232-235.
Brolin, R.E., “Laparoscopic Verses Open Gastric Bypass to Treat Morbid Obesity”, Annals of Surgery, Apr. 2004, vol. 239, No. 4, pp. 438-440.
Brountzos, E. N. et al., “A New Optional Vena Cava Filter: Retrieval at 12 Weeks in an Animal Model”, Journal of Vascular and Interventional Radiology, Jun. 2003, 14:763-772.
Brown, D. R. et al., “Gadolinium, Carbon Dioxide, and Iodinated Contrast Material for Planning Inferior Vena Cava Filter Placement: a Prospective Trial”, Journal of Vascular and Interventional Radiology, Aug. 2003, 14:1017-1022.
Browne, R. J. et al., “Guidewire Entrapment During Greenfield Filter Deployment, Journal of Vascular Surgery,” Jan. 1998, 27:174-176.
Bruckheimer, E. et al., “In Vitro Evaluation of a Retrievable Low-Profile Nitinol Vena Cava Filter”, Journal of Vascular and Interventional Radiology, Apr. 2003, 14:469-474.
Bucker, A. et al., “Real-Time MR Guidance for Inferior Vena Cava Filter Placement in an Animal Model”, Journal of Vascular and Interventional Radiology, Jun. 2001, 12:753-756.
Buerger, P.M. et al., “Risk of Pulmonary Emboli in Patients With Pelvic Fractures”, The American Surgeon, Aug. 1993, vol. 59, pp. 505-508.
Burbridge, B. E. et al., “Incorporation of the Gunther Temporary Inferior Vena Cava Filter Into the Caval Wall”, Journal of Vascular and Interventional Radiology, Mar.-Apr. 1996, 7:289-290.
C.R. Bard Simon Nitinol Filter: For Use in the Vena Cava: Instructions for Use (1995, 1997).
CA 2648325 filed Sep. 23, 1999 Office Action dated Apr. 26, 2011.
Cahn, M. D. et al., “Long Term Follow-up of Greenfield Inferior Vena Cava Filter Placement in Children”, Journal of Vascular Surgery, Nov. 2001, 34:820-825.
Cain Jr., J.E. et al., “The Morbidity of Heparin Therapy After Development of Pulmonary Embolus in Patients Undergoing Thoracolumbar or Lumbar Spinal Fusion”, Spine, vol. 20, No. 14, 1995, pp. 1600-1603.
Campbell, J. J. et al., “Aortic Pseudoaneurysm From Aortic Penetration With a Bird's Nest Vena Cava Filter”, Journal of Vascular Surgery, Sep. 2003, 38:596-599.
Related Publications (1)
Number Date Country
20200390536 A1 Dec 2020 US
Provisional Applications (1)
Number Date Country
60680601 May 2005 US
Continuations (5)
Number Date Country
Parent 15877159 Jan 2018 US
Child 16907816 US
Parent 15291000 Oct 2016 US
Child 15877159 US
Parent 14070873 Nov 2013 US
Child 15291000 US
Parent 13170054 Jun 2011 US
Child 14070873 US
Parent 11429975 May 2006 US
Child 13170054 US